{
    "testId": 392412680,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 67,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 34,
    "correctToIncorrect": 1,
    "incorrectToCorrect": 4,
    "incorrectToIncorrect": 2,
    "timeInSeconds": 112,
    "averageTimeSpentInSeconds": 87,
    "otherAverageTimeSpentInSeconds": 72,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 4347,
            "questionIndex": 4347,
            "questionText": "<p>A 23-year-old man comes to the emergency department due to sudden-onset fatigue and dark urine.&nbsp; The patient was recently diagnosed with dermatitis herpetiformis.&nbsp; He began treatment with dapsone and a gluten-free diet 3 days ago.&nbsp; This morning, the patient felt weak and had difficulty getting out of bed.&nbsp; His urine also appeared dark.&nbsp; Temperature is 36.8 C (98.2 F), blood pressure is 130/76 mm Hg, pulse is 88/min, and respirations are 14/min.&nbsp; The patient appears tired.&nbsp; Examination shows scleral icterus and pale lips.&nbsp; There is a papular rash along the scalp, elbows, and knees with overlying excoriation.&nbsp; Laboratory evaluation reveals the following:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp; &nbsp; Hemoglobin</td><td>8.5 g/dL</td></tr><tr><td>&nbsp; &nbsp; Reticulocytes</td><td>7%</td></tr><tr><td>&nbsp; &nbsp; Platelets</td><td>160,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Urinalysis</td></tr><tr><td>&nbsp; &nbsp; Blood</td><td>moderate</td></tr><tr><td>&nbsp; &nbsp; Red blood cells</td><td>0/hpf</td></tr></tbody></table><p>Which of the following is the most likely mechanism for this patient&#39;s urinary findings?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient developed hemolytic anemia (eg, low hemoglobin, reticulocytosis, icterus) after taking dapsone, likely indicating underlying <strong>glucose-6-phosphate dehydrogenase (G6PD) deficiency</strong>.&nbsp; In this condition, erythrocytes are unable to generate sufficient NADPH to counter <strong>oxidative injury</strong> (eg, superoxide anions) from certain medications (eg, <strong>dapsone</strong>, trimethoprim-sulfamethoxazole, primaquine), infections, or foods (eg, fava beans).&nbsp; This results in periods of <strong>hemolytic anemia</strong>, whereby lysed erythrocytes release heme into the circulation, leading to:</p><ul><li><p><strong>Hyperbilirubinemia</strong> - heme is catabolized to bilirubin, which causes scleral icterus and jaundice</p></li><li><p><strong>Hemoglobinuria</strong> &ndash; heme is excreted in the kidneys, which causes dark-colored urine and a false-positive urine dipstick for blood (the heme in hemoglobin causes a positive urine dipstick test, but no erythrocytes are seen on urine microscopy)</p></li></ul><p><strong>(Choice A)</strong>&nbsp; Antibody-mediated hemolysis is seen with warm or cold <a href=\"15379\">agglutinin disease</a>.&nbsp; Certain medications can also cause immune-mediated hemolysis, but most cases are linked to cephalosporins, penicillins, and nonsteroidal antiinflammatory drugs.&nbsp; In contrast, dapsone is classically linked with G6PD exacerbations.</p><p><strong>(Choice B)</strong>&nbsp; Complement activation contributes to hemolytic uremic syndrome, which is associated with microangiopathic hemolytic anemia, thrombocytopenia, and acute renal injury.&nbsp; Urinalysis typically shows hematuria and proteinuria.&nbsp; This patient&#39;s platelets are normal and no red blood cells are present in the urine.</p><p><strong>(Choice C)</strong>&nbsp; Immune complex deposition causes membranous glomerulonephritis, leading to hematuria with dysmorphic red cells on urinalysis.&nbsp; Most cases are caused by chronic infection (eg, hepatitis B or C), rheumatic disease (eg, systemic lupus erythematosus), or monoclonal gammopathy (eg, multiple myeloma).</p><p><strong>(Choice D)</strong>&nbsp; Interstitial leukocyte infiltration is seen in acute interstitial nephritis, which can be associated with antibiotics (eg, trimethoprim-sulfamethoxazole).&nbsp; However, urinalysis typically shows erythrocytes, leukocytes, and white cell casts.&nbsp; Furthermore, patients frequently have rash, fever, and/or peripheral eosinophilia.</p><p><strong>Educational objective:</strong><br>Glucose-6-phosphate dehydrogenase deficiency causes hemolytic anemia due to oxidative injury to red blood cells.&nbsp; Hemolytic episodes can be precipitated by infection or medications, especially dapsone, antimalarials, and nitrofurantoin.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16454,
            "topic": "G6PD deficiency",
            "titleId": 16454,
            "title": "G6PD deficiency",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoantibody production",
                    "choiceNumber": 1,
                    "correctTaken": 1968,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Complement activation",
                    "choiceNumber": 2,
                    "correctTaken": 1177,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immune complex deposition",
                    "choiceNumber": 3,
                    "correctTaken": 1901,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Interstitial leukocyte infiltration",
                    "choiceNumber": 4,
                    "correctTaken": 530,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxidative injury",
                    "choiceNumber": 5,
                    "correctTaken": 10234,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "240,468,true,-1,1*775,927,true,-1,1*1106,1176,true,-1,1*1257,1321,true,-1,1*1444,1478,true,-1,1*1609,1639,true,-1,1*1751,1872,true,-1,1*1885,1960,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 80,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 15810,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 829,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 3609,
            "questionIndex": 3609,
            "questionText": "<p>A 25-year-old African American man is admitted to the hospital due to sudden-onset back pain, dark urine, and a day of fatigue.&nbsp; Four days ago, the patient began taking trimethoprim-sulfamethoxazole for right arm cellulitis.&nbsp; Yesterday he was unable to go to work due to fatigue and weakness.&nbsp; Medical history is otherwise unremarkable.&nbsp; Physical examination shows conjunctival pallor and improving cellulitis.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>7.5 g/dL</td></tr><tr><td>Hematology</td><td height=\"15\"></td></tr><tr><td>&nbsp; &nbsp; Mean corpuscular hemoglobin concentration</td><td>32% Hb/cell</td></tr><tr><td>&nbsp; &nbsp; Haptoglobin</td><td>15 mg/dL (normal: 30-200)</td></tr><tr><td>Liver function studies</td><td height=\"15\"></td></tr><tr><td>&nbsp; &nbsp; Total bilirubin</td><td>3.5 mg/dL</td></tr><tr><td>&nbsp; &nbsp; Direct bilirubin</td><td>0.8 mg/dL</td></tr><tr><td>Lactate dehydrogenase</td><td>700 U/L</td></tr></tbody></table><p>Peripheral smear shows bite cells.&nbsp; Glucose-6-phosphate dehydrogenase activity assay is sent on admission and returns within normal limits.&nbsp; Which of the following is the most likely cause of this patient&#39;s hemolysis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34899\"><table class=\"table-default-style table-footer-only-style\" style=\"width:528px\"><tbody><tr><td colspan=\"2\" style=\"width:70.0%;\"><p align=\"center\"><strong>Glucose-6-phosphate dehydrogenase deficiency</strong></p></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Epidemiology</strong></p></td><td style=\"width:70.0%;\"><ul><li>Hemolytic anemia due to oxidative stress (infection, sulfa drugs, fava beans)</li><li>X-linked: Asian, African, or Middle Eastern descent</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Manifestations</strong></p></td><td style=\"width:70.0%;\"><ul><li>Pallor &amp; fatigue</li><li>Dark urine, jaundice &amp; icterus</li><li>Abdominal/back pain</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Laboratory<br>findings</strong></p></td><td style=\"width:70.0%;\"><ul><li>Hemolysis: &#8595; hemoglobin, &#8595; haptoglobin,<br>&#8593; bilirubin &amp; LDH, &#8593; reticulocytes</li><li>Peripheral smear: bite cells &amp; Heinz bodies</li><li>Negative Coombs test</li><li>&#8595; G6PD activity level (may be normal during attack)</li></ul></td></tr><tr><td style=\"width:30.0%\"><p align=\"center\"><strong>Management</strong></p></td><td style=\"width:70.0%\"><ul><li>Remove or treat responsible agent/condition</li><li>Provide supportive care</li></ul></td></tr><tr><td colspan=\"2\" style=\"width:70.0%;\"><p><strong>G6PD</strong> = glucose-6-phosphate dehydrogenase; <strong>LDH</strong> = lactate dehydrogenase.</p></td></tr></tbody></table></div><p>This patient developed hemolytic anemia after receiving trimethoprim-sulfamethoxazole, raising strong suspicion for <strong>glucose-6-phosphate dehydrogenase (G6PD) deficiency</strong>.&nbsp; This X-linked, inherited disorder is seen in ~10% of <strong>Black men</strong> but also occurs in those of Mediterranean, Asian, and Middle Eastern descent.&nbsp; Patients are generally asymptomatic but develop hemolysis when exposed to <strong>oxidative stressors</strong> such as infection, medications (eg, <strong>trimethoprim-sulfamethoxazole</strong>, nitrofurantoin, primaquine), or certain foods (eg, fava beans).</p><p>Hemolysis generally manifests with pallor and fatigue (due to anemia), jaundice (due to elevated bilirubin) and dark urine (due to hemoglobinuria), and back/abdominal pain.&nbsp; Laboratory results will show low hemoglobin, <strong>elevated indirect bilirubin</strong>, elevated lactate dehydrogenase, and <strong>decreased haptoglobin</strong>.&nbsp; Peripheral blood smear typically reveals Heinz bodies (oxidized/precipitated hemoglobin) and <a href=\"1013\">bite cells</a> (bite-shaped membrane defects due to removal of Heinz bodies by splenic macrophages).&nbsp; Coombs testing will be negative, unlike antibody-mediated forms of hemolysis.</p><p><strong>G6PD activity</strong> testing can be normal (<strong>low sensitivity</strong>) in acute hemolytic episodes because older erythrocytes (lowest G6PD activity) have been hemolyzed and young erythrocytes/reticulocytes (higher G6PD activity) are disproportionally elevated.&nbsp; Therefore, in such settings, this test cannot be used to rule out G6PD deficiency; repeat testing should be done at 3 months to confirm the diagnosis in those whose initial test was negative.&nbsp; No intervention is generally required other than removing or treating the inciting oxidative stress.</p><p><strong>(Choice A)</strong>&nbsp; Galactokinase deficiency does not cause hemolytic anemia.&nbsp; The classic manifestation of this condition is bilateral cataract development.</p><p><strong>(Choice C)</strong>&nbsp; Hereditary spherocytosis is a genetic disorder associated with chronic hemolytic anemia due to erythrocyte membrane defects.&nbsp; However, mean corpuscular hemoglobin concentration will be &gt;36 g/dL, and blood smear will show <a href=\"3359\">spherocytes</a>.</p><p><strong>(Choice D)</strong>&nbsp; Pyruvate kinase deficiency is an autosomal recessive disorder that causes chronic hemolysis, hepatosplenomegaly, skin ulcers, and pigmented gallstones.&nbsp; Unlike with G6PD deficiency, hemolysis is constant, so there is no relationship to inciting events (eg, sulfa drug exposure).</p><p><strong>(Choice E)</strong>&nbsp; Sickle cell crisis is associated with worsened hemolytic anemia and acute pain.&nbsp; Peripheral blood smear will show <a href=\"2699\">sickle cells</a> or Howell-Jolly bodies.</p><p><strong>Educational objective:</strong><br>Glucose-6-phosphate dehydrogenase (G6PD) deficiency causes episodic hemolytic anemia after oxidative insults (eg, sulfa drugs, primaquine, infection, fava beans).&nbsp; Laboratory studies show hemolytic anemia (eg, elevated lactate dehydrogenase/bilirubin, low haptoglobin), and peripheral blood smear typically demonstrates bite cells and Heinz bodies.&nbsp; Diagnosis is made by G6PD activity level, but sensitivity is low in acute hemolytic crises; therefore, this test cannot be relied on to rule out the condition in the acute setting.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16454,
            "topic": "G6PD deficiency",
            "titleId": 16454,
            "title": "G6PD deficiency",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Galactokinase deficiency",
                    "choiceNumber": 1,
                    "correctTaken": 234,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose-6-phosphate dehydrogenase deficiency",
                    "choiceNumber": 2,
                    "correctTaken": 9658,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hereditary spherocytosis",
                    "choiceNumber": 3,
                    "correctTaken": 865,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pyruvate kinase deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 3072,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sickle cell disease",
                    "choiceNumber": 5,
                    "correctTaken": 1955,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "176,217,true,-1,1*483,511,true,-1,1*414,439,true,-1,1*1507,1699,true,-1,1*1777,2315,true,-1,1*2611,2711,true,-1,1*3123,3165,true,-1,1*2723,3002,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16225031",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of G6PD deficiency.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16225031",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18156501",
                    "mediaDataId": 0,
                    "title": "Glucose-6-phosphate dehydrogenase deficiency: a historical perspective.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18156501",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 15785,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1100,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 18205,
            "questionIndex": 19672,
            "questionText": "<p>A 15-year-old girl is brought to the emergency department due to pain in her arms, legs, and lower back.&nbsp; The patient has sickle cell disease and in the past has been hospitalized for pain crises and pneumococcal sepsis.&nbsp; Her current symptoms began this morning, but she is out of her medications, including oxycodone, hydroxyurea, and penicillin.&nbsp; Temperature is 37.6 C (99.7 F), blood pressure is 158/88 mm Hg, pulse is 110/min, and respirations are 24/min.&nbsp; Pulse oximetry is 99% on room air.&nbsp; The patient is alert but anxious.&nbsp; Cardiac examination shows a flow murmur.&nbsp; The lungs are clear to auscultation.&nbsp; The abdomen is soft with no organomegaly.&nbsp; The legs and back are moderately tender to palpation.&nbsp; Morphine is given for pain control, and 1 hour afterward the patient is suddenly unable to move her left side.&nbsp; Examination shows 1/5 strength in the left upper and lower extremities and 5/5 strength in the right upper and lower extremities.&nbsp; Sensation is also diminished on the left side.&nbsp; Fingerstick glucose is 110 mg/dL.&nbsp; CT scan of the head shows no acute pathology.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T61509\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Stroke in sickle cell disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Ischemic stroke<ul style=\"list-style-type:circle;\"><li>Intimal hyperplasia &amp; stenosis (vasculopathy)</li><li>Adhesion of sickled red blood cells to vasculature</li></ul></li><li>Hemorrhagic stroke<ul style=\"list-style-type:circle;\"><li>Weakened cerebral vessels</li><li>Cerebral aneurysm rupture</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Focal neurologic symptoms (eg, hemiparesis)</li><li>Seizure</li><li>Altered mental status</li></ul></td></tr><tr><td><p align=\"center\"><strong>Imaging</strong></p></td><td><ul><li>MRI of the head: ischemic stroke (large vessel region or watershed area)</li><li>CT scan of the head: hemorrhagic stroke</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Exchange transfusion</li><li>Simple transfusion if exchange transfusion is unavailable</li></ul></td></tr><tr><td><p align=\"center\"><strong>Primary prevention</strong></p></td><td><ul><li>Transcranial Doppler screening during childhood</li><li>Hydroxyurea</li><li>&plusmn; Chronic transfusions</li></ul></td></tr></tbody></table></div><p>This child with <strong>sickle cell disease</strong> (SCD) has sudden-onset unilateral weakness without intracranial hemorrhage, findings concerning for an ischemic stroke.</p><p>SCD increases the risk of <strong>ischemic stroke</strong> due to intimal hyperplasia and <strong>stenosis</strong> of large arteries, as well as <strong>occlusion</strong> of vasculature by adherent, stiff, sickled red blood cells.&nbsp; Vascular and oxidative injury leads to recruitment of inflammatory cells and activation of the coagulation cascade.&nbsp; Precipitating factors may include acute drops in oxygenation or hemoglobin (often seen in <strong>pain crises</strong>).&nbsp; This patient is at increased risk of SCD complications due to not taking hydroxyurea, which decreases frequency of pain crises by increasing fetal hemoglobin.</p><p>Treatment of stroke in SCD patients is <strong>exchange transfusion</strong> (ie, slowly removing the patient&#39;s blood and replacing it with allogeneic blood), which lowers the relative percentage of sickled cells compared to healthy red blood cells.&nbsp; By decreasing RBC sickling, exchange transfusion <strong>increases the oxygen-carrying capacity</strong> of the blood and <strong>improves hyperviscosity</strong>, <strong>limiting further occlusion</strong>.&nbsp; Exchange transfusion also decreases the risk of stroke recurrence.&nbsp; Simple transfusion (ie, packed red blood cell transfusion) should be performed when exchange transfusion is not available.</p><p><strong>(Choice A)</strong>&nbsp; Antiplatelet therapy is an appropriate treatment for many non-SCD patients with ischemic stroke when stroke is due to atherosclerosis, small vessel disease, or thromboembolism.&nbsp; However, stroke in SCD patients has a different etiology (ie, alteration in cerebral hemodynamics due to sickled red blood cells); antiplatelet therapy has not been shown to improve stroke outcomes or prevent recurrent stroke in SCD, unlike exchange transfusion.</p><p><strong>(Choice B)</strong>&nbsp; Due to impaired splenic function, SCD increases the risk of life-threatening infections caused by encapsulated bacteria (eg, <em>Streptococcus pneumoniae</em>).&nbsp; However, acute neurologic deficits in an afebrile patient make infection less likely and blood cultures and antibiotics unnecessary.</p><p><strong>(Choice D)</strong>&nbsp; Intravenous heparin, which can treat deep venous thrombosis and pulmonary embolism, is not typically used in acute ischemic stroke management due to risk of intracranial hemorrhage.</p><p><strong>(Choice E)</strong>&nbsp; Naloxone reverses the effects of opioid overdose, which typically presents as a decreased level of consciousness and respiratory depression; tachypnea, present in this patient, would not be seen.&nbsp; In addition, acute, unilateral weakness is not associated with opioid overdose.</p><p><strong>Educational objective:</strong><br>Exchange transfusion is the treatment of ischemic stroke in patients with sickle cell disease.&nbsp; Replacing sickled cells with healthy red blood cells increases oxygen-carrying capacity and improves hyperviscosity, limiting further occlusion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antiplatelet therapy",
                    "choiceNumber": 1,
                    "correctTaken": 3252,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Blood culture and antibiotic therapy",
                    "choiceNumber": 2,
                    "correctTaken": 350,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exchange transfusion",
                    "choiceNumber": 3,
                    "correctTaken": 6429,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous heparin",
                    "choiceNumber": 4,
                    "correctTaken": 4357,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Naloxone",
                    "choiceNumber": 5,
                    "correctTaken": 709,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2159,2411,true,-1,1*475,553,true,-1,1*73,185,true,-1,1*1112,1214,true,-1,1*1216,1375,true,-1,1*1438,1517,true,-1,1*1837,1958,true,-1,1*352,424,true,-1,1*573,655,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "619",
                    "mediaDataId": 0,
                    "title": "Sickle cell disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "622",
                    "mediaDataId": 0,
                    "title": "Sickle cell disease complications",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25824688",
                    "mediaDataId": 0,
                    "title": "How I treat and manage strokes in sickle cell disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25824688",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29962749",
                    "mediaDataId": 0,
                    "title": "Therapeutic red cell exchange transfusion as an adjuvant therapy for management of sickle cell crisis in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29962749",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 15097,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1068,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 4448,
            "questionIndex": 4448,
            "questionText": "<p>A 55-year-old man comes to the office for an annual visit.&nbsp; Medical history includes hypertension and hypercholesterolemia, for which he takes amlodipine and atorvastatin.&nbsp; He is adherent to his medication regimen.&nbsp; The patient feels well in general, but over the past few months, he has had difficulty achieving and maintaining an erection, despite having a normal libido.&nbsp; He drinks 2 or 3 glasses of wine daily and does not smoke.&nbsp; He works for a lawn care company, frequently driving the grass cutter.&nbsp; Blood pressure is 160/100 mm Hg and pulse is 80/min.&nbsp; BMI is 45 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Cardiopulmonary examination is normal.&nbsp; The abdomen is soft and nontender.&nbsp; The liver and spleen are not palpable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">19 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td style=\"vertical-align:middle;\">57%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">240,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">5,100/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td style=\"vertical-align:middle;\">14 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr></tbody></table><p>Which of the following is most likely responsible for this patient&#39;s increased hematocrit?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T57140\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Obstructive sleep apnea</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Relaxation of pharyngeal muscles, leading to closure of airway</li><li>Loud snoring with periods of apnea</li></ul></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><ul><li>Daytime somnolence</li><li>Nonrestorative sleep with frequent awakenings</li><li>Morning headaches</li><li>Affective &amp; cognitive symptoms</li></ul></td></tr><tr><td><p align=\"center\"><strong>Sequelae</strong></p></td><td><ul><li>Systemic hypertension</li><li>Pulmonary hypertension &amp; right-sided heart failure</li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation is most consistent with <strong>obstructive sleep apnea (OSA)</strong>.&nbsp; <strong>Obesity</strong> (particularly BMI &gt;35 kg/m<font size=\"2\"><sup>2</sup></font>) is the strongest risk factor for OSA.&nbsp; Not all patients have obvious respiratory symptoms (eg, snoring, gasping for air); the sequelae of OSA (eg, <strong>erectile dysfunction</strong>, arterial <strong>hypertension</strong>) may be what prompts the initial evaluation.</p><p>In patients with OSA, recurrent collapse of the pharynx during sleep results in transient airway obstruction.&nbsp; This causes short periods (20-40 seconds) of apnea or hypopnea, which reduce blood oxygen levels.&nbsp; The kidneys respond to the hypoxemia by <strong>increasing erythropoietin</strong>, which stimulates the bone marrow to differentiate more red blood cells (RBCs).&nbsp; Therefore, it is quite common for patients with OSA to have <strong>elevated hematocrit</strong> levels (polycythemia).</p><p>The terms polycythemia and erythrocytosis are often used interchangeably.&nbsp; Polycythemia is a laboratory finding of elevated RBC count and hematocrit.&nbsp; Relative polycythemia is generally due to reduced plasma volume, whereas absolute polycythemia (ie, erythrocytosis) is due to increased RBC mass and can be primary (eg, polycythemia vera) or secondary (eg, due to chronic hypoxia or erythropoietin-producing tumors).</p><p><strong>(Choice A)</strong>&nbsp; Carbon monoxide (CO) poisoning increases carboxyhemoglobin levels, shifting the oxygen dissociation curve to the left and resulting in tissue hypoxia.&nbsp; The kidneys respond by increasing erythropoietin, which may cause erythrocytosis.&nbsp; However, patients with CO poisoning typically have dizziness, headaches, nausea, and confusion.&nbsp; This patient has obesity, hypertension, and erectile dysfunction, making OSA far more likely.</p><p><strong>(Choice B)</strong>&nbsp; The clonal proliferation of myeloid cells can cause erythrocytosis in polycythemia vera.&nbsp; Patients are often asymptomatic, but signs of increased blood viscosity (eg, transient neurologic symptoms, thrombosis), aquagenic pruritus, and gout are common.</p><p><strong>(Choice D)</strong>&nbsp; Significant plasma volume contraction causes relative polycythemia because RBCs are concentrated due to lower intravascular volume.&nbsp; This patient&#39;s normal blood urea nitrogen and creatinine levels make significant volume contraction very unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Testosterone deficiency can result in erectile dysfunction.&nbsp; However, erythrocytosis can be caused by testosterone excess (eg, androgen use) rather than testosterone deficiency.&nbsp; OSA is an independent risk factor for erectile dysfunction, and treatment with continuous positive airway pressure may improve sexual function.&nbsp; Notably, testosterone supplementation (even to normal levels) can worsen OSA.</p><p><strong>Educational objective:</strong><br>Obstructive sleep apnea (OSA) can present without symptoms of snoring or witnessed apneic events.&nbsp; OSA causes transient periods of hypoxemia.&nbsp; The kidneys respond by increasing erythropoietin, which can result in erythrocytosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8026,
            "topic": "Obstructive sleep apnea",
            "titleId": 8026,
            "title": "Obstructive sleep apnea",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Carboxyhemoglobinemia",
                    "choiceNumber": 1,
                    "correctTaken": 4026,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clonal proliferation of myeloid cells",
                    "choiceNumber": 2,
                    "correctTaken": 1451,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased erythropoietin production",
                    "choiceNumber": 3,
                    "correctTaken": 10065,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma volume contraction",
                    "choiceNumber": 4,
                    "correctTaken": 1673,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Testosterone deficiency",
                    "choiceNumber": 5,
                    "correctTaken": 840,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2912,2982,true,-1,1*2758,2905,true,-1,1*2454,2568,true,-1,1*2056,2308,true,-1,1*845,938,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31715462",
                    "mediaDataId": 0,
                    "title": "The effect of CPAP and PDE5i on erectile function in men with obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31715462",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 59,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 18055,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 619,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 3200,
            "questionIndex": 3200,
            "questionText": "<p>A 1-year-old boy is brought to the emergency department for evaluation of a nosebleed that has been difficult to control.&nbsp; Since last week, the patient has had bouts of epistaxis that occurred with minimal trauma.&nbsp; His parents were previously able to control the bleeding episodes by pinching the nose and using ice, but this has not stopped the bleeding today.&nbsp; Temperature is 37.2 C (99 F) and pulse is 160/min.&nbsp; Examination shows an alert child who is well developed, anicteric, and pale.&nbsp; Examination of the nares shows slow, steady blood flow from the left anterior nasal septum.&nbsp; Cardiac examination reveals tachycardia.&nbsp; The abdomen is soft, nontender, and without hepatosplenomegaly.&nbsp; The skin has multiple ecchymoses over the left shoulder and bilateral lower extremities and many petechiae in the groin.&nbsp; Laboratory studies are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>7.9 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>22,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>2,100/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\"></td></tr><tr><td>Coagulation studies</td><td></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;PT</td><td>14 sec</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Activated PTT</td><td>34 sec</td></tr></tbody></table><p>Peripheral smear reveals morphologically normal-appearing leukocytes, erythrocytes, and platelets.&nbsp; Which of the following is the most likely cause of this patient&#39;s bleeding?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42378\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Aplastic anemia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Multipotent hematopoietic stem cells are destroyed by cytotoxic T&nbsp;cells or direct cytotoxic injury&nbsp;&rarr; bone marrow aplasia/hypoplasia&nbsp;&rarr; lack of circulating peripheral blood cells</li></ul></td></tr><tr><td><p align=\"center\"><strong>Common triggers</strong></p></td><td><ul><li>Autoimmune</li><li>Drugs: cytotoxic chemotherapy, immunosuppressants, idiosyncratic reactions</li><li>Ionizing radiation &amp; toxins</li><li>Viral infections (eg,&nbsp;viral hepatitis, HIV)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Anemia (eg,&nbsp;fatigue, weakness, pallor)</li><li>Thrombocytopenia (eg,&nbsp;bleeding, bruising)</li><li>Leukopenia (eg,&nbsp;recurrent infections)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Bone marrow biopsy: hypocellular marrow with abundance of stromal &amp; fat cells</li></ul></td></tr></tbody></table></div><p>Spontaneous epistaxis, petechiae, and scattered ecchymosis often indicate an underlying coagulation disorder or platelet deficiency.&nbsp; Because this patient&#39;s coagulation studies (PT/PTT) are normal, a coagulation disorder is unlikely; however, the presence of pancytopenia and diminished, morphologically normal cells on peripheral blood smear strongly suggests <strong>aplastic anemia</strong>.</p><p>Aplastic anemia is a form of <strong>acquired bone marrow failure</strong> typically caused by direct toxic injury or cytotoxic T-cell destruction of multipotent hematologic stem cells.&nbsp; This <strong>reduces production</strong> of the precursor cells (eg, <strong>megakaryocytes</strong>) that generate all blood cell lines.&nbsp; Although most pediatric cases have no discernable cause (idiopathic), a minority are triggered by viruses (eg, hepatitis, parvovirus), medications, or radiation exposure.</p><p>Patients generally present with symptoms of anemia (eg, fatigue, dyspnea), thrombocytopenia (eg, bruising, bleeding, petechiae), or leukopenia (eg, infection).&nbsp; Examination will show <strong>no hepatosplenomegaly</strong> because significant extramedullary hematopoiesis does not occur (stem cells are damaged and cannot effectively produce cells in any organ).&nbsp; Laboratory results will reveal <strong>pancytopenia</strong> with impaired reticulocyte response and <strong>diminished, morphologically normal blood cells </strong>on peripheral smear.&nbsp; Definitive diagnosis is made with <strong>bone marrow biopsy</strong>, which usually shows <strong>profound hypocellularity</strong> and <strong>fatty infiltration</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Conversion of fibrinogen to fibrin is the last step in the final common pathway of the <a href=\"466\">coagulation cascade</a>.&nbsp; PT/PTT would be prolonged and platelet level would be normal.</p><p><strong>(Choice B)</strong>&nbsp; Immune thrombocytopenia is associated with the formation of autoantibodies against platelet glycoproteins, which leads to thrombocytopenia due to platelet destruction by macrophages in the spleen.&nbsp; However, the other cell lines (ie, leukocytes, erythrocytes) are typically unaffected.</p><p><strong>(Choice D)</strong>&nbsp; Because many coagulation factors are produced in the liver, severe liver disease (eg, cirrhosis) can cause bleeding from coagulation factor deficiency.&nbsp; Although thrombocytopenia can also be seen due to congestive splenomegaly, PT and PTT are generally prolonged.</p><p><strong>(Choice E)</strong>&nbsp; Microvascular thrombosis can be seen with thrombotic microangiopathy.&nbsp; Although this can cause thrombocytopenia due to platelet consumption and anemia due to red blood cell shearing, patients would have schistocytes on peripheral blood smear.</p><p><strong>(Choice F)</strong>&nbsp; Von Willebrand factor deficiency is the most common inherited coagulation disorder.&nbsp; Although most patients are asymptomatic, a minority have bleeding and bruising due to an impaired ability of platelets to bind to damaged endothelium.&nbsp; However, platelet count is normal.</p><p><strong>Educational objective:</strong><br>Aplastic anemia is a form of bone marrow failure marked by decreased production of all cell lines (ie, platelets, erythrocytes, leukocytes) and morphologically normal cells on peripheral smear.&nbsp; It is caused by direct toxic injury or cytotoxic T-cell destruction of multipotent hematopoietic stem cells, which reduces the precursors (eg, megakaryocytes) that generate all blood cell lines.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3251,
            "topic": "Aplastic anemia",
            "titleId": 3251,
            "title": "Aplastic anemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acquired fibrinogen dysfunction",
                    "choiceNumber": 1,
                    "correctTaken": 532,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Circulating thrombocyte removal by macrophages",
                    "choiceNumber": 2,
                    "correctTaken": 1630,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased megakaryocyte production",
                    "choiceNumber": 3,
                    "correctTaken": 9487,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diminished liver coagulation factor synthesis",
                    "choiceNumber": 4,
                    "correctTaken": 558,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Microvascular thrombosis with erythrocyte lysis",
                    "choiceNumber": 5,
                    "correctTaken": 1564,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduction in protein involved in platelet adhesion and aggregation",
                    "choiceNumber": 6,
                    "correctTaken": 2646,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2629,2652,true,-1,1*2798,2833,true,-1,1*59,157,true,-1,1*573,631,true,-1,1*252,262,true,-1,1*387,409,true,-1,1*293,337,true,-1,1*1369,1455,true,-1,1*1660,1799,true,-1,1*1851,1881,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24237973",
                    "mediaDataId": 0,
                    "title": "Acquired aplastic anemia in children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24237973",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29143887",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of aplastic anemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29143887",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 122,
            "othersAvgTimeSpent": 92,
            "notes": null,
            "peopleTaken": 16417,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1170,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 14855,
            "questionIndex": 16278,
            "questionText": "<p>A 24-year-old Indian man comes to the emergency department due to 3 days of left upper quadrant abdominal pain.&nbsp; The pain began after he flew back&nbsp;from India, where he was visiting family.&nbsp; He has had no fever, palpitations, nausea, vomiting, or diarrhea.&nbsp; He does not use tobacco or alcohol regularly, but on the flight back to the United States, he had some alcohol to help him sleep.&nbsp; He has no chronic medical conditions and takes no medications.&nbsp; Temperature is 37.3 C (99.1 F), blood pressure is 120/80 mm Hg, pulse is 96/min, and respirations are 16/min.&nbsp; Pulse oximetry is 97% on room air.&nbsp; Mucous membranes are moist, and there is no jugular venous distension or palpable lymphadenopathy.&nbsp; Cardiopulmonary auscultation is normal.&nbsp; Abdominal examination reveals left upper quadrant tenderness with no rigidity or rebound guarding.&nbsp; Bowel sounds are present, and there is no hepatosplenomegaly.&nbsp; There is no lower extremity edema or skin rashes.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">14.1 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Reticulocytes</td><td style=\"vertical-align:middle;\">2.5%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">220,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">10,400/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Indirect bilirubin&nbsp;</td><td style=\"vertical-align:middle;\">1.7 mg/dL</td></tr></tbody></table><p>Abdominal ultrasound shows normal liver size, but the spleen is slightly enlarged with a hypoechoic wedge consistent with an infarction.&nbsp; Which of the following would be most helpful in determining the underlying cause of his current condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient underwent a long plane flight and developed a <strong>splenic infarction</strong>, an uncommon condition that usually arises in the setting of acute splenic artery (or subbranch) occlusion; possible underlying etiologies include a hypercoagulable state, embolic disease, or hemoglobinopathy.&nbsp; In this patient, a mild hemoglobinopathy such as&nbsp;<strong>sickle cell trait</strong>&nbsp;is most likely given&nbsp;the mild intravascular hemolysis (eg, elevated reticulocyte count, indirect hyperbilirubinemia), normal hemoglobin level, and negative past medical history for pain crises (making sickle&nbsp;cell disease unlikely).</p><p>Sickle hemoglobin mutations are often linked to Sub-Saharan Africa but are also common in other regions that have a high burden of malaria, including Central/South America, the Caribbean, the Middle East, the Mediterranean, and <strong>India</strong>.&nbsp; Most patients with sickle cell trait (eg, one altered beta-hemoglobin chain) are asymptomatic and considered benign carriers; however, certain stressors, such as <strong>flying at high altitude</strong> or dehydration due to <strong>alcohol consumption</strong>, can sometimes lead to intravascular hemolysis, tissue ischemia (eg, splenic infarction), and/or vasoocclusive pain.&nbsp; <strong>Hemoglobin electrophoresis</strong> is diagnostic.</p><p><strong>(Choice A)</strong>&nbsp; 24-hour ECG monitoring can diagnose atrial fibrillation, which can cause splenic infarction due to atrial thromboembolism.&nbsp; However, atrial fibrillation would be unusual in a 24-year-old and does not typically cause reticulocytosis or bilirubinemia.</p><p><strong>(Choice B)</strong>&nbsp; Blood cultures can diagnose infective endocarditis, which can cause splenic infarction due to septic thromboembolism.&nbsp; However, most patients are ill (eg, fever, chills, anorexia, weight loss) and cardiac murmur is usually present on examination.</p><p><strong>(Choice C)</strong>&nbsp; Bone marrow biopsy can diagnose hematopoietic malignancies such as myelofibrosis, which may cause splenic infarction due to venous occlusion from congestive splenomegaly.&nbsp; However, myelofibrosis typically presents in older adults&nbsp;and causes splenomegaly (a hallmark feature not seen in this patient).</p><p><strong>(Choice D)</strong>&nbsp; Factor V Leiden mutation is a common cause of thrombosis in middle-aged adults and typically causes venous thromboembolism, which can occasionally lead to splenic infarction.&nbsp; However, signs of intravascular hemolysis are not typically present.</p><p><strong>Educational objective:</strong><br>Splenic infarction usually occurs in the setting of splenic artery (or subbranch) occlusion due to hypercoagulable states, embolic disease, or hemoglobinopathy (eg, sickle cell disease or trait).&nbsp; Although patients with sickle cell trait are generally asymptomatic, they occasionally develop splenic infarction and intravascular hemolysis in the setting of certain stressors such as air travel or dehydration.&nbsp; Diagnosis of most hemoglobinopathies is made by hemoglobin electrophoresis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour ECG monitoring",
                    "choiceNumber": 1,
                    "correctTaken": 848,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bacterial blood cultures",
                    "choiceNumber": 2,
                    "correctTaken": 2383,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 1331,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Factor V Leiden mutation testing",
                    "choiceNumber": 4,
                    "correctTaken": 3820,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin electrophoresis",
                    "choiceNumber": 5,
                    "correctTaken": 11907,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "618,852,true,-1,1*1841,1947,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 57,
            "othersAvgTimeSpent": 87,
            "notes": null,
            "peopleTaken": 20289,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 791,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 14232,
            "questionIndex": 15640,
            "questionText": "<p>A 4-year-old girl is brought to the office by her father due to a day of dysuria and lower abdominal pain.&nbsp; The girl has been toilet-trained for a year but had an episode of urinary incontinence last night.&nbsp; The patient was hospitalized at age 2 for fatigue secondary to hemolytic anemia.&nbsp; Workup ultimately revealed a low glucose-6-phosphate dehydrogenase level at baseline.&nbsp; She has had no hematologic complications since then.&nbsp; Physical examination shows mild suprapubic tenderness but no costovertebral angle tenderness.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Urinalysis</td></tr><tr><td>&nbsp; &nbsp; Leukocyte esterase</td><td>positive</td></tr><tr><td>&nbsp; &nbsp; Nitrites</td><td>positive</td></tr><tr><td>&nbsp; &nbsp; Bacteria</td><td>many</td></tr></tbody></table><p>Which of the following antibiotics should be avoided in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t46010\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Medications that often trigger hemolysis in G6PD deficiency*</strong></p></td></tr><tr><td><p align=\"center\"><strong>Avoid</strong></p></td><td><p>Diaminodiphenyl sulfone (dapsone)</p><p>Isobutyl nitrite</p><p>Nitrofurantoin</p><p>Rasburicase</p><p>Primaquine</p></td></tr><tr><td><p align=\"center\"><strong>Use with caution</strong></p></td><td><p>Acetaminophen</p><p>Acetylsalicylic acid (aspirin)</p><p>Chloramphenicol</p><p>Chloroquine</p><p>Colchicine</p><p>Diphenhydramine (Benadryl)</p><p>Glyburide</p><p>Isoniazid</p><p>L-Dopa</p><p>Quinine</p><p>Sulfamethoxazole</p><p>Trimethoprim</p><p>Vitamin K</p></td></tr><tr><td colspan=\"2\"><p>*This list, although&nbsp;not exhaustive,&nbsp;includes medications commonly used in the clinical setting.</p><p><strong>G6PD</strong> = glucose-6-phosphate dehydrogenase.</p></td></tr></tbody></table></div><p>This patient&#39;s dysuria, lower abdominal pain, urinary incontinence, and urinalysis findings suggest a urinary tract infection, for which antibiotic therapy is indicated.&nbsp; However, she likely has <strong>glucose-6-phosphate dehydrogenase (G6PD) deficiency</strong> given her prior hospitalization for&nbsp;<strong>hemolytic anemia</strong>&nbsp;with low baseline G6PD levels.&nbsp; G6PD deficiency is an inherited disorder associated with episodes of hemolysis during oxidative stress.&nbsp; In these patients, oxidative medications such as <strong>nitrofurantoin</strong> are particularly likely to trigger hemolysis and must be <strong>avoided</strong>.&nbsp; Other common oxidative triggers include infections (leukocytes release highly oxidative reactive oxygen metabolites) and fava beans (metabolized into highly oxidative compounds).</p><p>G6PD deficiency is X-linked and primarily affects male patients.&nbsp; However, female patients who have homozygous mutations or skewed lyonization of heterozygous mutations (overexpression of erythrocytes with the mutated X-chromosome) can also express the disorder.</p><p><strong>(Choices A, B, C, and D)</strong>&nbsp; Penicillin-class medications (eg, amoxicillin)&nbsp;and cephalosporins (eg, cefixime, cefpodoxime, cephalexin) are generally safe to use in patients with G6PD deficiency.</p><p><strong>Educational objective:</strong><br>Glucose-6-phosphate dehydrogenase deficiency is an X-linked disorder associated with episodes of hemolytic anemia during oxidative stress.&nbsp; In order to prevent hemolysis, oxidative medications such as nitrofurantoin should be avoided.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16454,
            "topic": "G6PD deficiency",
            "titleId": 16454,
            "title": "G6PD deficiency",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amoxicillin-clavulanate",
                    "choiceNumber": 1,
                    "correctTaken": 1911,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cefixime",
                    "choiceNumber": 2,
                    "correctTaken": 485,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cefpodoxime",
                    "choiceNumber": 3,
                    "correctTaken": 291,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cephalexin",
                    "choiceNumber": 4,
                    "correctTaken": 871,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nitrofurantoin",
                    "choiceNumber": 5,
                    "correctTaken": 12921,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26417175",
                    "mediaDataId": 0,
                    "title": "Caring for glucose-6-phosphate dehydrogenase (G6PD)-deficient patients: implications for pharmacy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26417175",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 64,
            "othersAvgTimeSpent": 42,
            "notes": null,
            "peopleTaken": 16479,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 19,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 3062,
            "questionIndex": 3062,
            "questionText": "<p>A 20-year-old man from northern Europe comes to the emergency department with a 2-month history of intermittent right upper quadrant pain.&nbsp; The patient&#39;s medical history is unremarkable, and he considers himself healthy.&nbsp; His mother had her gallbladder removed at a young age.&nbsp; Abdominal ultrasound reveals cholelithiasis.&nbsp; Laboratory results show a hemoglobin level of 10.2 g/dL.&nbsp; Peripheral blood smear is shown in the image below.</p><p><img  draggable=\"false\" id=\"21397\" src=\"https://www.uworld.com/media/U22871.png\"  ></p><p>This patient most likely has which of the following additional laboratory findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40923\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hereditary spherocytosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Usually autosomal dominant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Hemolytic anemia</li><li>Jaundice</li><li>Splenomegaly</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&#8593; MCHC</li><li>Negative Coombs test</li><li>Spherocytes on peripheral smear</li><li>&#8593; Osmotic fragility on acidified glycerol lysis test</li><li>Abnormal eosin-5-maleimide binding test</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Folic acid supplementation</li><li>Blood transfusion</li><li>Splenectomy</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MCHC</strong> = mean corpuscular hemoglobin concentration.</p></td></tr></tbody></table></div><p>This patient is anemic and has spherocytes (small, round, hyperchromic red blood cells [RBCs] without central pallor) on <a href=\"21398\">peripheral smear</a>, which are indicative of <strong>hereditary spherocytosis</strong> (HS).&nbsp; HS is usually an <strong>autosomal dominant</strong> disorder and is most common in northern Europeans.&nbsp; A defect in RBC membrane proteins (eg, spectrin, ankyrin) results in spherocytes that are less deformable than normal biconcave RBCs and are more prone to splenic sequestration.</p><p>Depending on the extent of hemolysis, patients can have the classic triad of <strong>hemolytic anemia</strong>, jaundice, and splenomegaly (generally seen with severe hemolysis).&nbsp; <strong>Pigment gallstones</strong> can develop from excess bilirubin and cause right upper quadrant pain, as seen in this patient.&nbsp; Laboratory studies usually show <strong>elevated mean corpuscular hemoglobin concentration</strong> due to membrane loss and RBC dehydration.&nbsp; Other findings include <strong>reticulocytosis</strong>, normal to elevated red cell distribution width due to various RBC forms (eg, reticulocytes, spherocytes, normal RBCs), and low to normal mean corpuscular volume <strong>(Choice D)</strong>.</p><p>Diagnosis is clinical but can be confirmed with specific tests (eg, osmotic fragility test, eosin-5-maleimide binding test).&nbsp; Treatment is generally supportive (eg, folic acid, transfusions for severe anemia); in severe cases,&nbsp;<strong>splenectomy</strong> may be considered to improve anemia and reduce gallstone risk.</p><p><strong>(Choice A)</strong>&nbsp; The CD55 molecule helps protect cells from complement-mediated destruction, and its absence leads to the hemolytic anemia seen in paroxysmal nocturnal hemoglobinuria.&nbsp; This condition typically presents with red urine and normal RBC morphology on blood smear.</p><p><strong>(Choice B)</strong>&nbsp; Hemoglobin A2 levels are increased in patients with beta thalassemia trait.&nbsp; Hemoglobin F levels are increased in patients with sickle cell anemia, beta thalassemia, congenital aplastic anemia, and hereditary persistence of fetal hemoglobin.&nbsp; These conditions do not cause spherocytes on peripheral smear.</p><p><strong>(Choice E)</strong>&nbsp; Iron deficiency anemia presents with low serum iron, low serum ferritin, and peripheral smear showing <a href=\"665\">microcytic and hypochromic RBCs</a>.</p><p><strong>Educational objective:</strong><br>Hereditary spherocytosis is usually an autosomal dominant disorder characterized by hemolytic anemia, jaundice, splenomegaly, and spherocytes on peripheral blood smear.&nbsp; Mean corpuscular hemoglobin concentration is elevated due to red blood cell dehydration and membrane loss.&nbsp; Pigment gallstones are a common complication.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7183,
            "topic": "Hereditary spherocytosis",
            "titleId": 7183,
            "title": "Hereditary spherocytosis",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Absence of CD55 in red blood cell membranes",
                    "choiceNumber": 1,
                    "correctTaken": 2455,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High hemoglobin A2 and hemoglobin F levels",
                    "choiceNumber": 2,
                    "correctTaken": 940,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High mean corpuscular hemoglobin concentration",
                    "choiceNumber": 3,
                    "correctTaken": 10747,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High mean corpuscular volume",
                    "choiceNumber": 4,
                    "correctTaken": 960,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low serum iron and ferritin levels",
                    "choiceNumber": 5,
                    "correctTaken": 730,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "236,328,true,-1,1*183,203,true,-1,1*728,906,true,-1,1*1217,1310,true,-1,1*2108,2350,true,-1,1*1525,1826,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22055020",
                    "mediaDataId": 0,
                    "title": "Guidelines for the diagnosis and management of hereditary spherocytosis2011 update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22055020",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 15832,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1357,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 4081,
            "questionIndex": 4081,
            "questionText": "<p>A 62-year-old man comes to the office due to several months of fatigue.&nbsp; The patient has no chest pain, vomiting, diarrhea, weight loss, or back pain.&nbsp; Review of systems is significant for occasional leg cramps.&nbsp; He takes lisinopril for hypertension and atorvastatin for hyperlipidemia.&nbsp; The patient no longer smokes cigarettes but has a 30-pack-year history.&nbsp; He does not consume alcohol.&nbsp; Blood pressure is 132/80 mm Hg and pulse is 95/min.&nbsp; Conjunctiva are pale.&nbsp; Cardiopulmonary auscultation reveals clear lungs and a soft 2/6 ejection murmur at the right upper sternal border.&nbsp; The abdomen is soft and nontender without palpable masses.&nbsp; There are no skin rashes or peripheral edema.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>7.7 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td>72 fL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>180,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>8,200/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>12 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.8 mg/dL</td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Blood, plasma, and serum</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Ferritin, serum</td><td>7 ng/mL</td></tr></tbody></table><p>Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has clinical findings (fatigue, pallor, ejection murmur) consistent with <strong>anemia</strong> and laboratory evidence (low mean corpuscular volume and ferritin) of <strong>iron deficiency</strong>.</p><p>Iron is derived from dietary sources (eg, animal meat) and is mostly absorbed in the duodenum.&nbsp; Body iron is distributed to red blood cells (hemoglobin), other iron-containing proteins (eg, myoglobin), and ferritin/hemosiderin in the reticuloendothelial system.&nbsp; In developed countries, iron deficiency rarely stems from dietary or absorption inadequacies.&nbsp; Most cases are due to overt or occult <strong>blood loss</strong>.</p><p>History and physical examination can often identify an overt source of bleeding (eg, menorrhagia); otherwise, referral to a gastroenterologist for <strong>endoscopic evaluation</strong> (eg, colonoscopy, esophagogastroduodenoscopy) is usually required (particularly in those age &gt;50) as patients may have gastritis, telangiectasia, or <strong>malignancy</strong> (eg, colon cancer).</p><p><strong>(Choice A)</strong>&nbsp; Although bone marrow biopsy is considered the gold standard for assessing iron stores, less invasive testing (eg, ferritin) has largely supplanted this diagnostic modality.&nbsp; Bone marrow biopsy is used primarily to evaluate for hematologic malignancies (eg, myelodysplastic syndrome) and stem cell abnormalities (eg, aplastic anemia).</p><p><strong>(Choice B)</strong>&nbsp; Atorvastatin may cause hepatotoxicity and myopathy but is not associated with iron deficiency anemia.</p><p><strong>(Choice D)</strong>&nbsp; C-reactive protein is usually elevated in infection or inflammatory conditions.&nbsp; Patients with these illnesses often have anemia of chronic disease due to poor iron utilization and impaired erythrocytosis.&nbsp; Anemia of chronic disease is usually associated with normal or high ferritin levels.</p><p><strong>(Choice E)</strong>&nbsp; Erythropoietin (EPO) stimulates erythrocytosis.&nbsp; Low levels of EPO can be seen in many chronic diseases (eg, renal insufficiency).&nbsp; EPO is not often measured, and conditions that result in low EPO are usually associated with anemia of chronic disease (normal or high ferritin levels).</p><p><strong>(Choice F)</strong>&nbsp; Monoclonal light chains can be elevated in plasma cell disorders such as multiple myeloma.&nbsp; Although anemia is common, it is usually normocytic and normochromic (not microcytic).</p><p><strong>Educational objective:</strong><br>Gastrointestinal blood loss is the most common occult cause of iron deficiency anemia, especially in patients age &gt;50.&nbsp; Referral to a gastroenterologist for endoscopy is usually required.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16566,
            "topic": "Iron deficiency anemia",
            "titleId": 16566,
            "title": "Iron deficiency anemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bone marrow biopsy",
                    "choiceNumber": 1,
                    "correctTaken": 398,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinuation of atorvastatin",
                    "choiceNumber": 2,
                    "correctTaken": 578,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endoscopic evaluation",
                    "choiceNumber": 3,
                    "correctTaken": 10075,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum C-reactive protein",
                    "choiceNumber": 4,
                    "correctTaken": 758,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum erythropoietin level",
                    "choiceNumber": 5,
                    "correctTaken": 1287,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum free monoclonal light chains",
                    "choiceNumber": 6,
                    "correctTaken": 545,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "210,472,true,-1,1*763,966,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 73,
            "othersAvgTimeSpent": 90,
            "notes": null,
            "peopleTaken": 13641,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 286,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 2875,
            "questionIndex": 2875,
            "questionText": "<p>An 8-month-old boy is brought to the physician for evaluation of pale mucous membranes, irritability, and listlessness.&nbsp; The stool examination is negative for blood, ova, and parasites.&nbsp; Serum laboratory studies are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"575\"><tbody><tr><td>Hemoglobin</td><td>6&nbsp;g/L</td></tr><tr><td>Mean corpuscular hemoglobin concentration</td><td>25%</td></tr><tr><td>Mean corpuscular hemoglobin</td><td>16.5 pg</td></tr><tr><td>Mean corpuscular volume</td><td>68 fl</td></tr><tr><td>Red cell distribution width</td><td>22% (normal: 11.5-14.5%)</td></tr><tr><td>Reticulocytes</td><td>0.6%</td></tr><tr><td>Platelets</td><td>230,000/&micro;L</td></tr><tr><td>Leukocytes</td><td>5,500/&micro;L</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td>Iron</td><td>40 &micro;g/dL</td></tr><tr><td>Total iron binding capacity</td><td>460 &micro;g/dL (normal: 300-350 &micro;g/dL)</td></tr><tr><td>Transferrin saturation</td><td>8.7% (normal 15-50 %)</td></tr><tr><td>Total bilirubin</td><td>0.9 mg/dL</td></tr></tbody></table></blockquote><p>The peripheral blood smear shows marked anisocytosis, microcytosis, and hypochromia.&nbsp; Which of the following is the most likely cause of this patient&#39;s anemia?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t81835\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"6\"><p align=\"center\"><strong>Iron studies in microcytic anemia</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>MCV</strong></p></td><td><p align=\"center\"><strong>Iron</strong></p></td><td><p align=\"center\"><strong>Ferritin</strong></p></td><td><p align=\"center\"><strong>Transferrin<br />(TIBC)</strong></p></td><td><p align=\"center\"><strong>Transferrin<br />saturation<br />(iron/TIBC)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Iron deficiency</strong></p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">&uarr;</p></td><td><p align=\"center\">&darr;</p></td></tr><tr><td><p align=\"center\"><strong>Thalassemia</strong></p></td><td><p align=\"center\">&darr;&darr;</p></td><td><p align=\"center\">Normal/&uarr;</p></td><td><p align=\"center\">Normal/&uarr;</p></td><td><p align=\"center\">Normal/&darr;</p></td><td><p align=\"center\">Normal/&uarr;</p></td></tr><tr><td><p align=\"center\"><strong>Anemia of<br />chronic disease</strong><br />(inflammation)</p></td><td><p align=\"center\">Normal/&darr;</p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">Normal/&uarr;</p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">Normal/&darr;</p></td></tr><tr><td colspan=\"6\"><p><strong>MCV </strong>= mean corpuscular volume;<strong> TIBC</strong> = total iron binding capacity.</p></td></tr></tbody></table></div></p><p>This patient&#39;s history and laboratory results are most likely due to <strong>iron deficiency</strong>, the most common nutritional deficiency in infants.&nbsp; Iron deficiency is typically due to the introduction of cow, goat, or soy milk before age 1 and inadequate consumption of iron-rich foods.&nbsp; In older children and adults, the cause is usually chronic blood loss from the gastrointestinal tract.</p><p>The characteristic laboratory findings of iron deficiency anemia are shown in the table.&nbsp; Anisocytosis (red blood cells of unequal size) is often the first finding on peripheral smear, and the <strong>increased red blood cell distribution width (RDW)</strong> is a quantification of this abnormality.&nbsp; Gradually, the <strong>mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) decline</strong>, correlating with <strong>microcytosis</strong> and <strong>hypochromia</strong> on peripheral smear.&nbsp; The iron stores become depleted, resulting in a low reticulocyte count, decreased transferrin saturation (serum iron/total iron binding capacity [TIBC]), and increased TIBC.</p><p><strong>(Choices A and D)</strong>&nbsp; Thalassemia is associated with normal or elevated iron and ferritin levels due to high red blood cell turnover.&nbsp; Reticulocyte count and total bilirubin are increased as a result of hemolysis.</p><p><strong>(Choice B)</strong>&nbsp; Anemia of chronic disease is associated with decreased TIBC.&nbsp; Serum ferritin is often increased due to ongoing inflammation.</p><p><strong>(Choice C)</strong>&nbsp; Autoimmune hemolysis typically causes an increased reticulocyte count due to the bone marrow response in an attempt to compensate for red blood cell destruction.&nbsp; The breakdown of red blood cells also causes indirect hyperbilirubinemia, which is not seen in this patient.</p><p><strong>(Choices E and H)</strong>&nbsp; Folate and vitamin B<font size=\"2\"><sub>12</sub></font> deficiency cause megaloblastic anemia, which is characterized by an elevated MCV, elevated MCH, and normal mean corpuscular hemoglobin concentration.</p><p><strong>(Choice G)</strong>&nbsp; Sideroblastic anemia is characterized by increased serum iron levels and normal TIBC.</p><p><strong>Educational objective:</strong><br>The characteristic laboratory findings of iron deficiency anemia are decreased mean corpuscular volume (MCV), increased red blood cell distribution width (RDW), decreased serum iron, decreased transferrin saturation, and increased total iron binding capacity (TIBC).&nbsp; The peripheral smear will show small, hypochromic red blood cells.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16566,
            "topic": "Iron deficiency anemia",
            "titleId": 16566,
            "title": "Iron deficiency anemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alpha thalassemia",
                    "choiceNumber": 1,
                    "correctTaken": 456,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anemia of chronic disease",
                    "choiceNumber": 2,
                    "correctTaken": 292,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autoimmune hemolysis",
                    "choiceNumber": 3,
                    "correctTaken": 134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Beta thalassemia",
                    "choiceNumber": 4,
                    "correctTaken": 1046,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Folate deficiency",
                    "choiceNumber": 5,
                    "correctTaken": 20,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron deficiency",
                    "choiceNumber": 6,
                    "correctTaken": 8955,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sideroblastic anemia",
                    "choiceNumber": 7,
                    "correctTaken": 452,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin B<font size=\"2\"><sub>12</sub></font> deficiency",
                    "choiceNumber": 8,
                    "correctTaken": 10,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "492,630,true,-1,1*1374,1484,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20923825",
                    "mediaDataId": 0,
                    "title": "Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20923825",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20540485",
                    "mediaDataId": 0,
                    "title": "Evaluation of anemia in children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20540485",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 92,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 11365,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1259,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 3774,
            "questionIndex": 3774,
            "questionText": "<p>A 7-week-old boy is brought to the office for routine follow-up after being discharged from the neonatal intensive care unit (NICU).&nbsp; He was born at 32 weeks gestation, and the pregnancy was complicated only by preterm labor.&nbsp; After delivery, the patient received a short course of prophylactic antibiotics while awaiting blood culture results, which were negative for bacterial growth.&nbsp; Other than difficulty feeding, he had no other issues in the NICU.&nbsp; By age 6 weeks, the patient was taking a normal volume of fortified preterm formula and gaining weight appropriately.&nbsp; He was discharged from the hospital last week and has continued taking formula and ferrous sulfate.&nbsp; Temperature is 37.5 (99.5 F), pulse is 150/min, and respirations are 30/min.&nbsp; Pulse oximetry is 98% on room air.&nbsp; The patient is awake and alert.&nbsp; Cardiac auscultation reveals a 2/6 systolic flow murmur with no gallop.&nbsp; The abdomen is soft with no organomegaly.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>8 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Reticulocytes</td><td>1.4%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>230,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>7,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td>60%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td>33%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td>7%</td></tr></tbody></table><p>The peripheral smear shows normocytic, normochromic red blood cells.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s laboratory findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T75485\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Anemia of prematurity</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>&#8593; Oxygenation at birth &#8594; &#8595; EPO production<ul style=\"list-style-type:circle;\"><li>Impaired transition from hepatic to renal EPO*</li></ul></li><li>Exacerbating factors in premature infants:<ul style=\"list-style-type:circle;\"><li>&#8595; RBC life span</li><li>Frequent blood draws</li><li>Iron depletion</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Often asymptomatic</li><li>Tachycardia, poor weight gain, apnea, hypoxia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Normocytic, normochromic anemia</li><li>Inadequate reticulocyte response</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>RBC transfusion if severe or symptomatic</li><li>Minimize exacerbating factors (eg, iron supplementation, limit blood draws)</li></ul></td></tr><tr><td colspan=\"2\"><p>*Typically occurs in the 3rd trimester.</p><p><strong>EPO</strong> = erythropoietin; <strong>RBC</strong> = red blood cell.</p></td></tr></tbody></table></div><p>This patient has normocytic, normochromic anemia with a minimal reticulocyte response, which indicates that the bone marrow is not producing adequate red blood cells (RBCs) to compensate for the anemia.&nbsp; The most likely cause in this 7-week-old, preterm infant is <strong>anemia of prematurity</strong> (AOP).</p><p>After birth, increased oxygenation (ie, breathing, ductus closure) triggers <strong>reduced erythropoietin</strong> (EPO) production by the liver and kidney.&nbsp; Low levels of circulating EPO impair erythropoiesis in the bone marrow, which normally causes a mild, <strong>transient anemia</strong> that reaches a <a href=\"44546\">nadir</a> of around 9-11 g/dL at age 2-3 months in term infants (ie, physiologic anemia of infancy).&nbsp; Compared to term infants, <strong>preterm </strong>infants have a lower initial hematocrit at birth, a shorter erythrocyte life span, and less capacity to produce renal EPO.&nbsp; Therefore, their erythrocyte nadir tends to be <strong>more severe</strong> (eg, ~7 g/dL) and occur <strong>earlier</strong> (eg, 1-2 months), resulting in AOP.&nbsp; Frequent phlebotomy in the neonatal intensive care unit can further exacerbate the condition.</p><p>Many cases of AOP are asymptomatic.&nbsp; However, mild tachycardia is common and a flow murmur, apnea, and poor weight gain also can occur.&nbsp; Laboratory evaluation shows <strong>normocytic, normochromic anemia</strong> with normal platelets and leukocytes.&nbsp; Although the absolute reticulocyte count may be normal for age, <strong>reticulocytosis</strong> in response to anemia is <strong>absent</strong>, as seen in this patient.</p><p><strong>(Choice A)</strong>&nbsp; Anemia due to thalassemia (ie, abnormal alpha or beta globin production) causes hypochromic, microcytic RBCs and abnormal cell morphology (eg, <a href=\"2698\">target cells</a>) on peripheral smear.</p><p><strong>(Choice B)</strong>&nbsp; Hemolytic anemia (eg, antibiotic-mediated immune hemolysis) is characterized by increased intra- or extravascular RBC destruction.&nbsp; Subsequent reduced tissue oxygenation drives increased erythropoietin, leading to reticulocytosis.</p><p><strong>(Choice D)</strong>&nbsp; Iron deficiency anemia causes microcytic, hypochromic RBCs and would be less likely in the setting of fortified formula and iron supplementation.</p><p><strong>(Choice E)</strong>&nbsp; Iron sequestration in macrophages is characteristic of anemia of chronic disease, which is marked by normocytic/microcytic anemia and poor reticulocytosis.&nbsp; However, it is typically due to chronic inflammation, infection, or malignancy and usually occurs in older children and adults.&nbsp; Given the timeline of this patient&#39;s anemia and the minimal systemic symptoms, AOP is far more likely.</p><p><strong>Educational objective:</strong><br>Anemia of prematurity, the most common cause of anemia in preterm infants, results from impaired erythropoietin production.&nbsp; Patients have normocytic, normochromic anemia with minimal reticulocyte response.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 4248,
            "topic": "Preterm newborn",
            "titleId": 4248,
            "title": "Preterm newborn",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abnormal hemoglobin subunit ratio",
                    "choiceNumber": 1,
                    "correctTaken": 2351,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antibiotic-mediated immune hemolysis",
                    "choiceNumber": 2,
                    "correctTaken": 1900,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired erythropoietin production",
                    "choiceNumber": 3,
                    "correctTaken": 8402,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inadequate iron dosage",
                    "choiceNumber": 4,
                    "correctTaken": 1818,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron sequestration in macrophages",
                    "choiceNumber": 5,
                    "correctTaken": 1903,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2384,2482,true,-1,1*65,152,true,-1,1*352,416,true,-1,1*428,543,true,-1,1*197,248,true,-1,1*922,1579,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23025780",
                    "mediaDataId": 0,
                    "title": "Erythropoiesis and the approach to anemia in premature infants.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23025780",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 172,
            "othersAvgTimeSpent": 97,
            "notes": null,
            "peopleTaken": 16374,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1976,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 2884,
            "questionIndex": 2884,
            "questionText": "<p>A 51-year-old man comes to the office due to frequent itching, especially after bathing.&nbsp; He otherwise feels well except for occasional headaches and dizziness.&nbsp; He has no fever or weight loss.&nbsp; The patient has not visited a doctor in 10 years and does not take medications.&nbsp; He does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient&#39;s sister has bipolar disorder, and both parents died in a car accident many years ago.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 140/80 mm Hg, pulse is 76/min, and respirations are 14/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; His face has a ruddy cyanotic appearance.&nbsp; Oropharynx is clear.&nbsp; There is no lymphadenopathy in his cervical, supraclavicular, or axillary chains.&nbsp; Jugular venous pressure is normal.&nbsp; Cardiopulmonary examination shows no abnormalities.&nbsp; Abdomen is soft and nontender; the spleen is palpable 4 cm below the left lower ribs.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"250\"><tbody><tr><td>Hemoglobin</td><td>21.5 g/dL</td></tr><tr><td>Hematocrit</td><td>64%</td></tr><tr><td>Platelets</td><td>521,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Leukocytes</td><td>14,800/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table></blockquote><p>Which of the following is most likely to be seen on further workup?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t36742\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Polycythemia vera</strong></p></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>&uarr; Blood viscosity<ul style=\"list-style-type:circle;\"><li><strong>Hypertension</strong></li><li><strong>Erythromelalgia</strong> (burning cyanosis in hands/feet)</li><li>Transient visual disturbances</li></ul></li><li>&uarr; RBC turnover (gouty arthritis)</li><li><strong>Aquagenic pruritus</strong></li><li>Bleeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Examination</strong></p></td><td><ul><li>Facial plethora (ruddy cyanosis)</li><li>Splenomegaly</li></ul></td></tr><tr><td>&nbsp;<p align=\"center\"><strong>Laboratory</strong></p><p align=\"center\"><strong>findings</strong></p></td><td><ul><li><strong>Elevated hemoglobin</strong></li><li>Leukocytosis &amp; thrombocytosis</li><li><strong>Low erythropoietin</strong> level</li><li><strong><em>JAK2</em> mutation</strong> positive</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li><strong>Thrombosis</strong></li><li>Myelofibrosis &amp; acute leukemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li><strong>Phlebotomy </strong></li><li>Hydroxyurea (if &uarr; risk of thrombus)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>RBC</strong> = red blood cell.</p></td></tr></tbody></table></div></p><p>This patient with <strong>aquagenic pruritus</strong> (itching after bathing), <strong>facial plethora</strong> (ruddy cyanosis), <strong>splenomegaly</strong>, and elevations in all 3 cell lines on complete blood count likely has <strong>polycythemia vera</strong> (PV).</p><p>PV is a clonal <strong>myeloproliferative</strong> disorder characterized by <strong>erythrocytosis</strong> (increase in red blood cell mass).&nbsp; It is a <strong>primary form</strong> of polycythemia, almost always caused by a <strong><em>JAK2</em> mutation</strong>.&nbsp; Normally, red blood cell production is dependent on erythropoietin (EPO), a cytokine released by the kidneys (and liver) in response to <strong>tissue hypoxia</strong>; EPO activates the JAK2 tyrosine kinase, which differentiates late myeloid cells into erythrocytes.&nbsp; In PV, red blood cell production is driven by a constitutively active <em>JAK2</em> gene rather than by tissue hypoxia; therefore, <strong>EPO levels tend to be low</strong>.</p><p>Secondary forms of polycythemia (eg, due to chronic hypoxia or EPO-secreting tumors) are caused by circulating factors (usually EPO) that stimulate the bone marrow to produce more red blood cells.&nbsp; These forms of polycythemia are often characterized by high EPO levels.</p><p><strong>(Choice A)</strong>&nbsp; Erythrocyte sedimentation rate (ESR) is increased in inflammatory or infectious states due to elevated circulating plasma proteins (usually fibrinogen).&nbsp; In PV, there is a higher relative concentration of erythrocytes to fibrinogen, which causes a low (not high) ESR.</p><p><strong>(Choice B)</strong>&nbsp; Serum iron levels are low in most patients with PV due to increased hematopoiesis with subsequent increased iron utilization.</p><p><strong>(Choice C)</strong>&nbsp; Patients with hypoxia-driven forms of secondary erythrocytosis may have low resting arterial oxygen saturations.&nbsp; Patients with PV usually have normal oxygen saturations; the erythrocytosis in PV is EPO (hypoxemic) independent.</p><p><strong>(Choice E)</strong>&nbsp; The BCR-ABL fusion protein is usually seen in chronic myeloid leukemia (CML).&nbsp; CML is typically associated with severe leukocytosis (with leukocytes often &gt;100,000/mm<font size=\"2\"><sup>3</sup></font>) and anemia.&nbsp; This patient has mild leukocytosis and severe erythrocytosis, making PV far more likely.</p><p><strong>Educational objective</strong>:<br>Polycythemia vera is a myeloproliferative disorder marked by erythrocytosis.&nbsp; It is a form of primary polycythemia, almost always caused by a mutation of <em>JAK2</em> in a myeloid precursor cell.&nbsp; Erythropoietin levels tend to be low (unlike most causes of secondary polycythemia).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 19259,
            "topic": "Polycythemia",
            "titleId": 19259,
            "title": "Polycythemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Elevated erythrocyte sedimentation rate",
                    "choiceNumber": 1,
                    "correctTaken": 2133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Elevated serum iron levels",
                    "choiceNumber": 2,
                    "correctTaken": 1642,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low resting arterial oxygen saturation",
                    "choiceNumber": 3,
                    "correctTaken": 1500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low serum erythropoietin level",
                    "choiceNumber": 4,
                    "correctTaken": 17677,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Positive BCR-ABL fusion protein",
                    "choiceNumber": 5,
                    "correctTaken": 1813,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1907,2033,true,-1,1*1627,1895,true,-1,1*1065,1344,true,-1,1*82,206,true,-1,1*226,234,true,-1,1*365,389,true,-1,1*438,468,true,-1,1*491,526,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "10088639",
                    "mediaDataId": 0,
                    "title": "Apoptosis and polycythemia vera.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/10088639",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16919893",
                    "mediaDataId": 0,
                    "title": "Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16919893",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 60,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 24765,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1358,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 17698,
            "questionIndex": 19158,
            "questionText": "<p>A 5-year-old girl is brought to the emergency department due to 3 days of fever and cough.&nbsp; Physical examination shows increased respiratory effort and right-sided crackles.&nbsp; Neutrophilic leukocytosis and a right lower lobe consolidation are present.&nbsp; The patient is admitted to the hospital, and intravenous ceftriaxone and azithromycin are started.&nbsp; An hour later, the patient reports upper abdominal discomfort, and the urine is noted to be dark colored.&nbsp; On repeat examination, the patient appears listless and has tachycardia, tachypnea, and mild upper abdominal tenderness.&nbsp; Repeat laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">6.3 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">285,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">13,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Total bilirubin</td><td style=\"vertical-align:middle;\">2.3 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">66 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">42 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">28 U/L</td></tr></tbody></table><p>Which of the following is most likely to reveal the cause of this patient&#39;s deterioration after hospitalization?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t59785\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.25in;\"><strong>Drug-induced, immune-mediated hemolytic anemia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Drug coats erythrocytes &rarr; IgG binding &rarr; splenic destruction of RBCs (extravascular hemolysis)</li><li>Drug triggers immune complexes &rarr; complement-mediated destruction of RBCs (intravascular hemolysis)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Sudden onset (within hours of exposure)</li><li>Anemia: fatigue, pallor, dyspnea</li><li>Hemolysis: jaundice, dark urine, abdominal or back pain<ul style=\"list-style-type:circle;\"><li>&uarr; Reticulocytes, indirect bilirubin &amp; LDH</li><li>&darr; Haptoglobin</li><li>Spherocytes on peripheral blood smear</li><li>+ Direct Coombs test (anti-IgG, anti-C3)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Discontinue offending drug</li><li>Transfusion (if severe)</li><li>&plusmn; Glucocorticoids, IVIG</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>IVIG</strong> = intravenous immunoglobulin; <strong>LDH</strong> = lactate dehydrogenase; <strong>RBCs</strong> = red blood cells.</p></td></tr></tbody></table></div><p>This patient developed dark-colored urine, elevated bilirubin, and anemia shortly after receiving antibiotics, raising strong suspicion for <strong>drug-induced hemolytic anemia</strong>.&nbsp; The most common triggers are nonsteroidal anti-inflammatory drugs (eg, diclofenac), penicillins (eg, piperacillin), and cephalosporins (eg, <strong>ceftriaxone</strong>).</p><p>Although medications can trigger hemolysis through a variety of mechanisms (eg, oxidative injury, complement-mediated injury), penicillins and cephalosporins typically cause hemolysis when they bind to the erythrocyte surface, acting as a hapten that facilitates IgG attachment.&nbsp; Subsequently, the IgG-coated erythrocytes are destroyed by splenic macrophages, leading to <strong>extravascular hemolysis</strong>.</p><p>Manifestations typically arise <strong>within hours</strong> or a few days of drug administration and include signs of anemia (eg, tachycardia, dyspnea) and hemolysis (eg, elevated bilirubin, <strong>dark-colored urine</strong>).&nbsp; Severe hemolysis can cause back or abdominal pain due to erythrocytosis in the vertebral bodies, liver, and spleen.&nbsp; Laboratory evaluation usually shows increased bilirubin, lactate dehydrogenase, and reticulocytes; haptoglobin, which binds free hemoglobin, will be very low.</p><p>The diagnosis of immune-mediated hemolysis is made with the <strong>direct antiglobulin (Coombs) test</strong>, which detects IgG or C3 (a complement component) on the erythrocyte surface.&nbsp; Withdrawal of the offending drug typically leads to resolution of symptoms within hours or days.&nbsp; However, blood transfusion or corticosteroids are sometimes required in severe cases.</p><p><strong>(Choices B and D)</strong>&nbsp; Abdominal CT scan or liver ultrasonography can diagnose biliary obstruction and choledocholithiasis.&nbsp; Although these conditions are often associated with elevated bilirubin, patients typically have severe (not mild) abdominal pain, elevated alkaline phosphatase, and elevated liver function tests.&nbsp; This patient&#39;s anemia, normal alkaline phosphatase/liver function tests, and mild abdominal pain make biliary obstruction less likely.</p><p><strong>(Choice C)</strong>&nbsp; Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at risk for acute hemolysis after exposure to oxidizing foods (eg, fava beans) or medications (eg, sulfa drugs).&nbsp; However, ceftriaxone and azithromycin do not typically incite hemolysis in these patients.&nbsp; In addition, symptoms usually arise 2-4 days after drug exposure, not within hours.</p><p><strong>(Choice E)</strong>&nbsp; Serum fibrinogen is rapidly consumed in disseminated intravascular coagulation (DIC), a consumptive coagulopathy characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and prolonged coagulation times.&nbsp; This patient&#39;s normal platelet count makes DIC unlikely.</p><p><strong>Educational objective:</strong><br>Drug-induced immune hemolysis can be triggered by penicillin and cephalosporin antibiotics, which bind to the surface of erythrocytes and act as a hapten for IgG attachment.&nbsp; IgG-coated erythrocytes are then destroyed by splenic macrophages (extravascular hemolysis), leading to anemia and signs of hemolysis (eg, jaundice, hemoglobinuria, elevated indirect bilirubin).&nbsp; The diagnosis is made with a Coombs test, which detects IgG on the erythrocyte surface.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 5616,
            "topic": "Hemolytic anemia",
            "titleId": 5616,
            "title": "Hemolytic anemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Coombs testing",
                    "choiceNumber": 1,
                    "correctTaken": 6959,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen",
                    "choiceNumber": 2,
                    "correctTaken": 949,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose-6-phosphate dehydrogenase level",
                    "choiceNumber": 3,
                    "correctTaken": 7131,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver ultrasonography",
                    "choiceNumber": 4,
                    "correctTaken": 779,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum fibrinogen level",
                    "choiceNumber": 5,
                    "correctTaken": 559,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2751,3111,true,-1,1*936,1060,true,-1,1*1654,1770,true,-1,1*90,282,true,-1,1*403,421,true,-1,1*422,425,true,-1,1*483,561,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "583",
                    "mediaDataId": 0,
                    "title": "Approach to anemia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25163809",
                    "mediaDataId": 0,
                    "title": "Ceftriaxone-induced immune hemolytic anemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25163809",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22502777",
                    "mediaDataId": 0,
                    "title": "Immune hemolytic anemia caused by drugs.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22502777",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 87,
            "othersAvgTimeSpent": 82,
            "notes": null,
            "peopleTaken": 16377,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 42,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1024,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 4013,
            "questionIndex": 4013,
            "questionText": "<p>A 66-year-old man comes to the office due to several weeks of severe constipation and increasing back pain.&nbsp; The patient notes that he has always had regular bowel movements; however, for the last 2 months, he has required over-the-counter laxatives to produce any stool.&nbsp; During this period, he has also had increasing pain in his lower back.&nbsp; He has had no trauma to that area.&nbsp; There is no radiation down the legs, bowel incontinence, or lower extremity weakness.&nbsp; The patient takes lisinopril for hypertension and ibuprofen as needed for back pain.&nbsp; He does not use tobacco or alcohol.&nbsp; Temperature is 36.1 C (97 F), blood pressure is 134/80 mm Hg, and pulse is 78/min.&nbsp; Mucosal pallor is present.&nbsp; He is anicteric.&nbsp; Cardiopulmonary and abdominal examinations are normal.&nbsp; Rectal examination reveals a smooth, nonenlarged prostate.&nbsp; The stool is negative for occult blood.&nbsp; Strength and reflexes are intact in his lower extremities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>9.6 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>260,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>140 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>4.4 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>28 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>2.2 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td>11.4 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>100 mg/dL</td></tr></tbody></table><p>Which of the following is the best explanation for this patient&#39;s constipation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42281\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Multiple myeloma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Plasma cell neoplasm produces <strong>monoclonal </strong>paraprotein (immunoglobulin)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Bone pain, fractures</li><li>Constitutional symptoms (weight loss, fatigue)</li><li>Recurrent infections</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory </strong></p></td><td><ul><li>Normocytic anemia</li><li>Renal insufficiency</li><li>Hypercalcemia (constipation, muscle weakness)</li><li>Monoclonal paraproteinemia <strong>(M-spike)</strong></li></ul></td></tr><tr><td><p align=\"center\"><strong>Radiology</strong></p></td><td><ul><li><strong>Osteolytic lesions</strong>/osteopenia (osteoclast activation)</li></ul></td></tr></tbody></table></div><p>This patient with constipation, back pain, and laboratory evidence of anemia, renal insufficiency, and hypercalcemia likely has <strong>multiple myeloma</strong> (MM).&nbsp; MM is a plasma cell neoplasm that commonly presents with manifestations related to bone marrow infiltration (bone pain, fractures, hypercalcemia, anemia) or elevations in serum monoclonal protein (<strong>renal insufficiency</strong>).&nbsp; At the time of diagnosis, approximately 25% of patients with MM have <strong>hypercalcemia</strong>.&nbsp; Typically, this is a result of osteolytic bone destruction by the neoplastic plasma cells.&nbsp; Although hypercalcemia may be asymptomatic with a calcium level &lt;12 mg/dL, fatigue, <strong>constipation</strong>, and depression are common.&nbsp; This patient&#39;s constipation is likely a result of hypercalcemia.</p><p>Patients with suspected MM should have serum/urine protein electrophoresis (M-spike), a peripheral blood smear (rouleaux), and a serum free light chain analysis.&nbsp; If these screening tests suggest MM, diagnosis can be confirmed by bone marrow biopsy.</p><p><strong>(Choice B)</strong>&nbsp; Hormonal causes of constipation include hypothyroidism and hyperparathyroidism (causing hypercalcemia).&nbsp; However, in an elderly patient, the cluster of renal insufficiency, anemia, and hypercalcemia are far more commonly associated with MM.</p><p><strong>(Choice C)</strong>&nbsp; Irritable bowel syndrome (IBS) is associated with abdominal pain and altered bowel habits.&nbsp; The laboratory findings in this patient would not be consistent with IBS.</p><p><strong>(Choice D)</strong>&nbsp; Mechanical causes of constipation are usually associated with pain and bloating.&nbsp; If severe, nausea and vomiting may result.&nbsp; This patient&#39;s examination (normal abdominal/prostate/occult blood examination) and laboratory findings make a mechanical cause less likely.</p><p><strong>(Choice E)</strong>&nbsp; Ibuprofen and lisinopril do not commonly cause constipation.</p><p><strong>(Choice F)</strong>&nbsp; Many neurologic conditions can affect colonic transit resulting in constipation.&nbsp; However, given the patient&#39;s laboratory findings, including hypercalcemia, this would be less likely.</p><p><strong>Educational objective:</strong><br>Hypercalcemia is common in patients with multiple myeloma.&nbsp; It is caused by osteolytic bone destruction.&nbsp; Fatigue, constipation, and depression are common symptoms of mild hypercalcemia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3483,
            "topic": "Multiple myeloma",
            "titleId": 3483,
            "title": "Multiple myeloma",
            "topicAttributeId": 330657,
            "topicAttribute": "Plasma cell disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Electrolyte disturbance",
                    "choiceNumber": 1,
                    "correctTaken": 17038,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hormonal disturbances",
                    "choiceNumber": 2,
                    "correctTaken": 1611,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Irritable bowel syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 339,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mechanical obstruction",
                    "choiceNumber": 4,
                    "correctTaken": 3870,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication side effect",
                    "choiceNumber": 5,
                    "correctTaken": 1185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neurologic dysfunction",
                    "choiceNumber": 6,
                    "correctTaken": 846,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "980,1173,true,-1,1*1174,1423,true,-1,1*216,236,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17634143",
                    "mediaDataId": 0,
                    "title": "Multiple myeloma/hypercalcemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17634143",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 163,
            "othersAvgTimeSpent": 82,
            "notes": null,
            "peopleTaken": 24889,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 716,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 14004,
            "questionIndex": 15406,
            "questionText": "<p>A 3-year-old boy is brought to the clinic due to decreased energy and yellow skin.&nbsp; The patient first became ill 2 days ago when he developed a runny nose and cough.&nbsp; Yesterday, he had abdominal pain with nausea, but he has not had vomiting or diarrhea.&nbsp; The mother also noticed yellowing of the patient&#39;s eyes and skin, and this morning he did not want to play or eat.&nbsp; Medical history includes similar yellowing of the skin after birth that required phototherapy.&nbsp; Otherwise, he has been healthy.&nbsp; Several members of his family had similar intermittent episodes of skin yellowing during childhood, and 2 relatives underwent splenectomies in adulthood.&nbsp; The patient takes no medications.&nbsp; Physical examination shows a tired-appearing toddler with mild jaundice.&nbsp; Eye examination shows mild scleral icterus.&nbsp; The abdomen is soft and tender in the left upper quadrant.&nbsp; The spleen is 4 cm below the costal margin.&nbsp; The remainder of the examination shows no abnormalities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">8.6 g/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">160,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">7,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr></tbody></table><p>Additional evaluation of this patient would most likely reveal which of the following laboratory findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40923\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hereditary spherocytosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Usually autosomal dominant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Hemolytic anemia</li><li>Jaundice</li><li>Splenomegaly</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&uarr; MCHC</li><li>Negative Coombs test</li><li>Spherocytes on peripheral smear</li><li>&uarr; Osmotic fragility on acidified glycerol lysis test</li><li>Abnormal eosin-5-maleimide binding test</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Folic acid supplementation</li><li>Blood transfusion</li><li>Splenectomy</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MCHC</strong> = mean corpuscular hemoglobin concentration.</p></td></tr></tbody></table></div><p>This patient has <strong>splenomegaly</strong> and signs of hemolysis (anemia, <strong>jaundice</strong>) following an upper respiratory illness.&nbsp; These clinical features, along with a family history of multiple relatives requiring splenectomy, make&nbsp;<strong>hereditary spherocytosis</strong> (HS) the most likely cause of his <strong>hemolytic anemia</strong>.</p><p>HS is usually due to an autosomal dominant defect in red blood cell (RBC) membrane proteins (eg, spectrin, ankyrin) that results in sphere-shaped, fragile RBCs.&nbsp; Due to their shape, these abnormal RBCs get trapped and destroyed in the spleen.</p><p>In all types of hemolytic anemia, the bone marrow produces <strong>increased reticulocytes</strong> in response to RBC destruction.&nbsp; However, <strong>elevated mean corpuscular hemoglobin concentration</strong> (MCHC) (due to membrane loss and RBC dehydration)&nbsp;distinguishes HS from other forms of hemolysis.&nbsp; Other laboratory findings include low to normal mean corpuscular volume, <strong>negative direct Coombs</strong> test, and <a href=\"2941\">spherocytes</a> on peripheral smear.&nbsp; Treatment involves supportive care (eg, folic acid, transfusions) and <strong>splenectomy</strong> for severe hemolysis.</p><p><strong>(Choice B)</strong>&nbsp; Glucose-6-phosphate dehydrogenase deficiency, which can also present with jaundice and splenomegaly and affect different family members (X-linked recessive inheritance pattern), would cause elevated reticulocytes, negative direct Coombs test, and low (rather than high) MCHC. &nbsp;However, management is with avoidance of hemolytic triggers rather than splenectomy. &nbsp;This patient&#39;s family history of several relatives requiring splenectomies makes HS a much more likely diagnosis.</p><p><strong>(Choice C)</strong>&nbsp; Warm autoimmune hemolytic anemia (AIHA) can present with jaundice and splenomegaly but is characterized by a positive direct Coombs test.&nbsp; AIHA may be triggered by an upper respiratory illness but is unlikely to involve multiple family members because it is not inherited like HS.&nbsp; In addition, autoantibody production is rarely seen in the newborn period.</p><p><strong>(Choice D)</strong>&nbsp; A patient with HS will have abnormally low reticulocytes in the case of a transient aplastic crisis (eg, parvovirus infection).&nbsp; This patient has no signs of concurrent parvovirus infection (eg, fever, rash).</p><p><strong>(Choice E)</strong>&nbsp; Low reticulocytes, negative direct Coombs test, and normal MCHC are normal findings that would not be expected in a child with signs of hemolytic anemia.</p><p><strong>Educational objective:</strong><br>Hereditary spherocytosis (HS) is a genetic defect in red blood cell (RBC) membrane proteins that results in sphere-shaped RBCs.&nbsp; HS should be suspected in a patient with jaundice, splenomegaly, and a family history suggestive of hemolytic anemia requiring splenectomy.&nbsp; Laboratory findings include elevated reticulocytes and mean corpuscular hemoglobin concentration and negative direct Coombs test.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7183,
            "topic": "Hereditary spherocytosis",
            "titleId": 7183,
            "title": "Hereditary spherocytosis",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"390\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">High</td><td width=\"33%\">Negative</td><td width=\"33%\">High</td></tr></tbody></table>",
                    "choiceNumber": 1,
                    "correctTaken": 9810,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"390\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">High</td><td width=\"33%\">Negative</td><td width=\"33%\">Low</td></tr></tbody></table>",
                    "choiceNumber": 2,
                    "correctTaken": 3359,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"390\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">High</td><td width=\"33%\">Positive</td><td width=\"33%\">Normal</td></tr></tbody></table>",
                    "choiceNumber": 3,
                    "correctTaken": 2386,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"390\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">Low</td><td width=\"33%\">Negative</td><td width=\"33%\">High</td></tr></tbody></table>",
                    "choiceNumber": 4,
                    "correctTaken": 404,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"390\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">Low</td><td width=\"33%\">Negative</td><td width=\"33%\">Normal</td></tr></tbody></table>",
                    "choiceNumber": 5,
                    "correctTaken": 626,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2369,2579,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22055020",
                    "mediaDataId": 0,
                    "title": "Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22055020",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 119,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 16586,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"390\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\"><strong>Reticulocyte count</strong></td><td width=\"33%\"><strong>Direct Coombs</strong></td><td width=\"33%\"><strong>Mean corpuscular hemoglobin concentration</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 844,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 2258,
            "questionIndex": 2258,
            "questionText": "<p>A 43-year-old woman comes to the emergency department with abdominal pain and dark urine.&nbsp; Physical examination shows right upper-quadrant tenderness without guarding or rebound.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"425\"><tbody><tr><td>Hemoglobin</td><td>8.9 g/dL</td></tr><tr><td>Platelets</td><td>134,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Total bilirubin</td><td>6.3 mg/dL</td></tr><tr><td>Lactate dehydrogenase</td><td>740 U/L</td></tr><tr><td>Haptoglobin</td><td>30 mg/dL (50&ndash;150 mg/dL)</td></tr></tbody></table></blockquote><p>Further workup, including MRI of the abdomen, shows hepatic vein thrombosis.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t81696\"><table class=\"table-default-style\" style=\"width:524px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of paroxysmal nocturnal hemoglobinuria</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Hemolysis &rarr; fatigue</li></ul><ul><li>Cytopenias (impaired hematopoiesis)</li></ul><ul><li>Venous thrombosis (intraabdominal, cerebral veins)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Work-up</strong></p></td><td><ul><li>Complete blood count (hypoplastic/aplastic anemia, thrombocytopenia, leukopenia)</li><li>Elevated lactate dehydrogenase and low haptoglobin (hemolysis)</li><li>Indirect hyperbilirubinemia</li><li>Urinalysis (hemoglobinuria)</li><li>Flow cytometry (absence of CD55 &amp; CD59)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Iron &amp; folate supplementation</li><li>Eculizumab (monoclonal antibody that inhibits complement activation)</li></ul></td></tr></tbody></table></div><p>The most likely diagnosis in this case is <strong>paroxysmal nocturnal hemoglobinuria</strong> (PNH).&nbsp; PNH is a clonal stem cell disorder characterized by <strong>intravascular and extravascular hemolysis</strong> and hemoglobinuria.&nbsp; The disease is due to an acquired genetic defect that results in lack of the glycosylphosphatidylinositol anchor, which connects proteins, including CD55 and CD59, to the cell surface.&nbsp; These proteins normally inhibit the activation of complement on red blood cells, but their absence allows the complement <strong>membrane attack complex</strong> to form and results in hemolysis.</p><p>On average, patients have manifestations in the third decade of life resulting from one of the following:</p><ul><li><strong>Hemolysis</strong> leading to hemoglobinuria</li><li><strong>Cytopenias</strong> - fatigue and dyspnea from anemia</li><li><strong>Hypercoagulable</strong> state (eg, portal vein thrombosis, hepatic vein thrombosis)</li></ul><p>This patient&#39;s anemia and low haptoglobin accompanied by elevated bilirubin and lactate dehydrogenase (LDH) are all consistent with intravascular hemolysis.&nbsp; The key to the diagnosis is the patient&#39;s hepatic vein thrombosis <strong>in conjunction</strong> with these signs of hemolysis.&nbsp; The pathophysiology of thrombosis is unclear but may be related to release of procoagulant molecules as a result of hemolysis and possibly to changes in complement levels.&nbsp; Unusual sites of thrombosis may be noted, and cerebral and intraabdominal vein involvement is classic.&nbsp; Abdominal pain may be due to severe hemolysis, thrombosis, or effects on smooth muscle.</p><p><strong>Flow cytometry tests</strong> are used to confirm the diagnosis by assessing for the absence of the CD55 and CD59 proteins on the surface of the red blood cells.</p><p><strong>(Choice A)</strong>&nbsp; Acute intermittent porphyria may also present with abdominal pain and dark red/brown urine.&nbsp; However, the pigmented urine is due to porphyrins and/or porphyrin precursors (not hemoglobinuria), and hematologic abnormalities and thromboembolism are rare.</p><p><strong>(Choice B)</strong>&nbsp; The elevated LDH and bilirubin accompanied by the low haptoglobin make a hemolytic anemia much more likely than an aplastic anemia.</p><p><strong>(Choice C)</strong>&nbsp; G6PD deficiency can cause hemolytic anemia but is more common in male patients, particularly those of African descent.&nbsp; Patients are generally asymptomatic when there is no anemia, but disease can be triggered by medications or infections.&nbsp; Venous thrombosis is unlikely.</p><p><strong>(Choice D)</strong>&nbsp; Symptomatic hereditary spherocytosis would likely have led to some symptoms in this patient before age 43, and it is not usually associated with venous thromboses.</p><p><strong>Educational objective:</strong><br>Paroxysmal nocturnal hemoglobinuria should be suspected in patients who have a combination of hemolytic anemia, cytopenias, and hypercoagulable state (intraabdominal or cerebral venous thrombosis).&nbsp; Flow cytometry tests are used to confirm the diagnosis by assessing for absence of the CD55 and CD59 proteins on the surface of red blood cells.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8054,
            "topic": "Paroxysmal nocturnal hemoglobinuria",
            "titleId": 8054,
            "title": "Paroxysmal nocturnal hemoglobinuria",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute intermittent porphyria",
                    "choiceNumber": 1,
                    "correctTaken": 39554,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aplastic anemia",
                    "choiceNumber": 2,
                    "correctTaken": 2510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "G6PD deficiency",
                    "choiceNumber": 3,
                    "correctTaken": 8860,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hereditary spherocytosis",
                    "choiceNumber": 4,
                    "correctTaken": 15938,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Paroxysmal nocturnal hemoglobinuria",
                    "choiceNumber": 5,
                    "correctTaken": 54764,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "476,574,true,-1,1*775,1140,true,-1,1*1141,1245,true,-1,1*1247,1403,true,-1,1*2306,2457,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24488565",
                    "mediaDataId": 0,
                    "title": "Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24488565",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23610373",
                    "mediaDataId": 0,
                    "title": "Thrombosis in paroxysmal nocturnal hemoglobinuria.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23610373",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 40,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 121626,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 750,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 18247,
            "questionIndex": 19714,
            "questionText": "<p>An 18-year-old woman with hemoglobin SS disease comes to the office due to worsening fatigue.&nbsp; At her last office visit 3 months ago, hydroxyurea and folic acid were prescribed.&nbsp; The patient has had no vasoocclusive pain crises since her last visit but has been significantly more fatigued.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 116/72 mm Hg, pulse is 100/min, and respirations are 18/min.&nbsp; Cardiopulmonary examination is unremarkable, and the abdomen is soft with no organomegaly.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td></td><td><strong>Today</strong></td><td><strong>3 months ago</strong></td></tr><tr><td>Hemoglobin</td><td>6.5 g/dL</td><td>8.6 g/dL</td></tr><tr><td>Mean corpuscular volume</td><td>106 &micro;m<font size=\"2\"><sup>3</sup></font></td><td>90 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Reticulocytes</td><td>3%</td><td>5%</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s laboratory findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T68001\"><table class=\"table-default-style table-header-footer-style\" style=\"width:570px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Common causes of macrocytosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Increased reticulocytes</strong></p></td><td><ul><li>Hemolytic anemia</li><li>Bone marrow recovery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Impaired RBC maturation</strong></p></td><td><ul><li>Vitamin B<sub>12</sub>/folate deficiency</li><li>Medications (eg, hydroxyurea, methotrexate)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Bone marrow disorders</strong></p></td><td><ul><li>Myelodysplastic syndrome</li><li>Sideroblastic anemia</li><li>Multiple myeloma</li></ul></td></tr><tr><td><p align=\"center\"><strong>Lipid abnormalities</strong></p></td><td><ul><li>Liver disease</li><li>Hypothyroidism</li></ul></td></tr><tr><td colspan=\"2\"><p>RBC = red blood cell.</p></td></tr></tbody></table></div><p>This patient with sickle cell disease (SCD) has worsened anemia with new <strong>macrocytosis</strong>.&nbsp; Macrocytosis is often a byproduct of:</p><ul><li><p>Increased circulating reticulocytes:&nbsp; Reticulocytes are larger (MCV: 125-135 &micro;m<font size=\"2\"><sup>3</sup></font>) than mature erythrocytes due to retention of some nuclear products (eg, messenger RNA).&nbsp; Therefore, increased circulating reticulocytes can significantly increase MCV; this is often seen with acute hemolysis and bone marrow recovery following toxic/infectious insult.</p></li><li><p><strong>Abnormal erythrocyte development:</strong>&nbsp; Erythrocyte precursors decrease in size as they mature; therefore, conditions that impair erythrocyte maturation can cause macrocytosis.&nbsp; This is often seen with severe vitamin B<font size=\"2\"><sub>12</sub></font>/folate deficiency or as an <strong>adverse effect of medications</strong> (eg, hydroxyurea).</p></li></ul><p><strong>Hydroxyurea</strong> is the major disease-modifying medication for patients with SCD because it reduces expression of the mutated beta-globulin gene and increases gamma-globulin gene expression, which promotes <a href=\"19042\">fetal hemoglobin</a> (Hb F alpha<font size=\"2\"><sub>2</sub></font>, gamma<font size=\"2\"><sub>2</sub></font>) production.&nbsp; Erythrocytes with increased Hb F sickle less in the microvasculature; therefore, patients with SCD on hydroxyurea have lower risk for vasoocclusive pain crises, organ ischemia, and hospitalization.</p><p>However, hydroxyurea also <strong>inhibits ribonucleoside reductase</strong>, an enzyme that generates deoxyribonucleoside triphosphates for DNA synthesis and repair.&nbsp; Blockade of ribonucleoside reductase <strong>inhibits</strong> erythrocyte nuclear <strong>maturation</strong> and increases nuclear/cytoplasmic ratio, which <strong>elevates MCV</strong>.&nbsp; High doses also cause <strong>myelosuppression</strong> (eg, anemia, thrombocytopenia, leukopenia) with a<strong> low reticulocyte count </strong>due to cell cycle arrest of rapidly dividing hematopoietic cells.</p><p><strong>(Choice A)</strong>&nbsp; Anemia of inflammation is marked by normocytic (or slightly microcytic) anemia with a low reticulocyte response due to iron-trapping in reticuloendothelial macrophages.&nbsp; Macrocytosis would be atypical.</p><p><strong>(Choice B)</strong>&nbsp; Acute hemolysis can cause macrocytosis due to increased circulating reticulocytes.&nbsp; However, this patient&#39;s reticulocyte count is lower than it was 3 months ago.</p><p><strong>(Choice D)</strong>&nbsp; Myelodysplastic syndrome is a clonal, hematopoietic neoplasm marked by cytopenias and abnormal cellular maturation.&nbsp; Although anemia, macrocytosis, and impaired reticulocytosis are common, almost all cases arise in adults age &gt;50.</p><p><strong>(Choice E)</strong>&nbsp; Patients with SCD can develop pure red cell aplasia following viral infections (eg, parvovirus).&nbsp; Although erythrocyte aplasia causes anemia with a low reticulocyte count, macrocytosis is uncommon.</p><p><strong>(Choice F)</strong>&nbsp; Although severe vitamin B<font size=\"2\"><sub>12</sub></font>/folate depletion causes macrocytic anemia with minimal reticulocytes, this patient takes folic acid, and vitamin B<font size=\"2\"><sub>12</sub></font> deficiency takes years to develop due to high total body stores.&nbsp; Because her laboratory abnormalities coincided with the initiation of hydroxyurea, a medication adverse effect is more likely.</p><p><strong>Educational objective:</strong><br>Hydroxyurea reduces complications of sickle cell disease by increasing fetal hemoglobin production and reducing production of hemoglobin S.&nbsp; Hydroxyurea also causes macrocytosis and myelosuppression due to inhibition of ribonucleotide reductase.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anemia of inflammation",
                    "choiceNumber": 1,
                    "correctTaken": 440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperhemolytic crisis",
                    "choiceNumber": 2,
                    "correctTaken": 773,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication adverse effect",
                    "choiceNumber": 3,
                    "correctTaken": 7118,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Myelodysplastic syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 913,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral-induced pure red cell aplasia",
                    "choiceNumber": 5,
                    "correctTaken": 726,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin B<font size=\"2\"><sub>12</sub></font> deficiency",
                    "choiceNumber": 6,
                    "correctTaken": 6373,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "60,121,true,-1,1*220,304,true,-1,1*1233,1398,true,-1,1*1604,2064,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "619",
                    "mediaDataId": 0,
                    "title": "Sickle cell disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 16343,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1436,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 4466,
            "questionIndex": 4466,
            "questionText": "<p>A 66-year-old woman comes to the office due to 2 days of increasing productive cough and low-grade fever.&nbsp; She was treated for community-acquired pneumonia 4 months ago and sinusitis 2 months ago.&nbsp; Her review of systems is positive for fatigue, generalized weakness, and right-sided chest pain.&nbsp; The patient is otherwise healthy and takes no medications.&nbsp; She has never smoked cigarettes and drinks alcohol only on rare social occasions.&nbsp; Temperature is 38.4 C (101.2 F), blood pressure is 126/72 mm Hg, pulse is 98/min, and respirations are 16/min.&nbsp; Pulse oximetry is 96%.&nbsp; She is well-appearing.&nbsp; There is mucosal pallor.&nbsp; There is no lymphadenopathy in her cervical or supraclavicular chains.&nbsp; Bronchial breath sounds and crackles are present in the left lower lung field.&nbsp; There is point tenderness over the right seventh and eighth ribs at the midclavicular line.&nbsp; The abdomen is soft with no hepatosplenomegaly.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>9.4 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td>88 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>235,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>13,500/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Chest x-rays shows consolidation in the left lower lung and right-sided osteolytic lesions with fractures at the seventh and eighth ribs.&nbsp; This patient is at increased risk for recurrent infections due to which of the following abnormalities?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42281\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Multiple myeloma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Plasma cell neoplasm produces <strong>monoclonal </strong>paraprotein (immunoglobulin)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Bone pain, fractures</li><li>Constitutional symptoms (weight loss, fatigue)</li><li>Recurrent infections</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory </strong></p></td><td><ul><li>Normocytic anemia</li><li>Renal insufficiency</li><li>Hypercalcemia (constipation, muscle weakness)</li><li>Monoclonal paraproteinemia <strong>(M-spike)</strong></li></ul></td></tr><tr><td><p align=\"center\"><strong>Radiology</strong></p></td><td><ul><li><strong>Osteolytic lesions</strong>/osteopenia (osteoclast activation)</li></ul></td></tr></tbody></table></div><p><strong>Multiple myeloma</strong> (MM) is a monoclonal plasma cell neoplasm.&nbsp; <strong>Bone marrow infiltration</strong> by neoplastic cells causes <strong>osteolytic lesions, fractures</strong>, hypercalcemia (from bone destruction), and anemia.&nbsp; In addition, the excessive production of monoclonal protein can clog the renal tubules, resulting in renal insufficiency.</p><p>Patients with MM are prone to <strong>infection</strong>.&nbsp; Neoplastic infiltration of the bone marrow alters and impairs the normal lymphocyte population, resulting in ineffective antibody production and <strong>hypogammaglobulinemia</strong>.&nbsp; Respiratory (eg, streptococcal pneumonia) and urinary tract infections are the most common infections seen in MM.</p><p><strong>(Choices A and B)</strong>&nbsp; The complement system helps form the terminal membrane attack complex.&nbsp; Deficiencies in this system cause problems with the innate immune system, making patients particularly vulnerable to encapsulated bacteria (eg, <em>Neisseria meningitides</em>).&nbsp; These are relatively rare disorders and would not account for this patient&#39;s osteolytic lesions and fractures.</p><p><strong>(Choice C)</strong>&nbsp; CD4+ T lymphocytes are destroyed by HIV.&nbsp; HIV increases infection risk but would not account for this patient&#39;s osteolytic lesions and pathologic fractures.</p><p><strong>(Choice D)</strong>&nbsp; Defective chemotaxis may contribute to recurrent infections in patients with rare genetic conditions, HIV, and bone marrow transplants.&nbsp; It does not contribute significantly to the predisposition to infection in patients with MM.</p><p><strong>(Choice F)</strong>&nbsp; Defects in phagocytic oxidative metabolism impair the ability of phagocytes to produce reactive oxygen intermediaries that aid in the destruction of pathogens and cancerous cells.&nbsp; This may be seen in chronic granulomatous disease.&nbsp; These defects would not explain this patient&#39;s osteolytic lesions and laboratory abnormalities.</p><p><strong>Educational objective:</strong><br>Patients with multiple myeloma are at increased risk for infection due to bone marrow infiltration by neoplastic cells, which alters the normal leukocyte population and causes hypogammaglobulinemia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3483,
            "topic": "Multiple myeloma",
            "titleId": 3483,
            "title": "Multiple myeloma",
            "topicAttributeId": 330657,
            "topicAttribute": "Plasma cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Complement deficiency",
                    "choiceNumber": 1,
                    "correctTaken": 2130,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Defective membrane attack complex",
                    "choiceNumber": 2,
                    "correctTaken": 1664,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Destruction of CD4+ T lymphocytes",
                    "choiceNumber": 3,
                    "correctTaken": 2333,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired chemotaxis",
                    "choiceNumber": 4,
                    "correctTaken": 2546,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired effective antibody production",
                    "choiceNumber": 5,
                    "correctTaken": 21252,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired phagocytic oxidative metabolism",
                    "choiceNumber": 6,
                    "correctTaken": 4755,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "380,432,true,-1,1*641,751,true,-1,1*793,1076,true,-1,1*1629,1859,true,-1,1*1871,2200,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 94,
            "othersAvgTimeSpent": 90,
            "notes": null,
            "peopleTaken": 34680,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 937,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 2889,
            "questionIndex": 2889,
            "questionText": "<p>A 66-year-old man comes to the office due to increasing pain in his left arm.&nbsp; The patient works as a furniture transporter and initially attributed the pain to a muscular strain, but it has slowly worsened and stopped responding to over-the-counter pain medications.&nbsp; The pain started 3 months ago and is mainly near the left elbow.&nbsp; He also notes back pain.&nbsp; He has not had fever or chills.&nbsp; His other medical problems include hypertension and hypercholesterolemia.&nbsp; The patient has never smoked.&nbsp; Temperature is 36.8 C (98.2 F), blood pressure is 132/86 mm Hg, pulse is 88/min, and respirations are 14/min.&nbsp; He appears comfortable.&nbsp; His mucous membranes are pale.&nbsp; There is no lymphadenopathy.&nbsp; Cardiopulmonary examination is normal.&nbsp; The abdomen is soft without organomegaly.&nbsp; The prostate is smooth, nontender, and moderately enlarged.&nbsp; Neurologic examination is unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">9.8 g/dL</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">89 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">254,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">6,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 3em; vertical-align:middle;\">Neutrophils</td><td style=\"vertical-align:middle;\">60%</td></tr><tr><td style=\"padding-left: 3em; vertical-align:middle;\">Lymphocytes</td><td style=\"vertical-align:middle;\">32%</td></tr><tr><td style=\"padding-left: 3em; vertical-align:middle;\">Monocytes</td><td style=\"vertical-align:middle;\">8%</td></tr></tbody></table><p>X-ray of the left arm is shown in the <a href=\"44631\">exhibit</a>.&nbsp; Which of the following tests would be the most useful next step in the management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"44632\" src=\"https://www.uworld.com/media/highresdefault/L7295.png\" ></p><p>This patient has back pain, normocytic anemia, and arm pain with an x-ray showing multiple <strong>osteolytic</strong> (lucent) <strong>lesions</strong>.&nbsp; In an elderly patient, this raises suspicion for <strong>multiple myeloma</strong> (MM).</p><p>MM is a plasma cell neoplasm.&nbsp; Pathology stems from bone marrow infiltration (fractures, hypercalcemia, anemia) and monoclonal protein production (renal insufficiency).&nbsp; <strong>Serum protein electrophoresis</strong> (SPEP) is a common <strong>screening test</strong> for MM that detects elevated serum monoclonal protein (<strong>M-spike</strong>).&nbsp; <strong>Bone marrow biopsy</strong>, a more invasive procedure, can then <strong>confirm diagnosis</strong> (&gt;10% clonal plasma cells).</p><p><strong>(Choice A)</strong>&nbsp; Blood cultures are useful for diagnosing infections.&nbsp; This patient has symptoms of bone pain and evidence of osteolytic lesions.&nbsp; He has not had fevers, chills, or other systemic symptoms.&nbsp; Infection is much less likely than malignancy.</p><p><strong>(Choice B)</strong>&nbsp; Bone marrow biopsy is an invasive test and performed only after gathering more information with peripheral smear (rouleaux), serum free light chain analysis, SPEP, and urine protein electrophoresis.</p><p><strong>(Choice C)</strong>&nbsp; Bone scans are not useful in the diagnosis of MM as they detect only osteoblastic activity (as is often seen in metastatic solid tumors).&nbsp; In MM, the lesions are osteoclastic (lytic), so whole body cross-sectional bone imaging (eg, low dose CT scan), is needed to identify bone involvement.</p><p><strong>(Choice D)</strong>&nbsp; Prostate cancer can cause bone lesions, but they tend to be osteoblastic (sclerotic) not osteolytic.&nbsp; In a patient with osteolytic lesions alone, MM is far more likely.</p><p><strong>(Choice E)</strong>&nbsp; Hyperparathyroidism can cause osteopenia with subsequent fractures but is unlikely to cause osteolytic lesions.&nbsp; Osteitis fibrosa cystica (eg, brown tumors of the long bones) is associated with hyperparathyroidism; however, it is very rare in the United States, lesions are typically well-defined (vs moth-eaten appearance), and other radiographic abnormalities are common (eg, subperiosteal bone resorption of the middle phalanx, highly specific for hyperparathyroidism).&nbsp; MM is far more common and more likely.</p><p><strong>Educational objective:</strong><br>Bone pain is a common presenting symptom in multiple myeloma (MM).&nbsp; In an elderly patient with evidence of osteolytic lesions on x-ray, MM should always be suspected.&nbsp; The screening tests of choice for MM are serum protein electrophoresis, urine protein electrophoresis, and free light chain analysis.&nbsp; Diagnosis can be confirmed with bone marrow biopsy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3483,
            "topic": "Multiple myeloma",
            "titleId": 3483,
            "title": "Multiple myeloma",
            "topicAttributeId": 330657,
            "topicAttribute": "Plasma cell disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Blood cultures",
                    "choiceNumber": 1,
                    "correctTaken": 176,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 2299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone scan",
                    "choiceNumber": 3,
                    "correctTaken": 1976,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prostate biopsy",
                    "choiceNumber": 4,
                    "correctTaken": 1409,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum parathyroid hormone levels",
                    "choiceNumber": 5,
                    "correctTaken": 1821,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum protein electrophoresis",
                    "choiceNumber": 6,
                    "correctTaken": 9498,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "525,626,true,-1,1*1097,1236,true,-1,1*1401,1502,true,-1,1*1583,1694,true,-1,1*1696,2055,true,-1,1*2286,2473,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "247",
                    "mediaDataId": 0,
                    "title": "Multiple myeloma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 61,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 17179,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 714,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 3067,
            "questionIndex": 3067,
            "questionText": "<p>A 58-year-old man comes to the office due to 2 months of exertional shortness of breath and easy fatigability.&nbsp; The patient has no chronic medical problems and takes no medications.&nbsp; He eats a balanced diet.&nbsp; He does not use tobacco, alcohol, or recreational drugs.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows conjunctival pallor and areas of depigmentation on the arms suggestive of vitiligo.&nbsp; The tongue appears shiny.&nbsp; The spleen is not palpable.&nbsp; The remainder of the examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle; padding-left: 2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">7.5 g/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left: 2em;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">110 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle; padding-left: 2em;\">Platelets</td><td style=\"vertical-align:middle;\">135,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle; padding-left: 2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">4,100/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31787\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td><p align=\"center\" style=\"margin-left:4.5pt;\"><strong>Common causes of macrocytic anemia*</strong></p></td></tr><tr><td><ul><li>Folate deficiency</li><li>Vitamin B<sub>12</sub> deficiency</li><li>Myelodysplastic syndromes</li><li>Acute myeloid leukemias</li><li>Drug-induced (eg, hydroxyurea, zidovudine,<br>chemotherapy agents)</li><li>Liver disease</li><li>Alcohol use disorder</li><li>Hypothyroidism</li></ul></td></tr><tr><td><p>*Mean corpuscular volume &gt;100 &#956;m<sup>3</sup>.</p></td></tr></tbody></table></div><p>Macrocytic anemia, mild thrombocytopenia/leukopenia, and glossitis (smooth, shiny tongue) indicate likely <strong>vitamin B<font size=\"2\"><sub>12</sub></font>&nbsp;deficiency</strong>.&nbsp; The leading cause&nbsp;is <strong>pernicious anemia</strong>, due to&nbsp;<strong>antibodies against intrinsic factor</strong> (carrier-protein crucial for vitamin B<font size=\"2\"><sub>12</sub></font> absorption).&nbsp; Most cases occur in <strong>older patients</strong> with other autoimmune conditions (eg, <strong>vitiligo</strong>, autoimmune thyroid disease).</p><p>Vitamin B<font size=\"2\"><sub>12</sub></font> is a crucial cofactor for DNA synthesis, particularly in rapidly dividing cells (eg, hematologic, gastrointestinal).&nbsp; Therefore,&nbsp;significant vitamin B<font size=\"2\"><sub>12</sub></font> deficiency often causes:</p><ul><li><p><strong>Megaloblastic changes</strong> (eg, macrocytosis, hypersegmented neutrophils)&nbsp;due to reduced rates of nuclear division relative to cytoplasmic maturation (nuclear-cytoplasmic desynchrony).&nbsp; Macrocytic erythrocytes are at greater risk for hemolysis, leading to <strong>anemia</strong>; increased rates of apoptosis frequently results in <strong>mild thrombocytopenia and leukopenia</strong>.</p></li><li><p><strong>Glossitis</strong> due to impaired replication of tongue epithelial cells.</p></li></ul><p>Because vitamin B<font size=\"2\"><sub>12 </sub></font>is also required for myelin sheath maintenance, many (but not all) patients with clinically significant B<font size=\"2\"><sub>12 </sub></font>deficiency also have neuropsychiatric findings (sensory ataxia, mood changes).&nbsp; The diagnosis of pernicious anemia can be confirmed by the detection of anti&ndash;intrinsic factor antibodies; parenteral&nbsp;vitamin B<font size=\"2\"><sub>12</sub></font> supplementation is generally curative.</p><p><strong>(Choice B)</strong>&nbsp; Hypothyroidism from autoimmune thyroiditis usually causes normocytic, normochromic anemia (due to bone marrow hypoproliferation).&nbsp; Occasionally, mild macrocytic anemia can occur, but no megaloblastic changes or other signs of vitamin B<font size=\"2\"><sub>12</sub></font> deficiency (eg, glossitis) would be present.&nbsp; Most cases arise in young women.</p><p><strong>(Choice C)</strong>&nbsp; Nutritional folate deficiency, which can also cause megaloblastic anemia, is rare in developed countries due to grain fortification&nbsp;with folate, although folate body stores are lower than those of vitamin B<font size=\"2\"><sub>12</sub></font> and can be depleted in a few months when nutrition is poor (eg, alcohol use disorder).&nbsp; This patient eats a balanced diet and is unlikely to have folate deficiency.</p><p><strong>(Choice D)</strong>&nbsp; Dietary vitamin B<font size=\"2\"><sub>12</sub></font> deficiency is uncommon in those who eat a balanced diet because the vitamin is found in a wide range of animal proteins (eg, meat, dairy, eggs) and total body stores are generally sufficient for &gt;1 year (total stores are 2-5 mg and daily requirement is ~2 &micro;g/day).&nbsp; However, patients with long-standing poor nutrition (eg, alcohol&nbsp;use disorder) or vegan dietary habits may be at risk.</p><p><strong>(Choice E)</strong>&nbsp; Aplastic anemia is associated with the destruction of hematopoietic stem cells, leading to the replacement of bone marrow with fat.&nbsp; Although pancytopenia is common, macrocytosis is rarely seen and glossitis would be atypical.</p><p><strong>Educational objective:</strong><br>Pernicious anemia, associated with auto-antibodies against intrinsic factor, is the most common cause of vitamin B<font size=\"2\"><sub>12</sub></font> deficiency.&nbsp; It occurs most often in older adults with other autoimmune conditions.&nbsp; Manifestations include megaloblastic anemia, atrophic glossitis (smooth, shiny tongue), and/or neurologic abnormalities (eg, paresthesia, subacute combined degeneration).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 9867,
            "topic": "Vitamin b12 deficiency",
            "titleId": 9867,
            "title": "Vitamin b12 deficiency",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoantibodies to intrinsic factor",
                    "choiceNumber": 1,
                    "correctTaken": 8745,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autoimmune (Hashimoto) thyroiditis",
                    "choiceNumber": 2,
                    "correctTaken": 347,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dietary folic acid deficiency",
                    "choiceNumber": 3,
                    "correctTaken": 948,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dietary vitamin B<font size=\"2\"><sub>12</sub></font> deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 1001,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Replacement of bone marrow with fat cells",
                    "choiceNumber": 5,
                    "correctTaken": 1219,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2691,2800,true,-1,1*2564,2618,true,-1,1*2255,2303,true,-1,1*2083,2155,true,-1,1*107,156,true,-1,1*188,198,true,-1,1*235,255,true,-1,1*687,816,true,-1,1*1059,1225,true,-1,1*1293,1668,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "583",
                    "mediaDataId": 0,
                    "title": "Approach to anemia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 37,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 12260,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 659,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 14003,
            "questionIndex": 15405,
            "questionText": "<p>A 4-week-old girl is brought to the clinic for post-hospitalization follow-up.&nbsp; Her mother moved from Greece to the United States for a diplomatic position&nbsp;a few months prior to giving birth.&nbsp; The patient was born at term, and the mother&#39;s prenatal course and delivery were uncomplicated.&nbsp; Due to hyperbilirubinemia, the patient was in the nursery for 3 weeks of phototherapy.&nbsp; Bilirubin was normal at discharge.&nbsp; Since discharge, the girl&#39;s skin and eyes have remained yellow.&nbsp; Maternal blood type is AB, Rh-D positive.&nbsp; Infant blood type is A, Rh-D positive.&nbsp; The patient has been breastfeeding exclusively.&nbsp; Weight and length were at the 50th percentile at 2 weeks of age and remain at the 50th percentile today.&nbsp; Laboratory results today are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">9 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td style=\"vertical-align:middle;\">84 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Reticulocytes</td><td style=\"vertical-align:middle;\">15%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">225,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">9,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">6.5 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Direct bilirubin</td><td style=\"vertical-align:middle;\">0.4 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Hematology</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular hemoglobin concentration</td><td style=\"vertical-align:middle;\">40% Hb/cell</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40923\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hereditary spherocytosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Usually autosomal dominant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Hemolytic anemia</li><li>Jaundice</li><li>Splenomegaly</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&#8593; MCHC</li><li>Negative Coombs test</li><li>Spherocytes on peripheral smear</li><li>&#8593; Osmotic fragility on acidified glycerol lysis test</li><li>Abnormal eosin-5-maleimide binding test</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Folic acid supplementation</li><li>Blood transfusion</li><li>Splenectomy</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MCHC</strong> = mean corpuscular hemoglobin concentration.</p></td></tr></tbody></table></div><p>This infant has jaundice, hemolytic anemia, and elevated mean corpuscular hemoglobin concentration (MCHC) consistent with <strong>hereditary spherocytosis</strong> (HS).&nbsp; HS is due to an inherited <strong>defect in red blood cell</strong> (RBC) <strong>membrane</strong> proteins (eg, spectrin, ankyrin), which results in fragile, sphere-shaped RBCs that become trapped and hemolyzed in the spleen.</p><p>Newborns with HS often have hyperbilirubinemia that requires phototherapy.&nbsp; Although physiologic jaundice is expected in the first week of life due to increased RBC turnover (shorter fetal RBC lifespan) and decreased bilirubin clearance, severe or <strong>prolonged neonatal jaundice</strong> (&gt;1 week) raises suspicion for inherited <strong>hemolytic anemia</strong>.&nbsp; Reticulocytosis on bloodwork confirms hemolysis, and <strong>elevated MCHC</strong> reflects spherocytosis due to membrane loss and RBC dehydration.&nbsp; Other laboratory findings include low to normal mean corpuscular volume, negative direct Coombs test, and spherocytes on peripheral smear.</p><p>Treatment is primarily supportive.&nbsp; RBC or exchange transfusion may be considered for infants with severe hemolysis.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"22256\">ABO incompatibility</a> refers to hemolysis when a mother with blood type O transfers anti-A and/or anti-B antibodies to her fetus with a nonmatching blood type (ie, A, B, AB).&nbsp; In this case, maternal blood type is AB; therefore, the mother has no anti-A or anti-B antibodies to cause hemolysis of fetal RBCs.</p><p><strong>(Choice B)</strong>&nbsp; Beta thalassemia is caused by a defect in the beta globin chain. &nbsp;It is common among patients of Mediterranean heritage and&nbsp;can&nbsp;result in microcytic, nonimmune, hemolytic anemia. &nbsp;However, it does not typically present until after age 6 months when fetal hemoglobin decreases.&nbsp; In addition, MCHC is usually decreased in beta thalassemia.</p><p><strong>(Choice C)</strong>&nbsp; Breastfeeding failure jaundice presents in the first week of life with indirect, nonhemolytic hyperbilirubinemia due to inadequate breastmilk intake, resulting in significant weight loss.&nbsp; This patient&#39;s jaundice has persisted despite appropriate weight gain.</p><p><strong>(Choice D)</strong>&nbsp; Glucose-6-phosphate dehydrogenase (G6PD) deficiency can cause hemolysis and prolonged jaundice in the newborn period but is an X-linked disorder more commonly seen in male patients.&nbsp; In addition, MCHC is typically normal in G6PD deficiency.</p><p><strong>Educational objective:</strong><br>Hereditary spherocytosis (HS) is an inherited disorder caused by a defect in red blood cell membrane proteins, leading to spherocyte formation and hemolysis.&nbsp; Hemolytic anemia with an elevated mean corpuscular hemoglobin concentration in an infant with prolonged neonatal jaundice is suggestive of HS.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7183,
            "topic": "Hereditary spherocytosis",
            "titleId": 7183,
            "title": "Hereditary spherocytosis",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "ABO incompatibility",
                    "choiceNumber": 1,
                    "correctTaken": 557,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Beta thalassemia",
                    "choiceNumber": 2,
                    "correctTaken": 3538,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Breastfeeding failure jaundice",
                    "choiceNumber": 3,
                    "correctTaken": 1018,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose-6-phosphate dehydrogenase deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 1094,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hereditary spherocytosis",
                    "choiceNumber": 5,
                    "correctTaken": 10326,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "868,1129,true,-1,1*2037,2124,true,-1,1*2197,2458,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28847351",
                    "mediaDataId": 0,
                    "title": "Hereditary spherocytosis in the neonatal period: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28847351",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26009624",
                    "mediaDataId": 0,
                    "title": "A pediatrician&#39;s practical guide to diagnosing and treating hereditary spherocytosis in neonates.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26009624",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 16533,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 660,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 2883,
            "questionIndex": 2883,
            "questionText": "<p>A 56-year-old man comes to the office due to an episode of transient right eye blindness that lasted an hour.&nbsp; He has had no weakness in his extremities or speech changes.&nbsp; He last saw a physician 3 years ago.&nbsp; The patient has smoked a pack of cigarettes daily for 30 years.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 160/94 mm Hg, pulse is 78/min, and respirations are 14/min.&nbsp; Pulse oximetry is 98% on room air.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; There is no carotid bruit.&nbsp; Facial plethora is present.&nbsp; Cardiopulmonary examination is normal.&nbsp; Abdominal examination reveals splenomegaly.&nbsp; There is no lower extremity edema, and peripheral pulses are intact.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"350\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>20 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td>60%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>545,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>13,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>141 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.6 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>16 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.7 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>96 mg/dL</td></tr></tbody></table></blockquote><p>In addition to counseling about smoking cessation, which of the following is the best therapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t36742\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Polycythemia vera</strong></p></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>&uarr; Blood viscosity<ul style=\"list-style-type:circle;\"><li><strong>Hypertension</strong></li><li><strong>Erythromelalgia</strong> (burning cyanosis in hands/feet)</li><li>Transient visual disturbances</li></ul></li><li>&uarr; RBC turnover (gouty arthritis)</li><li><strong>Aquagenic pruritus</strong></li><li>Bleeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Examination</strong></p></td><td><ul><li>Facial plethora (ruddy cyanosis)</li><li>Splenomegaly</li></ul></td></tr><tr><td>&nbsp;<p align=\"center\"><strong>Laboratory</strong></p><p align=\"center\"><strong>findings</strong></p></td><td><ul><li><strong>Elevated hemoglobin</strong></li><li>Leukocytosis &amp; thrombocytosis</li><li><strong>Low erythropoietin</strong> level</li><li><strong><em>JAK2</em> mutation</strong> positive</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li><strong>Thrombosis</strong></li><li>Myelofibrosis &amp; acute leukemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li><strong>Phlebotomy </strong></li><li>Hydroxyurea (if &uarr; risk of thrombus)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>RBC</strong> = red blood cell.</p></td></tr></tbody></table></div></p><p><strong>Polycythemia vera</strong> (PV) is a clonal <strong>myeloproliferative</strong> disorder characterized by <strong>erythrocytosis</strong>.&nbsp; Most cases are associated with a <em>JAK2</em> mutation.&nbsp; Patients are often asymptomatic at diagnosis but may present with symptoms related to increased blood viscosity (eg, <strong>transient visual disturbances</strong>, <strong>hypertension</strong>, thrombosis) and increased red blood cell (RBC) turnover (gouty arthritis).&nbsp; Itching after warm showers (aquagenic pruritus) is common.&nbsp; Physical examination often shows <strong>facial plethora</strong> (ruddy cyanosis) and <strong>splenomegaly</strong>.&nbsp; Unlike other causes of erythrocytosis (eg, chronic hypoxia, erythropoietin [EPO]-producing tumors), patients with PV usually have <strong>normal oxygen saturations</strong> and <strong>low EPO levels</strong>.&nbsp; Complete blood count often shows an increase in all 3 cell lines.</p><p>Serial <strong>phlebotomy</strong> is the mainstay of treatment for PV; it creates a relative iron deficiency and reduces hematocrit levels to normal range.&nbsp; Bone marrow suppressive drugs (eg, hydroxyurea) may be added in patients at high risk of thrombosis (eg, previous thrombosis, advanced age).</p><p>The terms polycythemia and erythrocytosis are often used interchangeably; however, not all polycythemia is truly erythrocytosis.&nbsp; Polycythemia implies a laboratory finding of elevated hematocrit and may be diagnosed as relative (usually due to a reduction in plasma volume) or absolute (due to increased RBC production).&nbsp; Only absolute polycythemia involves erythrocytosis (increased RBC mass).&nbsp; Absolute polycythemia/erythrocytosis is seen in patients with PV and secondary polycythemia (eg, chronic hypoxia, EPO-secreting tumors).</p><p><strong>(Choice A)</strong>&nbsp; Anticoagulation is used in the treatment of thromboembolic disease, antiphospholipid antibody syndrome (APLAS), and PV with evidence of thrombotic event.&nbsp; Transient ocular blindness in PV is not an indication for anticoagulation as it is due to microvascular sludging (from severe erythrocytosis), not thromboembolism.&nbsp; APLAS would not cause hypertension, facial plethora, splenomegaly, or thrombocytosis.</p><p><strong>(Choice C)</strong>&nbsp; Plasma exchange removes toxic substances (eg, autoantibodies, immune complexes, endotoxins, cryoglobulins) from plasma.&nbsp; It is used in conditions such as thrombotic thrombocytopenic purpura (characterized by microangiopathic anemia and thrombocytopenia) and hemolytic uremic syndrome (characterized by acute kidney injury).</p><p><strong>(Choice D)</strong>&nbsp; Prednisone is useful in tamping immune activation and is used in managing some forms of autoimmune hemolytic anemia (AIHA).</p><p><strong>(Choice E)</strong>&nbsp; Splenectomy is useful in many antibody-mediated hematologic disorders (eg, AIHA, idiopathic thrombocytopenia).&nbsp; In PV, the primary problem is myeloproliferation within the bone marrow; splenectomy would not reduce the hematocrit.</p><p><strong>Educational objective:</strong><br>Polycythemia vera is a myeloproliferative disorder characterized by erythrocytosis.&nbsp; It often presents with hypertension, transient vision disturbances, aquagenic pruritus, or thrombosis.&nbsp; Facial plethora and splenomegaly are common on physical examination.&nbsp; Treatment is primarily serial phlebotomy; bone marrow suppressive drugs (eg, hydroxyurea) may sometimes be added if there is a high risk of thrombosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 19259,
            "topic": "Polycythemia",
            "titleId": 19259,
            "title": "Polycythemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anticoagulation",
                    "choiceNumber": 1,
                    "correctTaken": 2019,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phlebotomy",
                    "choiceNumber": 2,
                    "correctTaken": 18323,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma exchange",
                    "choiceNumber": 3,
                    "correctTaken": 1308,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisone",
                    "choiceNumber": 4,
                    "correctTaken": 1036,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenectomy",
                    "choiceNumber": 5,
                    "correctTaken": 583,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1463,1603,true,-1,1*2303,2468,true,-1,1*2566,2890,true,-1,1*3037,3148,true,-1,1*3551,3702,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 49,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 23269,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2375,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 4331,
            "questionIndex": 4331,
            "questionText": "<p>A 12-year-old African American boy is brought to the emergency department with back pain, abdominal pain, and dark urine that began earlier this morning.&nbsp; The patient has never had symptoms like these before.&nbsp; Two days ago, he developed fever, runny nose, and cough, for which he took ibuprofen.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 110/60 mm Hg, and pulse is 100/min.&nbsp; The patient appears tired and has scleral icterus.&nbsp; There is clear rhinorrhea.&nbsp; Lung examination is unremarkable.&nbsp; Heart sounds are normal.&nbsp; Abdominal examination reveals mild, diffuse tenderness with palpation, but no rebound tenderness or rigidity.&nbsp; There is no rash.&nbsp; Hemoglobin is 8.2 g/dL.&nbsp; Peripheral blood smear reveals bite cells and red blood cell inclusions on crystal violet staining.&nbsp; Which of the following is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s upper respiratory infection (eg, fever, rhinorrhea, cough) followed a few days later by hemolytic anemia (eg, dark urine, scleral icterus, back/abdominal pain), raises strong suspicion for <strong>glucose-6-phosphate dehydrogenase (G6PD) deficiency</strong>.&nbsp; G6PD is an enzyme that generates NADPH, a cofactor required to make glutathione.&nbsp; Without glutathione, oxidative metabolites (eg, superoxide anion, hydrogen peroxide) accumulate in erythrocytes and denature/precipitate hemoglobin into <strong>Heinz bodies</strong> (dark red erythrocyte inclusions), which reduce erythrocyte flexibility and lead to red cell damage (<a href=\"20406\">bite cells</a>) and lysis in the reticuloendothelial system.</p><p>Although G6PD deficiency is often clinically silent at baseline, patients can develop <strong>episodes of hemolytic anemia</strong> following exposure to <strong>oxidative triggers</strong> such as <strong>infection</strong> (activated leukocytes release reactive oxygen species), medications (eg, trimethoprim-sulfamethoxazole, nitrofurantoin), or certain foods (eg, fava beans).&nbsp; G6PD deficiency is X-linked and affects approximately 10% of <strong>black men</strong> in the United States; it is also commonly seen in those of Mediterranean, Middle Eastern, and Asian descent.</p><p><strong>(Choice A)</strong>&nbsp; Acute intermittent porphyria is an autosomal dominant disorder due to a partial deficiency of a heme biosynthetic enzyme.&nbsp; Patients are largely asymptomatic but may develop episodes of abdominal pain, peripheral neuropathy, and dark red urine.&nbsp; Anemia and bite cells are not typically seen.</p><p><strong>(Choice C)</strong>&nbsp; Hereditary spherocytosis is an autosomal dominant disorder of proteins (eg, spectrin) that provide scaffolding for red blood cells.&nbsp; In this disease, erythrocytes are rigid and get trapped in the fenestrations of the spleen&#39;s red pulp, leading to chronic hemolysis and splenomegaly.&nbsp; Peripheral blood smear shows <a href=\"20407\">spherocytes</a> and increased reticulocytes.</p><p><strong>(Choice D)</strong>&nbsp; Paroxysmal nocturnal hemoglobinuria is a hematopoietic stem cell disease characterized by episodes of complement-mediated hemolysis, which may be triggered by stress or infection.&nbsp; Most patients have fatigue, dark urine, and dyspnea; blood smear shows reticulocytosis; bite cells and Heinz bodies would not be present.</p><p><strong>(Choice E)</strong>&nbsp; Sickle cell crises can be triggered by infection but are usually associated with significant pain.&nbsp; Furthermore, peripheral blood smear would show <a href=\"2550\">sickle cells</a>.</p><p><strong>(Choice F)</strong>&nbsp; Thalassemia minor is caused by mutations to 1 beta or 2 alpha globin chains.&nbsp; Patients are generally asymptomatic, but peripheral blood smear shows microcytic <a href=\"816\">target cells</a>.&nbsp; It is not associated with acute hemolytic anemia.</p><p><strong>Educational objective:</strong><br>Glucose-6-phosphate dehydrogenase deficiency is an X-linked disorder commonly seen in African American men.&nbsp; It is characterized by episodic hemolysis in response to oxidants, drugs, infections, or certain foods (eg, fava beans).&nbsp; Heinz bodies and bite cells are characteristically seen on peripheral blood smear.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16454,
            "topic": "G6PD deficiency",
            "titleId": 16454,
            "title": "G6PD deficiency",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute intermittent porphyria",
                    "choiceNumber": 1,
                    "correctTaken": 539,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose-6-phosphate dehydrogenase deficiency",
                    "choiceNumber": 2,
                    "correctTaken": 13521,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hereditary spherocytosis",
                    "choiceNumber": 3,
                    "correctTaken": 433,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Paroxysmal nocturnal hemoglobinuria",
                    "choiceNumber": 4,
                    "correctTaken": 568,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sickle cell disease",
                    "choiceNumber": 5,
                    "correctTaken": 1350,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thalassemia minor",
                    "choiceNumber": 6,
                    "correctTaken": 228,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "287,693,true,-1,1*857,923,true,-1,1*1025,1204,true,-1,1*1668,1804,true,-1,1*2388,2465,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 71,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 16639,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1150,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 3943,
            "questionIndex": 3943,
            "questionText": "<p>A 65-year-old woman comes to the office due to a month of back pain.&nbsp; The pain is primarily in her lumbar and thoracic spine and is partially relieved with acetaminophen.&nbsp; It is worse with activity and has limited her ability to take restorative yoga classes.&nbsp; The patient has a history of hypertension, type 2 diabetes mellitus, and osteopenia.&nbsp; She takes over-the-counter calcium and vitamin D supplements in addition to prescription medications.&nbsp; The patient had her yearly physical examination 4 months ago; physical and laboratory examinations were normal at that time.&nbsp; Temperature is 36.6 C (97.8 F), blood pressure is 148/82 mm Hg, and pulse is 94/min.&nbsp; The patient is thin but appears well.&nbsp; Mucous membranes are moist.&nbsp; There is no lymphadenopathy in the cervical or supraclavicular chains.&nbsp; Cardiopulmonary and abdominal examinations are normal.&nbsp; There is no focal tenderness over the spine.&nbsp; Muscle strength is 5/5 in all 4 extremities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>10.2 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>220,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>8,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>138 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>4.2 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td>102 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>26 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>30 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>2.5 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td>10.9 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>118 mg/dL</td></tr></tbody></table><p>Urine dipstick is negative and urine sediment is bland except for a few granular casts.&nbsp; Which of the following is the most likely cause of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Multiple myeloma</strong> (MM) is a plasma cell neoplasm.&nbsp; Patients with MM often present with constitutional symptoms (fatigue, weight loss) or <strong>bone pain</strong> (back, chest).&nbsp; MM is characterized by the proliferation of neoplastic cells in the bone marrow (bone destruction, <strong>hypercalcemia, anemia</strong>) and the excessive production of a single immunoglobulin (<strong>monoclonal protein</strong>).&nbsp; The latter can accumulate at high levels in the serum and deposit in the renal tubules.&nbsp; This can result in <strong>renal insufficiency</strong>, often with a bland urinalysis (urine dipstick protein typically detects albumin, not immunoglobulins) that may show evidence of granular casts.&nbsp; The monoclonal protein can also damage the glomeruli (amyloidosis, monoclonal immunoglobulin deposition disease), leading to nephrotic syndrome.</p><p><strong>(Choice A)</strong>&nbsp; Acetaminophen toxicity may occur at high doses.&nbsp; However, it typically affects the liver (hepatitis, jaundice) and would not account for this patient&#39;s hypercalcemia or anemia.</p><p><strong>(Choice B)</strong>&nbsp; Diabetic nephropathy usually develops over many years and is associated with albuminuria.&nbsp; With normal laboratory studies 4 months ago and a bland urinalysis, this patient is unlikely to have diabetic nephropathy.</p><p><strong>(Choice D)</strong>&nbsp; Primary hyperparathyroidism can cause hypercalcemia.&nbsp; However, most patients are asymptomatic or are diagnosed after developing calcium nephrolithiasis.&nbsp; This patient who has hypercalcemia associated with bone pain and anemia is more likely to have multiple myeloma.</p><p><strong>(Choice E)</strong>&nbsp; Systemic lupus erythematosus typically causes glomerular injury resulting in proteinuria and hematuria, often with an increase in creatinine.&nbsp; This patient has a bland urinalysis, making lupus nephritis unlikely.</p><p><strong>(Choice F)</strong>&nbsp; Vitamin D toxicity tends to occur only at exceedingly high doses and is associated with vomiting, confusion, polyuria, and polydipsia.&nbsp; Anemia and renal failure would be uncommon.</p><p><strong>Educational objective:</strong><br>Multiple myeloma is a plasma cell neoplasm.&nbsp; It is characterized by the excessive production of monoclonal protein that can accumulate in the kidneys and cause renal insufficiency.&nbsp; Approximately 50% of patients with multiple myeloma have renal insufficiency at diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3483,
            "topic": "Multiple myeloma",
            "titleId": 3483,
            "title": "Multiple myeloma",
            "topicAttributeId": 330657,
            "topicAttribute": "Plasma cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acetaminophen toxicity",
                    "choiceNumber": 1,
                    "correctTaken": 867,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diabetes mellitus",
                    "choiceNumber": 2,
                    "correctTaken": 575,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Monoclonal protein",
                    "choiceNumber": 3,
                    "correctTaken": 8831,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperparathyroidism",
                    "choiceNumber": 4,
                    "correctTaken": 1043,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic lupus erythematosus",
                    "choiceNumber": 5,
                    "correctTaken": 214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin D toxicity",
                    "choiceNumber": 6,
                    "correctTaken": 1918,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "321,393,true,-1,1*482,665,true,-1,1*667,811,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 63,
            "othersAvgTimeSpent": 104,
            "notes": null,
            "peopleTaken": 13448,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1016,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 18263,
            "questionIndex": 19731,
            "questionText": "<p>An 18-month-old boy is brought to the emergency department due to fatigue.&nbsp; Yesterday, his mother noticed that he was less active, and this morning, he did not want to get out of bed.&nbsp; The patient was born in Uganda, and the family recently moved to the United States.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 74/40 mm Hg, pulse is 190/min, and respirations are 30/min.&nbsp; The patient appears tired.&nbsp; Eye examination shows equal and reactive pupils with bilateral scleral icterus.&nbsp; The oropharynx is clear, and the oral mucosa is pale.&nbsp; The neck is supple, and there are several 1-cm, anterior cervical lymph nodes.&nbsp; The lungs are clear bilaterally, and cardiac examination reveals a 2/6 systolic ejection murmur.&nbsp; Abdominal examination reveals tenderness on the left side.&nbsp; The spleen is palpable at the level of the umbilicus; the liver is not palpable.&nbsp; Bilateral distal pulses are weak.&nbsp; Which of the following would most likely establish this patient&#39;s diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33231\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute splenic sequestration </strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology </strong></p></td><td><ul><li>Complication of sickle cell disease seen in early childhood</li><li>Vasoocclusion within spleen, causing trapping of red blood cells &amp; platelets</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features </strong></p></td><td><ul><li>Abdominal pain</li><li>Palpable splenomegaly</li><li>Signs of anemia (tachycardia, pallor, fatigue)</li><li>Hypotensive shock</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings </strong></p></td><td><ul><li>Acute drop in hemoglobin</li><li>Reticulocytosis</li><li>Thrombocytopenia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Isotonic fluid resuscitation &nbsp;</li><li>Red blood cell transfusion</li><li>&plusmn; Splenectomy</li></ul></td></tr></tbody></table></div><p>This patient has splenomegaly with associated left-sided abdominal tenderness and signs of acute anemia (eg, fatigue, pale mucosa, flow murmur).&nbsp; This presentation most likely represents <strong>acute splenic sequestration crisis</strong> associated with sickle cell disease.</p><p>Splenic sequestration is a potentially <strong>life-threatening </strong>complication of <strong>sickle cell disease </strong>that may be the presenting feature in some children.&nbsp; Because sickled <strong>red blood cells</strong> (RBCs) become <strong>trapped</strong> in the splenic sinuses, a large volume of blood pools in the <strong>spleen</strong>.&nbsp; The spleen rapidly enlarges (ie, <strong>tender splenomegaly</strong>), and <strong>hemoglobin drops acutely</strong> from baseline, resulting in fatigue, pallor, tachycardia, and even shock (eg, hypotension, weak pulses).&nbsp; Platelet counts are often low because of splenic sequestration, and reticulocyte production in the bone marrow increases in response to decreased circulating RBCs.&nbsp; Scleral icterus reflects underlying hemolysis.</p><p><a href=\"4208\">Hemoglobin electrophoresis</a> showing the presence of <strong>hemoglobin S</strong> (HbS) (beta globin gene mutation) confirms the diagnosis of sickle cell disease.&nbsp; HbS polymerization in its deoxygenated state causing RBCs to form a <a href=\"943\">sickle shape</a>.</p><p><strong>(Choice A)</strong>&nbsp; Heart failure can cause shock and can occur with severe anemia.&nbsp; However, signs of fluid overload (eg, tachypnea, crackles) would be present, and hepatomegaly could occur.&nbsp; This patient&#39;s systolic flow murmur due to anemia does not require evaluation with echocardiography.</p><p><strong>(Choice B)</strong>&nbsp; Glucose-6-phosphate dehydrogenase deficiency causes acute hemolytic episodes after oxidative stress (eg, sulfa drugs, fava beans), not seen in this patient.&nbsp; Fatigue and jaundice occur, but dark urine due to hemoglobinuria would be expected, and splenomegaly is rare.</p><p><strong>(Choice C)</strong>&nbsp; Paroxysmal nocturnal hemoglobinuria (PNH), characterized by absent CD55 and CD59 on flow cytometry, is an acquired, complement-mediated hemolytic anemia.&nbsp; Thrombosis (eg, splenic vein, causing splenomegaly) can occur but is rare as a presenting manifestation.&nbsp; In addition, PNH is extremely rare in children, often causes dark urine, and is not typically associated with hypotension and shock.</p><p><strong>(Choice E)</strong>&nbsp; Lymph node biopsy is performed for suspected malignancy (eg, lymphoma).&nbsp; However, this patient&#39;s acute presentation, normal lymph nodes (eg, 1-cm anterior cervical lymph nodes), and signs of hemolysis (eg, scleral icterus) make lymphoma unlikely.</p><p><strong>(Choice F)</strong>&nbsp; Viral hepatitis can cause jaundice and scleral icterus, but hepatomegaly is generally present, and hypotension and splenomegaly with left-sided tenderness would be unusual.</p><p><strong>Educational objective:</strong><br>Splenic sequestration is a potentially life-threatening complication of sickle cell disease, an inherited red blood cell (RBC) disorder characterized by the presence of hemoglobin S on electrophoresis.&nbsp; RBCs become entrapped within the spleen, causing acute anemia and tender splenomegaly.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Echocardiography",
                    "choiceNumber": 1,
                    "correctTaken": 603,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Erythrocyte glucose-6-phosphate dehydrogenase enzyme activity",
                    "choiceNumber": 2,
                    "correctTaken": 1802,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Flow cytometry for paroxysmal nocturnal hemoglobinuria",
                    "choiceNumber": 3,
                    "correctTaken": 488,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin electrophoresis",
                    "choiceNumber": 4,
                    "correctTaken": 11242,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lymph node biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 1773,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral hepatitis panel",
                    "choiceNumber": 6,
                    "correctTaken": 459,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "136,212,true,-1,1*496,754,true,-1,1*1213,1426,true,-1,1*2143,2193,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31985957",
                    "mediaDataId": 0,
                    "title": "Splenic sequestration crisis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31985957",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 141,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 16367,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1080,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 4341,
            "questionIndex": 4341,
            "questionText": "<p>A 17-year-old boy comes to the office due to leg pain in his left thigh for over a year.&nbsp; He first noticed the pain only while running, but it became more frequent and more intense even after walking short distances.&nbsp; For the last 3 weeks, the pain has occurred even while sitting down or lying in bed.&nbsp; He has taken acetaminophen and ibuprofen with no relief.&nbsp; The patient has a history of sickle cell disease and has previously been hospitalized for back, chest, and leg pain, but he says that the current pain is different.&nbsp; Three weeks ago, he had an upper respiratory illness that lasted for 3 days and resolved spontaneously.&nbsp; He does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 110/70 mm Hg, and pulse is 78/min.&nbsp; Height and weight are at the 10th percentile for age.&nbsp; Physical examination demonstrates an alert, uncomfortable adolescent.&nbsp; There is pain on flexion, extension, and rotation of the left hip, with restricted range of motion.&nbsp; Distal pulses and deep tendon reflexes are normal.&nbsp; Gait is notable for a slight limp.&nbsp; Complete blood count shows normocytic anemia with a normal white blood cell count.&nbsp; Which of the following would most likely explain this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t52715\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Avascular necrosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Steroid use</li><li>Alcohol abuse</li><li>Systemic lupus erythematosus</li><li>Antiphospholipid syndrome</li><li>Hemoglobinopathy (eg, sickle cell)</li><li>Infection (eg, osteomyelitis, HIV)</li><li>Kidney transplantation</li><li>Decompression sickness</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Groin pain on weight bearing</li><li>Pain on hip abduction &amp; internal rotation</li><li>No erythema, swelling, or point tenderness</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Normal white blood cell count</li><li>Normal ESR &amp; CRP</li></ul></td></tr><tr><td><p align=\"center\"><strong>Radiologic imaging</strong></p></td><td><ul><li>Crescent sign seen in advanced stage</li><li>MRI is most sensitive modality</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CRP</strong> = C-reactive protein; <strong>ESR</strong> = erythrocyte sedimentation rate.</p></td></tr></tbody></table></div></p><p>This patient most likely has <strong>osteonecrosis</strong>, or <strong>avascular necrosis</strong>, of the left hip due to <strong>sickle cell disease (SCD)</strong>.&nbsp; Osteonecrosis is a common complication of SCD secondary to red blood cell sickling, microinfarctions, and bone hyperplasia.&nbsp; The most common sites are the <strong>humeral</strong> and <strong>femoral heads</strong>.&nbsp; Clinical features typically include chronic <strong>groin, buttock, or thigh pain</strong> that initially occurs with weight bearing but progresses to occurring at rest.&nbsp; Examination demonstrates pain and limited range of motion with internal rotation and abduction of the hip.&nbsp; Because it is a chronic, noninflammatory process, avascular necrosis does not present with erythema or warmth of the joints, leukocytosis, or elevated inflammatory markers.&nbsp; X-rays of the hip may appear normal early in disease, and MRI should be performed to confirm the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; Splenic dysfunction in patients with SCD predisposes them to infections with encapsulated organisms (eg, <em>Streptococcus pneumoniae</em>, <em>Haemophilus influenzae</em>, <em>Neisseria meningitidis</em>).&nbsp; Given this patient&#39;s chronic pain, lack of fever, and normal white blood cell count, septic arthritis is very unlikely.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"7301\">Slipped capital femoral epiphysis (SCFE)</a> results in displacement of the proximal femur due to external shearing forces (eg, obesity, trauma).&nbsp; Patients with SCFE typically report hip or groin pain with weight bearing.&nbsp; Because SCFE relies on an open growth plate, it is more common in younger adolescents than in those of this patient&#39;s age.</p><p><strong>(Choice C)</strong>&nbsp; Femoral neck fractures can predispose to avascular necrosis as they may disrupt vascular flow to the femoral head.&nbsp; These fractures, however, typically occur in older adults and are associated with known trauma.&nbsp; Given the chronic nature of pain without preceding trauma, SCD is a more likely cause of avascular necrosis for this patient.</p><p><strong>(Choice D)</strong>&nbsp; Osteosarcoma is a malignancy that typically presents in adolescents with subacute or chronic lower extremity pain.&nbsp; Osteosarcoma typically involves the distal femur or proximal tibia, however, and patients with SCD are not at higher risk of osteosarcoma than the general population.</p><p><strong>(Choice F)</strong>&nbsp; Reactive arthritis presents with asymmetric arthritis most commonly in the lower extremities after a preceding gastrointestinal infection or genitourinary infection.&nbsp; The chronic nature of this patient&#39;s pain and preceding respiratory illness make reactive arthritis unlikely.</p><p><strong>Educational objective:</strong><br>Osteonecrosis, or avascular necrosis, is a common complication of sickle cell disease.&nbsp; Patients typically report chronic groin, thigh, or buttock pain without warmth or erythema of the joints, leukocytosis, or elevated inflammatory markers.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bacterial infection of the hip joint",
                    "choiceNumber": 1,
                    "correctTaken": 418,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Displacement of the femoral epiphysis",
                    "choiceNumber": 2,
                    "correctTaken": 807,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fracture of the femoral neck",
                    "choiceNumber": 3,
                    "correctTaken": 187,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignancy of the proximal femur",
                    "choiceNumber": 4,
                    "correctTaken": 1522,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osteonecrosis of the femoral head",
                    "choiceNumber": 5,
                    "correctTaken": 12202,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactive arthritis of the hip joint",
                    "choiceNumber": 6,
                    "correctTaken": 922,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "85,139,true,-1,1*175,255,true,-1,1*280,308,true,-1,1*309,350,true,-1,1*480,547,true,-1,1*729,855,true,-1,1*856,914,true,-1,1*1068,1174,true,-1,1*1926,2124,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22619100",
                    "mediaDataId": 0,
                    "title": "Avascular necrosis of the femoral head in sickle cell disease patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22619100",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 137,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16063,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1023,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 4069,
            "questionIndex": 4069,
            "questionText": "<p>An 18-year-old woman comes to the office to establish medical care.&nbsp; The patient had been seeing her pediatrician for annual evaluations and reports no history of serious medical illnesses.&nbsp; She has no symptoms.&nbsp; The patient does not use tobacco, alcohol, or recreational substances.&nbsp; She consumes a balanced diet and exercises regularly.&nbsp; Menses have been irregular and heavy since menarche at age 12.&nbsp; Family history is insignificant.&nbsp; Vital signs are within normal limits.&nbsp; BMI is 24.5 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows no abnormalities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">10.1 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">82 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Mean corpuscular hemoglobin concentration</td><td style=\"vertical-align:middle;\">28%</td></tr><tr><td style=\"padding-left: 2em;\">Reticulocytes</td><td style=\"vertical-align:middle;\">1.5%</td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td style=\"vertical-align:middle;\">380,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Sodium</td><td style=\"vertical-align:middle;\">136 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Potassium</td><td style=\"vertical-align:middle;\">4 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td style=\"vertical-align:middle;\">0.6 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Glucose</td><td style=\"vertical-align:middle;\">80 mg/dL</td></tr></tbody></table><p>Hemoglobin was 12.2 g/dL a year ago.&nbsp; Which of the following is the best next step in diagnosis of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"51602\" src=\"https://www.uworld.com/media/highresdefault/L80214.png\"  ></p><p>This patient has <strong>normocytic anemia</strong> (normal mean corpuscular volume [MCV]), which has a broad differential diagnosis.&nbsp; It is most commonly associated with chronic hematologic or nonhematologic (eg, chronic kidney disease, hypothyroidism, malignancy) disease.&nbsp; However,&nbsp;early blood loss and early stages of nutrient deficiencies (eg, vitamin B<font size=\"2\"><sub>12</sub></font>, iron) can also result in normocytic anemia.&nbsp; <strong>Reticulocyte count</strong> measurement can be helpful in distinguishing between anemia etiologies.&nbsp; A <strong>low</strong> or (as in this case)&nbsp;<strong>inappropriately normal reticulocyte count</strong>&nbsp;suggests disrupted or rate-limited <strong>red blood cell production</strong> (eg, nutrient deficiency, bone marrow disorders).</p><p>Given this patient&#39;s ongoing blood loss (eg, menometrorrhagia), <strong>iron deficiency</strong> is the most likely cause of her anemia.&nbsp; Although iron deficiency is classically associated with microcytosis (MCV &lt;80 &#956;m<font size=\"2\"><sup>3</sup></font>), low MCV is a late indicator seen in long-standing iron deficiency.&nbsp; In contrast, the <strong>earliest</strong> abnormalities include low indicators of <strong>iron stores</strong> (eg, serum ferritin levels, transferrin/total iron-binding capacity), followed by a decrease in hemoglobin.&nbsp; Therefore, in this patient with probable iron deficiency, measurement of <strong>serum iron markers</strong> is indicated and likely to confirm the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; Antiglobulin testing is positive in patients with autoimmune hemolytic anemia, as well as in some patients with hemolytic transfusion reactions and drug-induced hemolytic anemia.&nbsp; These disorders present with normocytic anemia, but the reticulocyte count is usually elevated.</p><p><strong>(Choice B)</strong>&nbsp; Bone marrow biopsy can be used to assess iron stores, but noninvasive tests (ie, serum iron studies) are typically performed first.&nbsp; Biopsy is also used in the evaluation of intrinsic bone marrow disorders (eg, myelodysplasia), but these disorders are much less common than iron deficiency, especially in young patients.</p><p><strong>(Choice C)</strong>&nbsp; Hemoglobin electrophoresis can be used to identify sickle cell trait, sickle cell anemia, and thalassemia.&nbsp; These disorders usually present with significant microcytosis.&nbsp; In addition, this patient&#39;s prior normal hemoglobin measurement makes hemoglobinopathy less likely.</p><p><strong>(Choice D)</strong>&nbsp; Serum folate and vitamin B<font size=\"2\"><sub>12</sub></font> levels are typically used in the evaluation of macrocytic anemia.&nbsp; Early stages of folate and vitamin B<font size=\"2\"><sub>12</sub></font> deficiency can occasionally present with normocytic anemia, but in a young woman with heavy menses, blood loss resulting in iron deficiency is much more likely.</p><p><strong>Educational objective:</strong><br>In early or mild iron deficiency, measures of iron stores (eg, serum ferritin, transferrin/total iron-binding capacity) decrease before measurable changes in red cell indices (eg, mean corpuscular volume [MCV]) are apparent.&nbsp; As iron deficiency progresses, hemoglobin may drop; low MCV is a late indicator seen in long-standing deficiency.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16566,
            "topic": "Iron deficiency anemia",
            "titleId": 16566,
            "title": "Iron deficiency anemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antiglobulin testing",
                    "choiceNumber": 1,
                    "correctTaken": 317,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 141,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin electrophoresis",
                    "choiceNumber": 3,
                    "correctTaken": 563,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum folate level",
                    "choiceNumber": 4,
                    "correctTaken": 32,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum iron studies",
                    "choiceNumber": 5,
                    "correctTaken": 3958,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "299,421,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "583",
                    "mediaDataId": 0,
                    "title": "Approach to anemia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 48,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 5011,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2402,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 3282,
            "questionIndex": 3282,
            "questionText": "<p>A 6-day-old girl is seen in the newborn unit for persistent jaundice.&nbsp; She was born at 39 weeks gestation to a primigravid 17-year-old woman with O+ blood type, who had an unremarkable pregnancy and&nbsp;normal prenatal laboratory results.&nbsp; On the first day of life, the infant developed jaundice on the face that has now spread to below the umbilicus and to the palms.&nbsp; Phototherapy was initiated, but repeated attempts at stopping therapy have resulted in rebound hyperbilirubinemia.&nbsp; The infant is feeding well, has normal urine output, and is passing soft, yellow stool.&nbsp; Temperature is 36.7 C (98 F).&nbsp; Vital signs are normal.&nbsp; On examination, the patient is asleep but easily aroused.&nbsp; The sclerae are icteric.&nbsp; The abdomen is soft and nontender, the liver is nonpalpable, and the spleen is enlarged.&nbsp; The skin shows generalized jaundice.&nbsp; Laboratory results at 24 hours of life showed hemoglobin of 15.7 g/dL, total bilirubin of 13 mg/dL, and direct bilirubin of 0.2 mg/dL.&nbsp; Current laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>10,000/mm<font size=\"2\"><sup>3</sup></font></td><td>(9,400-34,000/mm<font size=\"2\"><sup>3</sup></font>)</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>12 g/dL</td><td>(14.5-22.5 g/dL)</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td>98 &micro;m<font size=\"2\"><sup>3</sup></font></td><td>(95-121 &micro;m<font size=\"2\"><sup>3</sup></font>)</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular hemoglobin concentration</td><td>42% Hb/cell</td><td>(29%-37% Hb/cell)</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>230,000/mm<font size=\"2\"><sup>3</sup></font></td><td></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Red cell distribution width</td><td>18%</td><td>(11.5%-14.5%)</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Reticulocytes</td><td>6%</td><td>(1.8%-4.6%)</td></tr><tr><td colspan=\"3\">Hematology</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood type</td><td>A+</td><td></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Direct Coombs test</td><td>negative</td><td></td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s anemia?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40923\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hereditary spherocytosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Usually autosomal dominant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Hemolytic anemia</li><li>Jaundice</li><li>Splenomegaly</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&uarr; MCHC</li><li>Negative Coombs test</li><li>Spherocytes on peripheral smear</li><li>&uarr; Osmotic fragility on acidified glycerol lysis test</li><li>Abnormal eosin-5-maleimide binding test</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Folic acid supplementation</li><li>Blood transfusion</li><li>Splenectomy</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MCHC</strong> = mean corpuscular hemoglobin concentration.</p></td></tr></tbody></table></div><p>This infant has anemia, jaundice, and splenomegaly, concerning for <strong>hereditary spherocytosis</strong>, a common cause of <strong>hemolytic anemia</strong> in persons of Northern European descent.&nbsp; It is typically an autosomal dominant disorder caused by a <strong>defect</strong> of <strong>red blood cell membrane</strong> proteins (most commonly ankyrin), resulting in unstable, round (rather than biconcave) red blood cells.</p><p>These fragile spherocytes cannot traverse through tight spaces in the microcirculation, such as the spleen, which leads to the <strong>classic triad</strong> of hemolytic anemia, jaundice, and <strong>splenomegaly</strong>.&nbsp; Patients can have symptoms at any time of life, including the newborn period.&nbsp; Specifically, neonates may present with <strong>jaundice</strong> on the first day of life and persistent jaundice <strong>refractory</strong> to standard management (eg, phototherapy).</p><p>Laboratory findings in spherocytosis include anemia, <strong>increased mean corpuscular hemoglobin concentration (MCHC),</strong> indirect hyperbilirubinemia, and negative Coombs test.&nbsp; The increased MCHC is due to membrane loss and cellular dehydration.&nbsp; Reticulocytes are elevated to compensate for hemolysis, and <a href=\"818\">spherocytes</a> are usually present on peripheral smear.&nbsp; The diagnosis is confirmed by abnormal acidified glycerol lysis (osmotic fragility) and eosin-5-maleimide binding tests.</p><p><strong>(Choices A and F)</strong>&nbsp; Isoimmune hemolytic disease of the newborn (eg, ABO incompatibility) and autoimmune hemolytic anemia can cause anemia, reticulocytosis, and indirect hyperbilirubinemia.&nbsp; However, antibody-mediated hemolysis typically causes a positive direct Coombs test, not seen in this patient.</p><p><strong>(Choices B and E)</strong>&nbsp; Most alpha and beta thalassemias are microcytic anemias and are unlikely in an infant with normal mean corpuscular volume.&nbsp; Some thalassemias (eg, alpha thalassemia minima) are mild and may not cause microcytosis; however, these conditions are typically asymptomatic.</p><p><strong>(Choice D)</strong>&nbsp; Pyruvate kinase deficiency and glucose-6-phosphate dehydrogenase deficiency can cause hemolytic anemia due to inherited defects of erythrocyte glycolytic enzymes.&nbsp; However, MCHC would not be elevated.</p><p><strong>(Choice G)</strong>&nbsp; Folate deficiency can cause macrocytic anemia.&nbsp; Patients with hemolytic anemia are at risk of folate deficiency due to high cell turnover; however, this is uncommon in the neonatal period, and laboratory results would show an elevated mean corpuscular volume.</p><p><strong>Educational objective:</strong><br>Hereditary spherocytosis, caused by a defect of red blood cell membrane proteins, often presents with refractory jaundice and splenomegaly on examination and laboratory evidence of a hemolytic anemia with an increased mean corpuscular hemoglobin concentration.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7183,
            "topic": "Hereditary spherocytosis",
            "titleId": 7183,
            "title": "Hereditary spherocytosis",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoantibody-mediated hemolysis",
                    "choiceNumber": 1,
                    "correctTaken": 1012,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decrease in alpha-globin chain production",
                    "choiceNumber": 2,
                    "correctTaken": 367,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Defect of the red blood cell membrane",
                    "choiceNumber": 3,
                    "correctTaken": 11024,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Deficiency in erythrocyte glycolytic enzyme",
                    "choiceNumber": 4,
                    "correctTaken": 1087,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impairment of beta-globin chain production",
                    "choiceNumber": 5,
                    "correctTaken": 516,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incompatibility in maternal-fetal blood types",
                    "choiceNumber": 6,
                    "correctTaken": 2413,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Limited intestinal absorption of folic acid",
                    "choiceNumber": 7,
                    "correctTaken": 82,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1587,1708,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26009624",
                    "mediaDataId": 0,
                    "title": "A pediatrician&#39;s practical guide to diagnosis and treating hereditary spherocytosis in neonates.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26009624",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22055020",
                    "mediaDataId": 0,
                    "title": "Guidelines for the diagnosis and management of hereditary spherocytosis2011 update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22055020",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 73,
            "othersAvgTimeSpent": 101,
            "notes": null,
            "peopleTaken": 16501,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 211,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 4439,
            "questionIndex": 4439,
            "questionText": "<p>A 3-year-old girl is brought to the emergency department for sudden onset of weakness.&nbsp; She was well until this morning, when she woke up and was unable to climb out of bed.&nbsp; Her mother lifted her up, but the child was unable to bear weight on her right leg.&nbsp; She could not grasp her mother&#39;s hand to stand up.&nbsp; The patient has had no recent fevers or upper respiratory symptoms.&nbsp; She was adopted from Nigeria 6 months ago, and family history is unknown.&nbsp; The child has had no hospitalizations or illnesses since her adoption.&nbsp; Her developmental milestones have been appropriate for age.&nbsp; Temperature is 37.2 C (99 F), pulse is 140/min, and respirations are 18/min.&nbsp; The patient is awake and alert but has difficulty articulating.&nbsp; Her head is normocephalic and atraumatic.&nbsp; Pupils are 2 mm and react to light and accommodation.&nbsp; Tympanic membranes and pharynx are clear.&nbsp; Cardiovascular examination demonstrates tachycardia but normal S1 and S2 without murmurs.&nbsp; Lungs are clear on auscultation.&nbsp; There is significant weakness, hypotonia, and hyperreflexia of the right arm and leg.&nbsp; Neuroimaging studies are pending.&nbsp; Which of the following additional tests is most likely to reveal an underlying abnormality in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32197\"><table class=\"table-default-style\"><tbody><tr><td><p align=\"center\"><strong>Common etiologies of pediatric stroke </strong></p></td></tr><tr><td><ul><li>Sickle cell disease</li><li>Prothrombotic disorders</li><li>Congenital cardiac disease</li><li>Bacterial meningitis</li><li>Vasculitis</li><li>Focal cerebral arteriopathy</li><li>Head/neck trauma</li></ul></td></tr></tbody></table></div><p>This patient presents with <strong>acute, focal neurologic deficits</strong>, which should raise concern for <strong>stroke</strong>.&nbsp; Clinical features of stroke typically include <strong>focal weakness</strong>, <strong>hemiparesis</strong>, aphasia, seizures, or altered mental status.&nbsp; Although stroke is more common in older adults, it can occur in children, and the most common cause of pediatric stroke is <strong>sickle cell disease (SCD)</strong>.&nbsp; In addition, this patient&#39;s history of adoption from Nigeria, a country with a high prevalence of SCD, raises the likelihood of SCD.&nbsp; SCD is an autosomal recessive disorder in which a mutation in the beta globin chain of hemoglobin results in hemoglobin polymerization, red blood cell deformation, and microvascular occlusion.&nbsp; Diagnosis of SCD is made via <strong>hemoglobin electrophoresis</strong>, which can confirm the presence of sickle hemoglobin.</p><p>Chronic vasoocclusion can result in endothelial damage, intimal proliferation, and eventual vascular stenosis, which increases the risk of cerebral ischemia, resulting in stroke.&nbsp; If concern for stroke exists, an MRI should be performed to confirm the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; The inflammation present in bacterial meningitis can result in vascular thrombosis and cerebral ischemia.&nbsp; Diagnosis is confirmed by bacterial culture of the cerebrospinal fluid.&nbsp; In the absence of fever, neck stiffness, or photophobia, meningitis is unlikely.</p><p><strong>(Choice B)</strong>&nbsp; Cardiac disorders, most commonly congenital, can cause ischemic stroke via many mechanisms, including cerebral ischemia from decreased cardiac output, paradoxical emboli (venous clot shunted across septum to arterial circulation), infective endocarditis with septic emboli, and intracardiac thrombus.&nbsp; Echocardiography can assess cardiac anatomy and function, but cardiac disorders are unlikely without known cardiac history or murmur.</p><p><strong>(Choice C)</strong>&nbsp; Seizures can be followed by Todd paralysis, which is focal weakness or paresis that typically resolves in minutes to hours after the event.&nbsp; Electroencephalography can assess for intermittent seizures or generalized slowing.&nbsp; Seizure is less likely in this patient given her garbled speech and no history of seizures.</p><p><strong>(Choice E)</strong>&nbsp; Mitochondrial myopathies, specifically mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS), can present with acute neurologic changes, including hemiparesis.&nbsp; Muscle biopsy can confirm this diagnosis.&nbsp; These myopathies are much less common than SCD.&nbsp; Further noninvasive workup (eg, serum lactate/pyruvate, creatine kinase) must be performed before biopsy even if MELAS is suspected.</p><p><strong>(Choice F)</strong>&nbsp; Urea cycle disorders result in hyperammonemia, which can cause acutely altered mental status.&nbsp; Most urea cycle disorders are diagnosed in the newborn period, and hyperammonemia leads to generalized confusion, not focal weakness.</p><p><strong>Educational objective:</strong><br>Sickle cell disease is the most common cause of pediatric stroke, and diagnosis can be confirmed by hemoglobin electrophoresis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cerebrospinal fluid culture",
                    "choiceNumber": 1,
                    "correctTaken": 1595,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiography",
                    "choiceNumber": 2,
                    "correctTaken": 948,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Electroencephalography",
                    "choiceNumber": 3,
                    "correctTaken": 1326,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin electrophoresis",
                    "choiceNumber": 4,
                    "correctTaken": 8626,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Muscle biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 1141,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum ammonia",
                    "choiceNumber": 6,
                    "correctTaken": 542,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "140,160,true,-1,1*172,216,true,-1,1*724,917,true,-1,1*1028,1290,true,-1,1*1668,1875,true,-1,1*2353,2768,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26873822",
                    "mediaDataId": 0,
                    "title": "Sickle cell disease and stroke: diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26873822",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 14178,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 754,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 10046,
            "questionIndex": 10767,
            "questionText": "<p>A 53-year-old woman recently diagnosed with systemic sclerosis comes to the emergency department with headaches, increasing dyspnea, malaise, and nausea.&nbsp; Her medications include lansoprazole for heartburn and nifedipine for finger discoloration and pain.&nbsp; Physical examination reveals a distressed and anxious woman.&nbsp; Her blood pressure is 235/117 mm Hg and pulse is 120/min.&nbsp; She has visible skin tightening over the face, forearms, chest, and legs.&nbsp; She has difficulty opening her mouth due to tightening of the skin around the mouth.&nbsp; Lung examination shows bibasilar inspiratory crackles.&nbsp; Laboratory studies are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"250\"><tbody><tr><td>Hemoglobin</td><td>6.9 g/dL</td></tr><tr><td>Platelets</td><td>57,000/&micro;L</td></tr><tr><td>Leukocytes</td><td>5,700/&micro;L</td></tr><tr><td>Total bilirubin</td><td>2.2 mg/dL</td></tr><tr><td>Creatinine</td><td>3.8 mg/dL</td></tr></tbody></table></blockquote><p>Which of the following red blood cell abnormalities is most likely to be present in the peripheral blood smear?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s marked hypertension and acute kidney injury in the setting of systemic sclerosis (scleroderma) suggests scleroderma renal crisis (SRC), which can occur in up to 20% of patients with diffuse cutaneous systemic sclerosis (SSc).&nbsp; SRC usually occurs within the first 5 years of SSc diagnosis.&nbsp; The likely mechanism involves increased vascular permeability, activation of the coagulation cascade, and increased renin secretion.&nbsp; Patients typically develop sudden onset of renal failure (without previous kidney disease), and malignant hypertension (eg, headache, blurry vision, nausea).&nbsp; Urinalysis can be normal or show mild proteinuria.&nbsp; Peripheral blood smear can show microangiopathic hemolytic anemia (similar to hemolytic uremic syndrome/thrombotic thrombocytopenic purpura) or disseminated intravascular coagulation with fragmented red blood cells (eg, <a href=\"1016\">schistocytes</a>) and thrombocytopenia.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"942\">Burr cells</a> (also known as echinocytes) are spiculated appearing red blood cells (RBCs) with serrated edges that can be seen in liver disease and end-stage renal disease (ESRD).&nbsp; However, burr cells are less common in the acute kidney injury seen in SRC.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"2110\">Howell-Jolly (HJ) bodies</a> are basophilic remnants of the nucleus that appear as small, black pellets in RBCs.&nbsp; They are seen in patients with a history of splenectomy or functional asplenia.&nbsp; HJ bodies are not seen in healthy individuals as a normal spleen efficiently removes them.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"2111\">Spur cells</a> (acanthocytes) are RBCs with irregularly sized and spaced projections that are most commonly seen in liver disease.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"940\">Target cells</a> are red blood cells with a central density surrounded by pallor (bull&#39;s eye appearance).&nbsp; They are usually seen in patients with hemoglobinopathies (eg, thalassemia) or chronic liver disease (especially obstructive liver disease).</p><p><strong>Educational objective:</strong><br>Scleroderma renal crisis typically presents with acute renal failure (without previous kidney disease) and malignant hypertension (eg, headache, blurry vision, nausea).&nbsp; Urinalysis may show mild proteinuria.&nbsp; Peripheral blood smear can show microangiopathic hemolytic anemia with fragmented red blood cells (eg, schistocytes) and thrombocytopenia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3789,
            "topic": "Systemic sclerosis",
            "titleId": 3789,
            "title": "Systemic sclerosis",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Burr cells",
                    "choiceNumber": 1,
                    "correctTaken": 13128,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Howell-Jolly bodies",
                    "choiceNumber": 2,
                    "correctTaken": 8540,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schistocytes",
                    "choiceNumber": 3,
                    "correctTaken": 82418,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Spur cells",
                    "choiceNumber": 4,
                    "correctTaken": 9063,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Target cells",
                    "choiceNumber": 5,
                    "correctTaken": 6753,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "30,178,true,-1,1*290,315,true,-1,1*679,746,true,-1,1*335,466,true,-1,1*1808,1890,true,-1,1*1075,1123,true,-1,1*1612,1633,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": true,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24833760",
                    "mediaDataId": 0,
                    "title": "Scleroderma renal crisis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24833760",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20012923",
                    "mediaDataId": 0,
                    "title": "Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20012923",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 153,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 119902,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 780,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 4858,
            "questionIndex": 4858,
            "questionText": "<p>A previously healthy 1-year-old girl is brought in for a routine evaluation.&nbsp; She drinks 6 glasses of whole milk a day but is a very picky eater.&nbsp; The girl is otherwise developmentally appropriate.&nbsp; She lives with her parents and pet dog in a house built in 2008.&nbsp; The patient&#39;s height and weight are at the 50th percentile for her age and sex.&nbsp; Temperature is 37 C (98.6 F), pulse is 118/min, and respirations are 21/min.&nbsp; Her physical examination is unremarkable.&nbsp; Complete blood count results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"350\"><tbody><tr></tr><tr><td>Hemoglobin</td><td>10.5 g/dL</td></tr><tr><td>Hematocrit</td><td>34%</td></tr><tr><td>Mean corpuscular volume</td><td>70 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Red blood cells</td><td>2 million cells/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Reticulocytes</td><td>0.8%</td></tr><tr><td>Platelets</td><td>250,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Leukocytes</td><td>6,500/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table></blockquote><p>Which of the following is the most appropriate next step in management of this child?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38195\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Iron deficiency anemia in young children </strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Prematurity</li><li>Lead exposure</li><li>Age &lt;1<ul><li>Delayed introduction of solids (ie,&nbsp;exclusive<br />breastfeeding after 6 months)</li><li>Cow&#39;s, soy, or goat&#39;s milk</li></ul></li><li>Age &gt;1<ul><li>&gt;24 oz (&gt;700 mL) per day of cow&#39;s milk</li><li>&lt;3 servings/day of iron-rich foods</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Screening hemoglobin at age 1</li><li>Hemoglobin &lt;11 g/dL (&lt;6.83 mmol/L), &darr;&nbsp;MCV, &uarr;&nbsp;RDW</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Empiric trial of iron supplementation</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MCV</strong> = mean corpuscular volume; <strong>RDW</strong> = red blood cell distribution width.</p></td></tr></tbody></table></div><p><strong>Iron deficiency</strong> is the <strong>most common</strong> nutritional deficiency in children.&nbsp; An infant&#39;s iron stores are affected by the maternal iron stores, prenatal or perinatal hemorrhage, and the gestational age of the infant at delivery; also, prematurity is a risk factor for iron deficiency.&nbsp; Term infants usually have adequate iron stores for the first 6 months of life.&nbsp; After 6 months, inadequate dietary intake becomes the most important cause of iron deficiency.&nbsp; Early introduction or <strong>excessive intake of cow&#39;s milk</strong>&nbsp;is problematic as cow&#39;s milk has low iron content and bioavailability&nbsp;and can cause occult intestinal blood loss in infants.&nbsp; Children should not be started on cow&#39;s milk until age 1 year, and children age &#8805;1 year should consume <strong>&lt;24 ounces/day</strong> (ie, consumption of &gt;24 ounces [700 mL]/day is a risk factor for iron deficiency).&nbsp; A typical glass is about 8 ounces.</p><p>Children with iron deficiency are often asymptomatic and may not have telltale symptoms such as pica, fatigue, or pallor.&nbsp; Therefore, <strong>universal screening</strong> is recommended by age 1 year, and the diagnosis is typically based on a complete blood count, typically showing a low hemoglobin, low mean corpuscular volume, and elevated red blood cell distribution width.&nbsp; The reticulocyte count is classically low (because the bone marrow with iron deficiency cannot increase reticulocyte production), although a low (&lt;2%) reticulocyte index (reticulocyte count &times; hematocrit / normal hematocrit) is a better indicator of hypoproliferative anemia.&nbsp; A peripheral smear would be expected to show <strong>microcytic hypochromic</strong> erythrocytes, although it is usually <strong>not</strong> needed in the initial workup.&nbsp; Further testing (eg, iron studies)&nbsp;is not necessary in children with the classic presentation.&nbsp; The most cost-effective approach to treatment is <strong>empiric oral iron therapy</strong>.&nbsp; Hemoglobin should be rechecked in 4 weeks; if the hemoglobin level has risen 1 g/dL, the oral iron therapy should be continued for 2-3 months after the hemoglobin normalizes to replete iron stores.</p><p><strong>(Choice A)</strong>&nbsp; Blood transfusions are rarely necessary in the treatment of dietary iron deficiency anemia, even when the hemoglobin is as low as 4 g/dL.&nbsp; Iron therapy should be sufficient.</p><p><strong>(Choices B, C, and E)</strong>&nbsp; If the anemia does not resolve with empiric iron therapy and appropriate dietary changes, other causes must be considered.&nbsp; Hemoglobin electrophoresis (for hereditary anemias), colonoscopy (for lower gastrointestinal tract bleeding), or serum creatinine measurement (for renal disease) may be indicated.</p><p><strong>Educational objective:</strong><br>Iron deficiency anemia is common in infants and toddlers who drink excessive amounts of cow&#39;s milk.&nbsp; In addition to a decreased hemoglobin level, a low mean corpuscular volume and red blood cell count are also seen.&nbsp; Treatment consists of empiric oral iron therapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16566,
            "topic": "Iron deficiency anemia",
            "titleId": 16566,
            "title": "Iron deficiency anemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Blood transfusion",
                    "choiceNumber": 1,
                    "correctTaken": 128,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Colonoscopy",
                    "choiceNumber": 2,
                    "correctTaken": 58,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin electrophoresis",
                    "choiceNumber": 3,
                    "correctTaken": 1022,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral iron therapy",
                    "choiceNumber": 4,
                    "correctTaken": 10141,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum creatinine",
                    "choiceNumber": 5,
                    "correctTaken": 108,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "86,111,true,-1,1*968,1385,true,-1,1*1888,2022,true,-1,1*2164,2534,true,-1,1*2545,2720,true,-1,1*195,221,true,-1,1*314,343,true,-1,1*354,365,true,-1,1*404,441,true,-1,1*229,302,true,-1,1*155,194,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20540485",
                    "mediaDataId": 0,
                    "title": "Evaluation of anemia in children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20540485",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20923825",
                    "mediaDataId": 0,
                    "title": "Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20923825",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 57,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 11457,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 89,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 815,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 2864,
            "questionIndex": 2864,
            "questionText": "<p>A 68-year-old man is evaluated for exertional fatigue.&nbsp; He used to play tennis actively but now is having a hard time finishing a set.&nbsp; His only other medical problem is hypertension.&nbsp; He does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 126/86 mm Hg, and pulse is 82/min.&nbsp; Mild mucosal pallor is present.&nbsp; There is no lymphadenopathy.&nbsp; Cardiopulmonary examination is normal.&nbsp; There is no splenomegaly or lower extremity edema.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp; &nbsp; Hemoglobin</td><td>9.4 g/dL</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Mean corpuscular volume</td><td>92 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp; &nbsp;&nbsp;Platelets</td><td>180,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp; &nbsp;&nbsp;Leukocytes</td><td>5,100/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Sodium</td><td>136 mEq/L</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Potassium</td><td>4.4 mEq/L</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Bicarbonate</td><td>26 mEq/L</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Blood urea nitrogen</td><td>14 mg/dL</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Creatinine</td><td>1.3 mg/dL</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Calcium</td><td>10.7 mg/dL</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Glucose</td><td>100 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Total protein</td><td>9 g/dL</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Albumin</td><td>3.7 g/dL</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Total bilirubin</td><td>0.9 mg/dL</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Alkaline phosphatase</td><td>100 U/L</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Aspartate aminotransferase</td><td>30 U/L</td></tr><tr><td>&nbsp; &nbsp;&nbsp;Alanine aminotransferase</td><td>29 U/L</td></tr></tbody></table></blockquote><p>Peripheral blood smear is shown in the <a href=\"4452\">exhibit</a>.&nbsp; Which of the following is most likely to be found on the patient&#39;s bone marrow biopsy?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Multiple myeloma</strong> (MM) is a plasma cell neoplasm that often presents with <strong>constitutional symptoms</strong> (weight loss, fatigue) or bone pain.&nbsp; MM should be suspected in elderly patients with laboratory findings of <strong>hypercalcemia</strong>, <strong>normocytic anemia</strong>, renal insufficiency, and a <strong>protein gap</strong> (difference between total protein and albumin &gt;4 g/dL).&nbsp; A protein gap indicates elevated nonalbumin protein in the serum; it may be seen with polyclonal gammopathies (infection, connective tissue disease) or excessive monoclonal protein (MM, Waldenstr&ouml;m macroglobulinemia).&nbsp; Serum protein electrophoresis (SPEP) can determine if a protein gap is caused by a monoclonal or polyclonal source.&nbsp; In MM, SPEP typically shows a monoclonal spike (<strong>M-spike</strong>).&nbsp; Diagnosis is then confirmed by bone marrow biopsy (<strong>&gt;10% clonal plasma cells</strong>).</p><p>This patient&#39;s peripheral blood smear shows <strong>rouleaux</strong> formation (stacking of red blood cells like coins), a finding seen with elevated serum protein.</p><p><strong>(Choice B)</strong>&nbsp; Patients with myelofibrotic disorders may have hypocellular, fibrotic bone marrow.&nbsp; Manifestations of myelofibrosis include fatigue, anemia, and hepatosplenomegaly.&nbsp; Elevations in protein gap and hypercalcemia are not typical features of myelofibrosis, making MM more likely.</p><p><strong>(Choice C)</strong>&nbsp; In aplastic anemia, bone marrow biopsy often shows a hypoplastic, fat-filled marrow.&nbsp; Despite its name, aplastic anemia causes pancytopenia (not simply anemia).&nbsp; This patient has a normal leukocyte and platelet count.</p><p><strong>(Choice D)</strong>&nbsp; Megaloblastic erythroid hyperplasia is seen in megaloblastic anemia, typically caused by vitamin B<font size=\"2\"><sub>12</sub></font> or folate deficiency.&nbsp; Megaloblastic anemia would cause an elevated mean corpuscular volume (&gt;100 &micro;m<font size=\"2\"><sup>3</sup></font>) and would not explain the protein gap or hypercalcemia.</p><p><strong>(Choice E)</strong>&nbsp; Ring sideroblasts are seen in the sideroblastic anemias, which typically present with microcytic anemia with hemoglobin &lt;7 g/dL.&nbsp; Sideroblastic anemia would not account for the protein gap or hypercalcemia found in this patient.</p><p><strong>Educational objective:</strong><br>Multiple myeloma (MM) is a plasma cell neoplasm that infiltrates the bone marrow and may cause a monoclonal protein elevation (M-spike).&nbsp; MM is associated with hypercalcemia, anemia, renal insufficiency, and an elevated protein gap (&gt;4 g/dL).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3483,
            "topic": "Multiple myeloma",
            "titleId": 3483,
            "title": "Multiple myeloma",
            "topicAttributeId": 330657,
            "topicAttribute": "Plasma cell disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Clonal plasma cell proliferation",
                    "choiceNumber": 1,
                    "correctTaken": 28869,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypocellular and fibrotic bone marrow",
                    "choiceNumber": 2,
                    "correctTaken": 1744,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypoplastic fat-filled marrow",
                    "choiceNumber": 3,
                    "correctTaken": 1058,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Megaloblastic erythroid hyperplasia",
                    "choiceNumber": 4,
                    "correctTaken": 2417,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ring sideroblasts",
                    "choiceNumber": 5,
                    "correctTaken": 1556,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "363,838,true,-1,1*1876,1918,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 61,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 35644,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 504,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 3838,
            "questionIndex": 3838,
            "questionText": "<p>An 11-year-old boy with sickle cell disease is brought to the emergency department with worsening shortness of breath, weakness, and fatigue over the past 3 days.&nbsp; The patient has no fever, cough, or chest pain.&nbsp; He has had many hospitalizations for treatment of acute pain and a hospitalization for acute chest syndrome.&nbsp; Temperature is 36.7 C (98 F).&nbsp; Pulse oximetry is 98% on room air.&nbsp; Physical examination shows a pale, tired-appearing boy.&nbsp; Cardiac examination reveals tachycardia; a 3/6 systolic murmur is heard throughout the precordium.&nbsp; The lungs are clear to auscultation.&nbsp; The abdomen is soft and nontender with no palpable liver or spleen.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>4.5 g/dL</td></tr><tr><td>Reticulocytes</td><td>0.1%</td></tr><tr><td>Platelets</td><td>200,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Leukocytes</td><td>10,000/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34468\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Acute, severe anemia in sickle cell disease </strong></p></td></tr><tr><td><p align=\"center\"><strong>Cause</strong></p></td><td><p align=\"center\"><strong>Reticulocytes</strong></p></td><td><p align=\"center\"><strong>Key features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Aplastic crisis</strong></p></td><td><p align=\"center\">&darr;</p></td><td><ul><li>Transient arrest of erythropoiesis</li><li>Secondary to infection (eg, parvovirus B19)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Splenic sequestration crisis</strong></p></td><td><p align=\"center\">&uarr;</p></td><td><ul><li>Splenic vasoocclusion &rarr; rapidly enlarging spleen</li><li>Occurs in children prior to autosplenectomy</li></ul></td></tr></tbody></table></div><p><strong>Sickle cell disease</strong> (SCD) is characterized by chronic anemia with compensatory reticulocytosis.&nbsp; Patients with SCD have increased red blood cell destruction at baseline and are at risk for acutely worsening, <strong>severe anemia</strong>.&nbsp; An acute drop in hemoglobin accompanied by a <strong>low reticulocyte count</strong> (&lt;1%) <strong>without splenomegaly</strong> is consistent with an <strong>aplastic crisis</strong>, which is characterized by a sudden halt in red blood cell production (erythropoiesis).&nbsp; Anemia is typically severe (&lt;6 g/dL) and patients may have pallor, fatigue, and a functional systolic murmur (due to hyperdynamic blood flow).&nbsp; White blood cell and platelet counts are typically normal.</p><p>The most common cause of an aplastic crisis is <strong>parvovirus B19</strong>, which infects and destroys erythrocyte precursors.&nbsp; Aplastic crises generally present before age 15 as parvovirus outbreaks are most common in school-age children.&nbsp; Although erythema infectiosum (ie, fever, rash) is the classic presentation in children, parvovirus B19 infection can result in an aplastic crisis with no preceding viral symptoms.&nbsp; Blood transfusions are the mainstay of treatment.</p><p><strong>(Choice A)</strong>&nbsp; Acute chest syndrome is caused by pulmonary vasoocclusion or infection, and is characterized by fever, chest pain, and a new infiltrate on chest radiograph.&nbsp; Acute chest syndrome is less likely in patients without fever, cough, or chest pain and with clear lungs on auscultation.</p><p><strong>(Choice B)</strong>&nbsp; Aplastic anemia, in contrast to aplastic crisis, causes pancytopenia (eg, thrombocytopenia, anemia, leukopenia) due to bone marrow failure; the name &#x22;aplastic anemia&#x22; is a misnomer as manifestations are not limited to anemia.&nbsp; Aplastic anemia can be congenital (eg, Fanconi anemia) or acquired (eg, drug-induced, autoimmune).</p><p><strong>(Choice D)</strong>&nbsp; Both primary (eg, idiopathic) and secondary (eg, systemic lupus erythematosus) causes of autoimmune hemolytic anemia present with a dramatic decrease in hemoglobin.&nbsp; However, due to hemolysis, the reticulocyte count is markedly elevated.&nbsp; In addition, patients typically have jaundice due to hyperbilirubinemia from increased red blood cell turnover.</p><p><strong>(Choice E)</strong>&nbsp; Patients with SCD are at risk for cardiac disease due to increased cardiac output secondary to chronic anemia and infarction of myocardial microvasculature.&nbsp; Infarction is more likely in adults and typically presents with chest pain.</p><p><strong>(Choice F)</strong>&nbsp; Splenic sequestration, a condition that occurs in patients with SCD whose spleens have not yet autoinfarcted, is caused by vasoocclusion and pooling of red blood cells in the spleen.&nbsp; Splenic sequestration can cause acute severe anemia; however, patients have an elevated reticulocyte count and a rapidly enlarging spleen.</p><p><strong>Educational objective:</strong><br>Patients with sickle cell disease can develop aplastic crises characterized by an acute drop in hemoglobin, a reticulocyte count &lt;1%, and no splenomegaly.&nbsp; Parvovirus B19 is the most common cause.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute chest syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 973,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aplastic anemia",
                    "choiceNumber": 2,
                    "correctTaken": 1945,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aplastic crisis",
                    "choiceNumber": 3,
                    "correctTaken": 6580,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autoimmune hemolytic anemia",
                    "choiceNumber": 4,
                    "correctTaken": 409,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Myocardial infarction",
                    "choiceNumber": 5,
                    "correctTaken": 108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenic sequestration crisis",
                    "choiceNumber": 6,
                    "correctTaken": 1260,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1968,2067,true,-1,1*1449,1728,true,-1,1*1092,1437,true,-1,1*161,204,true,-1,1*285,328,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21585562",
                    "mediaDataId": 0,
                    "title": "Human parvovirus B19:  general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21585562",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17304869",
                    "mediaDataId": 0,
                    "title": "Clinical presentations of parvovirus B19 infection.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17304869",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 70,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 11275,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 545,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 8878,
            "questionIndex": 8894,
            "questionText": "<p>A 27-year-old woman, gravida 1 para 0, at 9 weeks gestation comes to the clinic for an initial prenatal visit.&nbsp; The patient has mild nausea but is otherwise feeling well.&nbsp; She recently completed law school and is studying for the bar examination.&nbsp; The patient has no known medical conditions and has had no surgeries.&nbsp; Her mother and sister have anemia.&nbsp; The patient eats fish but otherwise usually follows a vegetarian diet.&nbsp; Prior to this pregnancy, menses occurred monthly with 5-6 days of bleeding that was heaviest the first 2 days.&nbsp; The patient does not use tobacco, alcohol, or recreational drugs.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/80 mm Hg, pulse is 76/min, and respirations are 16/min.&nbsp; Examination shows no abnormalities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">9 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">75 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">7,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">300,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Ferritin</td><td style=\"vertical-align:middle;\">110 ng/mL (normal: 12-150)</td></tr><tr><td style=\"vertical-align:middle;\">Iron</td><td style=\"vertical-align:middle;\">90 &micro;g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Total iron binding capacity</td><td style=\"vertical-align:middle;\">310 &micro;g/dL</td></tr></tbody></table><p>Transvaginal ultrasound shows a 9-week intrauterine gestation with normal cardiac activity.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>During <strong>pregnancy</strong>, a mild <strong>physiologic anemia</strong> occurs due to hemodilution (increased plasma volume), but mean corpuscular volume (MCV) does not typically change.&nbsp; Therefore, pregnant patients with <strong>normocytic</strong>, mild anemia do not require additional evaluation.&nbsp; In contrast, microcytic and macrocytic anemias indicate pathology.</p><p>This patient at 9 weeks gestation has <strong>microcytic anemia</strong> (eg, <strong>MCV &lt;80 &micro;m</strong><font size=\"2\"><sup><strong>3</strong></sup></font>).&nbsp; Serum iron studies (eg, iron, ferritin, total iron binding capacity [TIBC]) can help determine the underlying etiology:</p><ul><li><p>Iron deficiency is most common cause of microcytic anemia in pregnancy due to increased demand for red blood cell production.&nbsp; This patient&#39;s normal serum iron level and normal TIBC make iron deficiency unlikely.</p></li><li><p>Anemia of chronic disease is associated with high ferritin (an inflammatory marker) and low iron.</p></li><li><p>Lead toxicity inhibits heme synthesis and causes sideroblastic anemia.&nbsp; Lead toxicity is associated with high serum iron and ferritin because <a href=\"3385\">lead inhibits ferrochelatase</a>, causing iron to accumulate; in contrast, this patient&#39;s serum iron and ferritin are normal <strong>(Choice C)</strong>.</p></li><li><p>Hemoglobinopathy causes anemia due to either abnormal globin production (eg, alpha- or beta-thalassemia) or hemoglobin structure (eg, Hgb S, C, E).</p></li></ul><p>In patients with microcytic anemia but <strong>normal serum iron studies</strong>,<strong> </strong>as seen in this patient, <strong>hemoglobinopathy</strong> is most likely.&nbsp; The best next step is <strong>hemoglobin electrophoresis</strong>, which would confirm the diagnosis and potentially change management.&nbsp; Hemoglobinopathy traits are inherited in an autosomal recessive manner.&nbsp; Therefore, if the mother is identified as a carrier, the father is also tested; and if both parents are carriers, genetic counseling (regarding implications for the offspring) and fetal testing (eg, chorionic villus sampling) are offered.</p><p><strong>(Choices A and E)</strong>&nbsp; Folate and vitamin B<font size=\"2\"><sub>12</sub></font> requirements increase in pregnancy, and deficiency of either causes anemia.&nbsp; Folate deficiency is common with malnutrition or antiepileptic drug use; vitamin B<font size=\"2\"><sub>12</sub></font> deficiency may be seen with poor gastrointestinal absorption (eg, gastric bypass) or inadequate dietary intake of vitamin B<font size=\"2\"><sub>12</sub></font>&ndash;rich animal products (eg, vegetarianism).&nbsp; However, folate and vitamin B<font size=\"2\"><sub>12</sub></font> deficiencies cause macrocytic (MCV &#8805;100 &micro;m<font size=\"2\"><sup>3</sup></font>) anemia.</p><p><strong>(Choice D)</strong>&nbsp; Hypothyroidism typically causes anemia via decreased red blood cell mass with a normocytic MCV (80-100 &micro;m<font size=\"2\"><sup>3</sup></font>) or in association with pernicious anemia (ie, macrocytic).&nbsp; In addition, TSH screening is not recommended for asymptomatic pregnant patients.</p><p><strong>Educational objective:</strong><br>Pregnant patients with microcytic anemia and normal iron studies require evaluation for hemoglobinopathy with hemoglobin electrophoresis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 5413,
            "topic": "Thalassemia",
            "titleId": 5413,
            "title": "Thalassemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Folate level",
                    "choiceNumber": 1,
                    "correctTaken": 2260,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin electrophoresis",
                    "choiceNumber": 2,
                    "correctTaken": 9934,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lead level",
                    "choiceNumber": 3,
                    "correctTaken": 1983,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "TSH level",
                    "choiceNumber": 4,
                    "correctTaken": 1092,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin B<font size=\"2\"><sub>12</sub></font> level",
                    "choiceNumber": 5,
                    "correctTaken": 652,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "199,353,true,-1,1*939,1064,true,-1,1*1532,1844,true,-1,1*2395,2481,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "583",
                    "mediaDataId": 0,
                    "title": "Approach to anemia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34293770",
                    "mediaDataId": 0,
                    "title": "Anemia in pregnancy: ACOG practice bulletin, number 233.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34293770",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23997449",
                    "mediaDataId": 0,
                    "title": "Physiological changes in hematological parameters during pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23997449",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 169,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 15921,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 456,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 3978,
            "questionIndex": 3978,
            "questionText": "<p>A 64-year-old woman comes to the emergency department due to headache and nausea over the past 2 days.&nbsp; Medical history is significant for advanced chronic kidney disease due to diabetic nephropathy and hypertension.&nbsp; She started receiving an erythropoiesis-stimulating agent and iron therapy 3 weeks ago for anemia due to chronic kidney disease.&nbsp; Blood pressure is 210/121 mm Hg and pulse is 76/min.&nbsp; Muscle strength, gait, and sensory examinations are unremarkable.&nbsp; There are no heart murmurs.&nbsp; The lungs are clear to auscultation.&nbsp; Trace bilateral edema is present and is unchanged from her previous visit.&nbsp; The skin is normal.&nbsp; Ophthalmoscopic examination shows bilateral retinal hemorrhages.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\"></td><td style=\"vertical-align:middle;\"><strong>Today</strong></td><td style=\"vertical-align:middle;\"><strong>3 weeks ago</strong></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">11 g/dL</td><td style=\"vertical-align:middle;\">8.3 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">240,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\">234,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">6,300/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\">7,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td style=\"vertical-align:middle;\">5.0 mEq/L</td><td style=\"vertical-align:middle;\">4.9 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td style=\"vertical-align:middle;\">22 mEq/L</td><td style=\"vertical-align:middle;\">22 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td style=\"vertical-align:middle;\">36 mg/dL</td><td style=\"vertical-align:middle;\">34 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">4.1 mg/dL</td><td style=\"vertical-align:middle;\">&nbsp; 4.0 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td style=\"vertical-align:middle;\">8.0 mg/dL</td><td style=\"vertical-align:middle;\">&nbsp; 8.1 mg/dL</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with advanced <strong>chronic kidney disease</strong> (CKD) and new-onset nausea and headache has retinal hemorrhages and a significantly elevated blood pressure consistent with <strong>hypertensive emergency</strong>.&nbsp; Hypertension is common in CKD patients and can be due to a variety of causes that include medication nonadherence; sodium and water retention; increased activity of the renin-angiotensin and sympathetic nervous systems; and an <strong>adverse effect</strong> of <strong>erythropoiesis-stimulating agents</strong> (ESAs) (eg, epoetin, darbepoetin).</p><p>Up to 30% of patients receiving an ESA for CKD-induced anemia develop new or worsening <strong>hypertension</strong>, which typically occurs <strong>2-8 weeks</strong> after treatment initiation.&nbsp; Hypertension is generally mild but can be severe, as in this patient.&nbsp; The mechanism by which ESAs cause hypertension appears to be independent of increased blood volume and likely involves <strong>systemic vasoconstriction</strong> caused by:</p><ul><li>Activation of erythropoietin receptors on vascular smooth muscle cells</li><li>Heightened sensitivity of alpha receptors</li><li>Depletion of endothelium-derived nitric oxide</li></ul><p>The risk of ESA-induced hypertension is increased by large doses and a <strong>rapidly rising hemoglobin</strong> soon after ESA administration, as in this patient whose hemoglobin increased from 8.3 to 11 g/dL in 3 weeks.&nbsp; Following acute treatment of hypertension, subsequent ESA doses should be decreased with a <strong>goal of slowly increasing hemoglobin</strong>.</p><p><strong>(Choice A)</strong>&nbsp; An acute hypertensive response is common with stroke.&nbsp; Cerebellar stroke can present with headache and nausea and/or vomiting; however, it is unlikely in the presence of a normal neurologic examination (eg, no ataxia or other gait disturbance).</p><p><strong>(Choice B)</strong>&nbsp; Cerebral venous sinus thrombosis most commonly affects young women with hypercoagulability risk factors (eg, use of oral contraceptives) and typically causes a headache with or without nausea and/or vomiting.&nbsp; Papilledema (not retinal hemorrhages) is common due to increased intracranial hypertension; systemic hypertension is not a typical feature.</p><p><strong>(Choice D)</strong>&nbsp; Although hypertensive emergency due to a pheochromocytoma may present with headache and retinal hemorrhages, signs and symptoms of a hyperadrenergic state (eg, sinus tachycardia, palpitations, tremor, diaphoresis) are also expected.</p><p><strong>(Choice E)</strong>&nbsp; Tertiary hyperparathyroidism represents progression of the secondary hyperparathyroidism typically present with CKD such that parathyroid hormone secretion is no longer inhibited by serum calcium level.&nbsp; Hypercalcemia is present and may cause mild hypertension (due to vasoconstriction), but hypertensive emergency would be extraordinarily rare.&nbsp; This patient&#39;s serum calcium level is low-normal.</p><p><strong>Educational objective:</strong><br>Hypertension is a common adverse effect of erythropoiesis-stimulating agents.&nbsp; Patients who receive large doses or experience a rapid rise in hemoglobin concentration are at greatest risk.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 4513,
            "topic": "Chronic kidney disease",
            "titleId": 4513,
            "title": "Chronic kidney disease",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cerebellar stroke",
                    "choiceNumber": 1,
                    "correctTaken": 317,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cerebral venous sinus thrombosis",
                    "choiceNumber": 2,
                    "correctTaken": 3025,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication adverse effect",
                    "choiceNumber": 3,
                    "correctTaken": 10848,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pheochromocytoma",
                    "choiceNumber": 4,
                    "correctTaken": 864,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tertiary hyperparathyroidism",
                    "choiceNumber": 5,
                    "correctTaken": 674,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "659,702,true,-1,1*887,1091,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "553",
                    "mediaDataId": 0,
                    "title": "Chronic kidney disease: an overview",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "10213636",
                    "mediaDataId": 0,
                    "title": "Mechanism of erythropoietin-induced hypertension.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/10213636",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "12587817",
                    "mediaDataId": 0,
                    "title": "Erythropoietin-induced hypertensive urgency in a patient with chronic renal insufficiency: case report and review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/12587817",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25416663",
                    "mediaDataId": 0,
                    "title": "Erythropoietin and resistant hypertension in CKD.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25416663",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 66,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 15728,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 480,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 2877,
            "questionIndex": 2877,
            "questionText": "<p>A 63-year-old man comes to the office due to fatigue.&nbsp; Medical history includes hypertension, for which he takes lisinopril, and osteoarthritis of the right knee, for which he has taken naproxen daily for the past 3 months.&nbsp; Blood pressure is 123/78 mm Hg, and pulse is 78/min.&nbsp; Examination shows that the right knee is mildly deformed due to bony overgrowth; there is no focal tenderness or edema.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">9 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">72 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">300,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">7,200/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">1.2 mg/dL</td></tr></tbody></table><p>Which of the following laboratory findings is most likely present in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81835\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"6\"><p align=\"center\"><strong>Iron studies in microcytic anemia</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>MCV</strong></p></td><td><p align=\"center\"><strong>Iron</strong></p></td><td><p align=\"center\"><strong>Ferritin</strong></p></td><td><p align=\"center\"><strong>Transferrin<br>(TIBC)</strong></p></td><td><p align=\"center\"><strong>Transferrin<br>saturation<br>(iron/TIBC)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Iron deficiency</strong></p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">&#8595;</p></td></tr><tr><td><p align=\"center\"><strong>Thalassemia</strong></p></td><td><p align=\"center\">&#8595;&#8595;</p></td><td><p align=\"center\">Normal/&#8593;</p></td><td><p align=\"center\">Normal/&#8593;</p></td><td><p align=\"center\">Normal/&#8595;</p></td><td><p align=\"center\">Normal/&#8593;</p></td></tr><tr><td><p align=\"center\"><strong>Anemia of<br>chronic disease</strong><br>(inflammation)</p></td><td><p align=\"center\">Normal/&#8595;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">Normal/&#8593;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">Normal/&#8595;</p></td></tr><tr><td colspan=\"6\"><p><strong>MCV</strong> = mean corpuscular volume; <strong>TIBC</strong> = total iron binding capacity.</p></td></tr></tbody></table></div><p>This patient with chronic use of <strong>nonsteroidal anti-inflammatory drugs</strong> (NSAIDs) (eg, naproxen) now has fatigue and <strong>microcytic anemia</strong>.&nbsp; The most likely cause is <strong>chronic blood loss</strong> due to NSAID-associated gastropathy, resulting in <strong>iron deficiency</strong>, a common cause of microcytic anemia.</p><p>Expected laboratory studies associated with iron deficiency include the following:</p><ul><li><strong>Low serum iron and ferritin</strong> (which reflects total body iron stores).</li></ul><ul><li><strong>Increased serum transferrin</strong>, which has an inverse relationship with serum iron.&nbsp; Transferrin, the primary iron transport protein in the plasma, is often reported as <strong>total iron-binding capacity</strong> (TIBC).</li></ul><ul><li><strong>Low transferrin saturation</strong>, which is the ratio of serum iron to TIBC.</li></ul><p><strong>(Choice A)</strong>&nbsp; Anemia of chronic disease (ACD) (ie, anemia of inflammation) is characterized by sequestration of iron in response to hepcidin and certain inflammatory cytokines.&nbsp; Serum iron is low, but ferritin is an acute phase reactant that may be increased due to the underlying inflammatory condition.&nbsp; Transferrin is reduced in response to inflammation, so TIBC is low; transferrin saturation is typically normal or mildly low due to reduced circulating iron.&nbsp; The low level of inflammation in osteoarthritis does not usually cause ACD.</p><p><strong>(Choice C)</strong>&nbsp; This combination of markers is not seen because transferrin saturation is the calculated ratio of serum iron to TIBC.&nbsp; As a result, having low iron and a high TIBC must correspond to a low transferrin saturation.</p><p><strong>(Choice D)</strong>&nbsp; An elevated serum iron, ferritin, and transferrin saturation with low TIBC suggests iron overload, as in hemochromatosis.&nbsp; Patients receiving frequent transfusions for anemia related to hemoglobinopathies (eg, thalassemia major) may also develop iron overload, but this would not be seen in a newly diagnosed patient.&nbsp; It is also unlikely that significant thalassemia or another hemoglobinopathy would not be diagnosed until age 63.</p><p><strong>(Choice E)</strong>&nbsp; Given this patient&#39;s significant microcytic anemia, his iron studies would not likely be entirely normal regardless of the diagnosis.</p><p><strong>Educational objective:</strong><br>Nonsteroidal anti-inflammatory drugs can cause chronic blood loss, leading to iron deficiency anemia.&nbsp; Iron deficiency anemia usually demonstrates a low serum iron, low ferritin, elevated total iron-binding capacity (TIBC), and low transferrin saturation (ie, iron/TIBC).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16566,
            "topic": "Iron deficiency anemia",
            "titleId": 16566,
            "title": "Iron deficiency anemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:650px\">\n\t\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 1,
                    "correctTaken": 835,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:650px\">\n\t\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 2,
                    "correctTaken": 3594,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:650px\">\n\t\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 3,
                    "correctTaken": 407,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:650px\">\n\t\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8595;\n\t\t\t</td>\n\t\t\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\t&#8593;\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 4,
                    "correctTaken": 127,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:650px\">\n\t\t<tbody style=\"text-align:center\">\n\t\t<tr>\n\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t\t<td style=\"vertical-align:middle;width:25%\">\n\t\t\t\tNormal\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
                    "choiceNumber": 5,
                    "correctTaken": 69,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1520,1596,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "583",
                    "mediaDataId": 0,
                    "title": "Approach to anemia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 49,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 5032,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:650px\"><tbody style=\"text-align:center\"><tr><td style=\"vertical-align:middle;width:25%\"><strong>Serum iron</strong></td><td style=\"vertical-align:middle;width:25%\"><strong>Serum ferritin</strong></td><td style=\"vertical-align:middle;width:25%\"><strong>Transferrin (total iron-binding capacity)</strong></td><td style=\"vertical-align:middle;width:25%\"><strong>Transferrin saturation</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 472,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 4440,
            "questionIndex": 4440,
            "questionText": "<p>A 32-year-old Italian-American man comes to the office for a routine checkup.&nbsp; The patient is a business executive and has been under significant stress recently.&nbsp; He drinks alcohol occasionally and has a 10-pack-year smoking history.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>10.8 g/dL</td></tr><tr><td>Red blood cell count</td><td>5.7 million cells/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Mean corpuscular volume</td><td>61 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Leukocytes</td><td>5,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Platelets</td><td>170,000/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Serial fecal occult blood tests are negative.&nbsp; Peripheral blood smear is shown in the image below.</p><p><img draggable=\"false\" id=\"6933\" src=\"https://www.uworld.com/media/U925.png\" ></p><p>Which of the following is the best treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35096\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Iron deficiency anemia &amp; thalassemias</strong></p></td></tr><tr><td><p align=\"center\"><strong>Parameter</strong></p></td><td><p align=\"center\"><strong>Iron deficiency<br />anemia</strong></p></td><td><p align=\"center\"><strong>&alpha;-Thalassemia<br />minor</strong></p></td><td><p align=\"center\"><strong>&beta;-Thalassemia<br />minor</strong></p></td></tr><tr><td><p align=\"center\"><strong>MCV</strong></p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">&darr;</p></td></tr><tr><td><p align=\"center\"><strong>RDW</strong></p></td><td><p align=\"center\">&uarr;</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">Normal</p></td></tr><tr><td><p align=\"center\"><strong>RBCs</strong></p></td><td><p align=\"center\">&darr;</p></td><td><p align=\"center\">Normal/&uarr;</p></td><td><p align=\"center\">Normal/&uarr;</p></td></tr><tr><td><p align=\"center\"><strong>Peripheral<br />smear</strong></p></td><td><p align=\"center\">Microcytosis,<br />hypochromia</p></td><td><p align=\"center\">Target cells</p></td><td><p align=\"center\">Target cells</p></td></tr><tr><td><p align=\"center\"><strong>Serum iron<br />studies</strong></p></td><td><p align=\"center\">&darr; Iron &amp; ferritin<br />&uarr; TIBC</p></td><td><p align=\"center\">Normal/&uarr; iron &amp; ferritin<br />(RBC turnover)</p></td><td><p align=\"center\">Normal/&uarr; iron &amp; ferritin<br />(RBC turnover)</p></td></tr><tr><td><p align=\"center\"><strong>Response to iron<br />supplementation</strong></p></td><td><p align=\"center\">&uarr; Hemoglobin</p></td><td><p align=\"center\">No improvement</p></td><td><p align=\"center\">No improvement</p></td></tr><tr><td><p align=\"center\"><strong>Hemoglobin<br />electrophoresis</strong></p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">&uarr; Hemoglobin A<sub>2</sub></p></td></tr><tr><td colspan=\"4\"><p><strong>MCV</strong>&nbsp;=&nbsp;mean corpuscular volume; <strong>RBCs</strong>&nbsp;=&nbsp;red blood cells; <strong>RDW</strong>&nbsp;=&nbsp;red blood cell distribution width; <strong>TIBC</strong>&nbsp;=&nbsp;total iron-binding capacity.</p></td></tr></tbody></table></div><p><strong>Microcytic anemia</strong> (eg, mean corpuscular volume [MCV] &lt;80 &micro;m<font size=\"2\"><sup>3</sup></font>) is most often due to iron deficiency or thalassemia minor.&nbsp; Although both can cause hypochromia and <a href=\"6934\">target cells</a>, <strong>significant microcytosis</strong> in the setting of mild anemia and a normal (rather than low) erythrocyte count suggests <strong>thalassemia</strong> (abnormal alpha- or beta-globin synthesis).</p><p>Thalassemia is classified based on the number and type of globin chains affected.&nbsp; Mutations to 3 or 4 globin genes are usually incompatible with life or require lifelong blood transfusions.&nbsp; In contrast, patients with defects in 1 or 2 of the alpha-globin chains (alpha-thalassemia minima or minor) or 1 beta-globin chain (<strong>beta-thalassemia minor</strong>) are usually asymptomatic.&nbsp; Patients of <strong>Mediterranean descent</strong> (as in this case) are most likely to have beta-thalassemia, whereas patients from Southeast Asia are more likely to have alpha-thalassemia; electrophoresis can confirm the diagnosis.</p><p>Laboratory findings in thalassemia minor typically demonstrate mild hematocrit reduction (&gt;28%), significantly low MCV (55-75 &micro;m<font size=\"2\"><sup>3</sup></font>), and disproportionally elevated red blood cell (RBC) counts.&nbsp; The <strong>disproportionately elevated RBC count</strong> (eg, normal or high rather than low) and decreased MCV help distinguish thalassemia minor from iron deficiency anemia, which does not typically cause microcytosis until hemoglobin is &lt;10 g/dL <strong>(Choice F)</strong>.&nbsp; Patients with thalassemia minor show no improvement in hemoglobin with iron supplementation and <strong>do not require specific treatment</strong>.</p><p><strong>(Choices A and D)</strong>&nbsp; Cobalamin (vitamin B<font size=\"2\"><sub>12</sub></font>) and folic acid deficiency cause macrocytosis rather than microcytosis.</p><p><strong>(Choices B and E)</strong>&nbsp; Deferoxamine is used to treat iron overload in those with transfusion-dependent thalassemia major or sickle cell disease (eg, <a href=\"2699\">sickle cells</a> on smear).&nbsp; Hydroxyurea decreases the frequency and severity of pain crises in patients with sickle cell anemia by increasing hemoglobin F levels.</p><p><strong>(Choice C)</strong>&nbsp; Erythropoietin (EPO) can be used to treat anemia associated with chronic kidney disease or transient bone marrow failure after chemotherapy.&nbsp; EPO level elevations may occur in thalassemia (in response to anemia) but cannot compensate for the hemoglobin defect.</p><p><strong>(Choices G and I)</strong>&nbsp; Prednisone is the treatment of choice for autoimmune hemolytic anemia (eg, spherocytes on smear).&nbsp; Splenectomy can reduce erythrocyte or platelet sequestration in certain hematologic conditions (eg, hereditary spherocytosis, immune thrombocytopenia).</p><p><strong>Educational objective:</strong><br>Thalassemia minor is usually asymptomatic and no treatment is required.&nbsp; Patients typically have mild anemia, low mean corpuscular volume (55-75 &micro;m<font size=\"2\"><sup>3</sup></font>), target cells on peripheral smear, and disproportionately high red blood cell (RBC) count.&nbsp; Iron deficiency anemia is associated with low RBC count and no microcytosis until hemoglobin is &lt;10 g/dL.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 5413,
            "topic": "Thalassemia",
            "titleId": 5413,
            "title": "Thalassemia",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "8",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cobalamin",
                    "choiceNumber": 1,
                    "correctTaken": 88,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Deferoxamine",
                    "choiceNumber": 2,
                    "correctTaken": 478,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Erythropoietin",
                    "choiceNumber": 3,
                    "correctTaken": 194,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Folic acid",
                    "choiceNumber": 4,
                    "correctTaken": 643,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydroxyurea",
                    "choiceNumber": 5,
                    "correctTaken": 1627,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron",
                    "choiceNumber": 6,
                    "correctTaken": 2934,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisone",
                    "choiceNumber": 7,
                    "correctTaken": 290,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance with no specific therapy required",
                    "choiceNumber": 8,
                    "correctTaken": 5649,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenectomy",
                    "choiceNumber": 9,
                    "correctTaken": 1575,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "157,170,true,-1,1*178,195,true,-1,1*239,263,true,-1,1*309,388,true,-1,1*435,464,true,-1,1*499,521,true,-1,1*775,998,true,-1,1*1204,1372,true,-1,1*1373,1590,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20492708",
                    "mediaDataId": 0,
                    "title": "Beta-thalassemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20492708",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 177,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 13478,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 42,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1015,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 18254,
            "questionIndex": 19721,
            "questionText": "<p>A 27-year-old man with sickle cell anemia comes to the emergency department due to increasing dyspnea that started 3 hours ago.&nbsp; The patient was seen in the emergency department 5 days ago for symptomatic anemia, and his hemoglobin level was 6.2 g/dL.&nbsp; He received a blood transfusion, after which his hemoglobin level improved to 8 g/dL, and he was sent home.&nbsp; Temperature is 38.1 C (100.6 F), blood pressure is 105/66 mm Hg, pulse is 112/min, and respirations are 28/min.&nbsp; Oxygen saturation is 97%.&nbsp; The patient appears pale; scleral icterus is present.&nbsp; Lungs are clear.&nbsp; Abdomen is soft and nontender with no hepatosplenomegaly.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">4.5 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Reticulocytes</td><td style=\"vertical-align:middle;\">7%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">327,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bilirubin, indirect</td><td style=\"vertical-align:middle;\">4.5 mg/dL</td></tr></tbody></table><p>Which of the following is the most likely cause of his current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t61409\"><table class=\"table-default-style table-header-footer-style\" style=\"width:504px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Delayed hemolytic transfusion reaction</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Anamnestic antibody response: antibody production against minor RBC antigen to which patient was previously* exposed</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />findings</strong></p></td><td><ul><li>Onset &gt;24 hr to a month after transfusion</li><li>Often asymptomatic</li><li>Fatigue, dyspnea, tachycardia</li><li>Jaundice</li><li>Low-grade fever</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Hemolytic anemia<ul style=\"list-style-type:circle;\"><li>&uarr; Indirect bilirubin, LDH, reticulocyte count</li><li>&darr; Hemoglobin, haptoglobin</li></ul></li><li>New positive direct antiglobulin (Coombs) test</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Supportive (eg, fluids)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention</strong></p></td><td><ul><li>Review transfusion history &amp; prior antibody screens</li><li>Transfuse when necessary with extended-antigen cross-matched blood</li></ul></td></tr><tr><td colspan=\"2\"><p>*Prior transfusion (eg, sickle cell disease), pregnancy, or transplant.</p><p><strong>LDH</strong> = lactate dehydrogenase; <strong>RBC</strong> = red blood cell.</p></td></tr></tbody></table></div><p>This patient with sickle cell disease has symptomatic anemia, indirect hyperbilirubinemia, and low-grade fever days after receiving a blood transfusion.&nbsp; These findings are concerning for a <strong>delayed hemolytic transfusion reaction</strong> (DHTR).</p><p>DHTRs occur in patients who have been previously exposed to a foreign red blood cell (RBC) antigen (eg, <strong>prior transfusion</strong>, pregnancy).&nbsp; The antigen is minor (non-ABO) and typically causes a low, often undetectable antibody response after initial exposure (ie, <a href=\"1151\">alloimmunization</a>, similar to that seen in a Rhesus-negative primigravida with a Rhesus-positive fetus).&nbsp; However, on subsequent exposure via repeat transfusion, an <strong>anamnestic antibody response</strong> occurs in which memory B cells rapidly produce more antibodies; these antibodies bind to donor RBCs, causing extravascular hemolysis.</p><p><strong>Sickle cell disease</strong> patients are at <strong>high risk</strong> of DHTRs due to <strong>frequent exposure</strong> to minor antigens via repeated transfusions.&nbsp; Onset of DHTR is <strong>&gt;24 hours</strong> up to a month <strong>after transfusion</strong>.&nbsp; Most patients are asymptomatic.&nbsp; However, sickle cell disease patients are more likely to have symptomatic, severe anemia due to sickle cell-related intravascular hemolysis in addition to DHTR-related extravascular hemolysis.&nbsp; Symptomatic DHTR causes fatigue, dyspnea, <strong>jaundice</strong>, and <strong>low-grade fever</strong>, with laboratory evidence of hemolysis, including elevated <strong>indirect bilirubin</strong>, lactate dehydrogenase, and <strong>reticulocyte count</strong> as well as decreased haptoglobin.&nbsp; Because these results may be present at baseline in sickle cell disease patients, a <strong>new positive direct antiglobulin (Coombs) test</strong> is important for diagnosing DHTR.</p><p>Management is supportive.&nbsp; Prevention includes thorough review of prior antibody screens and use of extended-antigen cross-matched blood when transfusion is required.</p><p><strong>(Choice B)</strong>&nbsp; Patients with sickle cell disease often have iron overload, not deficiency, due to frequent transfusions.&nbsp; In addition, iron deficiency anemia is associated with a low reticulocyte count.</p><p><strong>(Choice C)</strong>&nbsp; Splenic sequestration in young children with sickle cell disease causes splenomegaly and a rapid drop in hemoglobin with compensatory reticulocytosis.&nbsp; This patient&#39;s age is inconsistent with this diagnosis.</p><p><strong>(Choices D and E)</strong>&nbsp; Transfusion-transmitted parvovirus infection in sickle cell disease can cause a transient aplastic crisis with severe, acute anemia.&nbsp; However, reticulocyte count is low due to decreased erythropoiesis.&nbsp; Transfusion-transmitted viral hepatitis causing jaundice and hepatomegaly is rare due to blood donor screening, and it does not cause anemia.</p><p><strong>Educational objective:</strong><br>Sickle cell disease patients are at high risk of delayed hemolytic transfusion reactions due to alloimmunization from frequent transfusions.&nbsp; Reactions develop &gt;24 hours after transfusion and can cause hemolytic anemia.&nbsp; Diagnosis is confirmed with a newly positive Coombs test.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "1",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Delayed hemolytic transfusion reaction",
                    "choiceNumber": 1,
                    "correctTaken": 3695,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron deficiency anemia",
                    "choiceNumber": 2,
                    "correctTaken": 25,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenic sequestration crisis",
                    "choiceNumber": 3,
                    "correctTaken": 1021,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transfusion-transmitted parvovirus infection",
                    "choiceNumber": 4,
                    "correctTaken": 168,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transfusion-transmitted viral hepatitis",
                    "choiceNumber": 5,
                    "correctTaken": 63,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "82,110,true,-1,1*217,258,true,-1,1*442,488,true,-1,1*535,653,true,-1,1*2791,2997,true,-1,1*3160,3220,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31021439",
                    "mediaDataId": 0,
                    "title": "Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31021439",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30926306",
                    "mediaDataId": 0,
                    "title": "Prevention of delayed hemolytic transfusion reaction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30926306",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 76,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 5049,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1193,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 3786,
            "questionIndex": 3786,
            "questionText": "<p>A 16-year-old boy comes to the emergency department due to a day of severe left thigh pain.&nbsp; He was diagnosed with sickle cell disease during childhood.&nbsp; The boy has had several episodes of unbearable pain in his abdomen, thighs, and lower back that have required 6 separate hospitalizations for pain management and intravenous fluids.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 120/80 mm Hg, pulse is 100/min, and respirations are 16/min.&nbsp; Pulse oximetry shows an oxygen saturation of 97%.&nbsp; Examination shows an uncomfortable-appearing boy.&nbsp; Lungs are clear to auscultation.&nbsp; The left thigh is tender to palpation but has no erythema or swelling.&nbsp; The patient is able to bear weight and has no pain elsewhere.&nbsp; Adequate hydration and analgesics are administered, with improvement of symptoms.&nbsp; On discharge from the hospital, the patient&#39;s hematologist counsels him about starting a first-line medication to decrease the frequency of his pain crisis.&nbsp; What is the most common potential side effect of this first-line medication?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31704\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Management of sickle cell anemia </strong></p></td></tr><tr><td><p align=\"center\"><strong>Maintenance</strong></p></td><td><ul><li>Vaccination</li><li>Penicillin (until age 5)</li><li>Folic acid supplementation</li><li>Hydroxyurea (for patients with recurrent vaso-occlusive crises)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Acute pain crises</strong></p></td><td><ul><li>Hydration</li><li>Analgesia</li><li>+/- Transfusion</li></ul></td></tr></tbody></table></div><p>The hallmark of <strong>sickle cell disease</strong> (SCD) is recurrent, acute, painful episodes due to vaso-occlusion.&nbsp; Acute management consists of hydration and analgesia with nonsteroidal anti-inflammatory drugs and opioids.</p><p><strong>Hydroxyurea</strong> is indicated in patients with frequent pain crises, history of acute chest syndrome, and/or severe symptomatic anemia.&nbsp; The major <strong>beneficial effect</strong> of hydroxyurea is to <strong>increase fetal hemoglobin</strong>.&nbsp; Sickled hemoglobin is therefore proportionally decreased, resulting in reduced polymerization of red blood cells (RBCs) and fewer episodes of vaso-occlusion.&nbsp; Hydroxyurea also decreases the risk of acute chest syndrome and the need for blood transfusions.&nbsp; The primary dose-limiting <strong>side effect</strong> of hydroxyurea is <strong>myelosuppression</strong> (eg, neutropenia, anemia, thrombocytopenia), but it is otherwise relatively safe.</p><p><strong>(Choice A)</strong>&nbsp; Patients with SCD commonly develop renal disease due to sickling of RBCs in the renal medulla.&nbsp; Hydroxyurea is a rare cause of acute kidney injury (AKI), and patients with SCD presenting with AKI should be evaluated for alternative etiologies of AKI (eg, use of nonsteroidal anti-inflammatory drugs, papillary necrosis).</p><p><strong>(Choice B)</strong>&nbsp; Iron overload can also occur as a result of chronic RBC transfusions.&nbsp; Chronic iron overload can result in hemosiderosis-related cirrhosis and cardiomyopathy, and iron chelation therapy should therefore be used in patients with SCD who require chronic transfusion therapy for severe symptomatic anemia.</p><p><strong>(Choice D)</strong>&nbsp; Osteonecrosis in patients with SCD refers to the chronic loss of cartilage and bony tissue at the femoral heads due to avascular necrosis.&nbsp; Patients have progressive hip pain on weight-bearing.&nbsp; Hydroxyurea has no known negative effects on bone formation or growth.</p><p><strong>(Choice E)</strong>&nbsp; Patients with SCD are at increased risk for stroke.&nbsp; Hydroxyurea has been shown to improve transcranial Doppler ultrasound flow (a corollary for risk of stroke in patients with SCD).&nbsp; Hydroxyurea also decreases the risk of recurrent strokes in patients with SCD.</p><p><strong>(Choice F)</strong>&nbsp; Although blood banks routinely screen all products for disease, patients who require blood transfusions are at a slightly increased risk of acquiring viral infections (eg, HIV, hepatitis C).&nbsp; The neutropenia associated with hydroxyurea should not increase the risk of viral infection.</p><p><strong>Educational objective:</strong><br>Hydroxyurea, which works by increasing fetal hemoglobin levels, is indicated in patients with sickle cell disease who have frequent vaso-occlusive crises.&nbsp; It is a relatively safe therapy with a dose-limiting side effect of myelosuppression (neutropenia, anemia, thrombocytopenia).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 8502,
            "topic": "Sickle cell",
            "titleId": 8502,
            "title": "Sickle cell",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute kidney injury",
                    "choiceNumber": 1,
                    "correctTaken": 3032,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron overload",
                    "choiceNumber": 2,
                    "correctTaken": 883,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Myelosuppression",
                    "choiceNumber": 3,
                    "correctTaken": 10626,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osteonecrosis",
                    "choiceNumber": 4,
                    "correctTaken": 580,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stroke",
                    "choiceNumber": 5,
                    "correctTaken": 352,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral infection",
                    "choiceNumber": 6,
                    "correctTaken": 307,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "88,112,true,-1,1*242,257,true,-1,1*405,469,true,-1,1*470,600,true,-1,1*1159,1198,true,-1,1*1260,1423,true,-1,1*1750,1945,true,-1,1*2081,2210,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22517797",
                    "mediaDataId": 0,
                    "title": "Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22517797",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18458271",
                    "mediaDataId": 0,
                    "title": "National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18458271",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 55,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 15780,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 689,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 2872,
            "questionIndex": 2872,
            "questionText": "<p>A 50-year-old man comes to the office due to progressive fatigue and weakness over the past year.&nbsp; He becomes tired early in the day and also finds it difficult to remember things.&nbsp; The patient drinks several beers daily and is vague when prompted to clarify the quantity.&nbsp; He lives in a house with 4 friends.&nbsp; He used to be a line-order cook but has not been employed in several years.&nbsp; Vital signs are within normal limits.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">5,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">7.0 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">22%</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">196,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Red blood cells</td><td style=\"vertical-align:middle;\">1.7 million/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">116 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Mean corpuscular hemoglobin (MCH)</td><td style=\"vertical-align:middle;\">36 pg/cell</td></tr><tr><td style=\"vertical-align:middle;\">Reticulocytes</td><td style=\"vertical-align:middle;\">0.3%</td></tr></tbody></table><p>Peripheral blood smear shows macro-ovalocytes, anisocytosis, poikilocytosis, and basophilic stippling.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31787\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td><p align=\"center\" style=\"margin-left:4.5pt;\"><strong>Common causes of macrocytic anemia*</strong></p></td></tr><tr><td><ul><li>Folate deficiency</li><li>Vitamin B<sub>12</sub> deficiency</li><li>Myelodysplastic syndromes</li><li>Acute myeloid leukemias</li><li>Drug-induced (eg, hydroxyurea, zidovudine,<br>chemotherapy agents)</li><li>Liver disease</li><li>Alcohol use disorder</li><li>Hypothyroidism</li></ul></td></tr><tr><td><p>*Mean corpuscular volume &gt;100 &#956;m<sup>3</sup>.</p></td></tr></tbody></table></div><p>This patient&#39;s presentation is consistent with <strong>macrocytic anemia</strong>, usually suggested by abnormal red blood cell (RBC) indices, including an <strong>elevated </strong>(ie, &gt;100 &micro;m<font size=\"2\"><sup>3</sup></font>)&nbsp;<strong>mean corpuscular volume</strong> (MCV), elevated mean corpuscular hemoglobin (amount of hemoglobin), and normal mean corpuscular hemoglobin concentration (low values seen with microcytosis; elevated values seen with spherocytosis or some hemolytic anemias).</p><p>Macrocytic anemia is due to 2 primary etiologies, which the peripheral blood smear and reticulocyte count findings can help distinguish:</p><ul><li><p><strong>Megaloblastic</strong> causes (eg, impaired DNA synthesis due to deficiency in B12 or folate, crucial one-carbon donors in nucleotide production):&nbsp; <strong>MCV values&nbsp;&gt;110-115 &micro;m<font size=\"2\"><sup>3</sup></font></strong> are almost exclusively associated with these anemias, which are also typically characterized by <strong>low reticulocyte count</strong> (inability to efficiently generate new erythrocytes).</p></li><li><p>Nonmegaloblastic causes (eg, alcohol use, hypothyroidism, drugs, liver disease):&nbsp; These are associated with increased, normal, or decreased reticulocyte count.</p></li></ul><p>Other findings suggestive of megaloblastosis include hypersegmented neutrophils (mean lobe count &gt;5), RBCs of various sizes (anisocytosis) and shapes (poikilocytosis), and basophilic stippling (nonspecific; ribosomal remnants due to impaired erythrocyte maturation).&nbsp; Hemolysis markers (eg, lactate dehydrogenase, indirect bilirubin) may be slightly elevated (increased intramedullary and peripheral hemolysis), and mild thrombocytopenia and leukopenia can occur (increased apoptosis).</p><p>Patients in whom megaloblastic anemia is suspected&nbsp;should undergo serum <strong>vitamin B<font size=\"2\"><sub>12</sub></font> and folate level</strong>&nbsp;testing; methylmalonic acid and homocysteine levels can be added for those with inconclusive or borderline results.&nbsp; Workup for nonmegaloblastic causes can be undertaken when initial evaluation is unrevealing.</p><p><strong>(Choice A)</strong>&nbsp; Lead poisoning is associated with basophilic stippling but&nbsp;would cause microcytic (MCV &lt;80 &micro;m<font size=\"2\"><sup>3</sup></font>) rather than macrocytic anemia.&nbsp; Basophilic stippling can also be due to thalassemia, alcohol use, or vitamin deficiency.</p><p><strong>(Choice B)</strong>&nbsp; Bone marrow biopsy helps diagnose myelodysplasia, which usually causes cytopenia in &#8805;1 cell lines.&nbsp; Although patients can develop macrocytosis, bone marrow biopsy is invasive and would not be performed prior to laboratory workup.</p><p><strong>(Choice C)</strong>&nbsp; Direct antiglobulin test can help diagnose autoimmune hemolytic anemias.&nbsp; Patients typically have hemoglobin of 7-10 g/dL with elevated reticulocyte count, bilirubin, and lactate dehydrogenase.&nbsp; The haptoglobin is also markedly decreased, and peripheral smear usually shows spherocytes.&nbsp; However, it would not cause very high MCV.</p><p><strong>(Choice D)</strong>&nbsp; Measuring iron levels is useful for evaluating patients with microcytic anemia (MCV &lt;80 &micro;m<font size=\"2\"><sup>3</sup></font>).</p><p><strong>Educational objective:</strong><br>Macrocytic anemia can be due to megaloblastic (eg, B<font size=\"2\"><sub>12</sub></font> or folate deficiency) or nonmegaloblastic (eg, alcohol use disorder, hypothyroidism, drugs, liver disease) etiologies.&nbsp; Peripheral smear, reticulocyte count, and B<font size=\"2\"><sub>12</sub></font> and folate levels can aid diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 9867,
            "topic": "Vitamin b12 deficiency",
            "titleId": 9867,
            "title": "Vitamin b12 deficiency",
            "topicAttributeId": 330664,
            "topicAttribute": "Red blood cell disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Blood lead levels",
                    "choiceNumber": 1,
                    "correctTaken": 3019,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 640,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Direct antiglobulin test",
                    "choiceNumber": 3,
                    "correctTaken": 48,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron studies",
                    "choiceNumber": 4,
                    "correctTaken": 300,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum B<font size=\"2\"><sub>12</sub></font> and folate levels",
                    "choiceNumber": 5,
                    "correctTaken": 8310,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "565,717,true,-1,1*1114,1190,true,-1,1*1300,1352,true,-1,1*1620,1836,true,-1,1*2161,2177,true,-1,1*2329,2378,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "583",
                    "mediaDataId": 0,
                    "title": "Approach to anemia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 12317,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 675,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}